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ABSTRACT 
 
 
The cellular network of intermediate filaments (IFs) has been long known to be essential 
for establishing and maintaining cellular organization and tissue integrity. However, the 
functional versatility of the multimember IF protein family has started to emerge, as a 
variety of studies have demonstrated the role of IFs in diverse signaling processes. IFs 
have been shown to interact with receptors, kinases, and other key determinants of 
signal transduction machinery influencing the operation of signaling determinants in 
various processes including stress response and tissue growth. The extensive IF 
network distributed from the nuclear envelope throughout the cytoplasm to the cell 
membrane provides an enormous surface area to be employed as a protein scaffold. 
Furthermore, the highly dynamic nature of IFs at the level of both expression and 
assembly-state renders IFs ideal regulators of cell signaling.  
 
The IF protein nestin is a frequently employed stem and progenitor cell marker, but the 
physiological functions of nestin have remained largely unknown. An interaction between 
nestin and the Cyclin-dependent kinase 5 (Cdk5)/p35 signaling complex had been 
characterized in our laboratory prior to the beginning of this PhD work. Therefore, the 
aim of this thesis was to investigate the functional significance of nestin in the regulation 
of the Cdk5/p35 complex. Using oxidative stress-induced neuronal apoptosis as a model 
system we revealed a prominent antiapoptotic role of nestin deriving from the inhibition 
of detrimental Cdk5 activity. Through its ability to anchor the Cdk5/p35 signaling 
complex, nestin regulated the turnover of p35, the calpain-mediated processing of p35 to 
more stable activator, p25, and the subcellular localization of the Cdk5/p35 complex, 
thereby having a profound influence on Cdk5 activity and targeting. We succeeded also 
in illustrating the mechanisms of Cdk5 activation during myoblast differentiation. Atypical 
protein kinase C  (PKC) was revealed as a master controller of Cdk5 activity. By 
means of p35 phosphorylation and calpain activation, PKC promoted the calpain-
mediated cleavage of p35 to p25, thus enhancing Cdk5 activity. Nestin was observed 
critical for the onset and pace of myoblast differentiation both of which were significantly 
accelerated upon nestin downregulation. The absence of nestin induced a substantial 
increase in the generation of p25 indicating that nestin scaffold sets the pace for 
myoblast differentiation by affecting the p35 processing and Cdk5 activity. Moreover, we 
detected a strong bidirectional interrelationship between nestin and the PKC-Cdk5 
signaling axis in differentiating myoblasts. While nestin appeared to determine the Cdk5 
activation, nestin reorganization and stability where dependent on the PKC-Cdk5 
signaling cascade referring to the ability of Cdk5 to modulate its own activity and 
targeting by regulating the assembly-state and stability of the nestin scaffold. To 
summarize, this PhD thesis greatly expands the understanding of the regulatory 
mechanisms governing the Cdk5 activity introducing nestin and PKC as key 
determinants. Furthermore, this thesis provides novel information about the cellular 
functions of nestin, of which very little is still known, and reinforces the concept of IFs as 
signaling scaffolds.   
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INTRODUCTION 
 
 
Cell signaling is a communication mechanism enabling the transmission of messages 
both within the cells and between the cells. It is critical to all aspects of life; development, 
stress response, regeneration, aging as well as to the maintenance of normal 
homeostasis. By means of signal transduction cells convert chemical and mechanical 
stimuli to specific cellular responses. A diverse range of signaling determinants has been 
characterized and orchestrated into multifactorial signaling pathways converting the 
initial signals to functional modifications in proteins or changes in gene expression 
profiles. These modulations have profound influence on the functions of the cell. 
Disturbances in cell signaling can have detrimental consequences disturbing 
development, causing diseases, such as cancer, or posing a threat of cell death. 
 
The eukaryotic cytoskeleton, composed of microtubules, microfilaments, and 
intermediate filaments (IFs), maintains cell shape, enables cell movements and cell 
division and provides a framework for intracellular trafficking. IFs are encoded by a large 
number of genes, thereby giving rise to a multimember IF protein family. They have 
been long known to be essential for establishing and maintaining the mechanical 
integrity of cells and tissues. However, during the last decade IFs have been proven to 
interact with a vast number of signaling proteins, thus regulating the functions of these 
proteins and the operation of the signaling pathways these proteins represent. This 
intriguing feature of IFs to function as scaffolds for signaling determinants could explain 
the multiplicity and the complex expression patterns of IF proteins, the latter being 
determined by tissue type, developmental stage, and environmental signals. IF proteins 
could provide the cells with customized scaffolding material to adjust the signal 
transduction specifically for each cell type and for the ongoing physiological process. 
 
The emphasis of this PhD thesis is to illustrate that the functions of IFs extend beyond 
their role as structural elements and to introduce the elaborate role of IFs as signaling 
scaffolds. In the experimental part I have investigated the ability of IF protein nestin to 
function as a regulatory scaffold for the Cyclin-dependent kinase 5 (Cdk5)/p35 signaling 
complex critical both in development and disease. As my main model systems I have 
utilized oxidative stress-induced neuronal cell death and myogenic differentiation. In 
addition, I have examined the dynamic interplay between nestin and Cdk5, paying 
attention to the ability of Cdk5 to regulate its own nestin scaffold. Furthermore, this 
thesis describes the upstream regulatory events directing the activation of Cdk5 in 
differentiating myoblasts. In conclusion, the experimental part of my PhD thesis gives 
novel insight into the cellular functions of nestin and the regulation of the Cdk5/p35 
signaling complex as well as broadens the view on IFs as multifunctional signaling 
platforms.    
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REVIEW OF THE LITERATURE 
 
 
1 Intermediate filaments 
 
Intermediate filaments (IFs) represent one of the three cytoskeletal structures found in 
nearly all vertebrate cells, the other two being microtubules (MTs) and microfilaments 
(MFs). IFs are encoded by a large number of genes regulated in an elaborate manner 
(reviewed by Toivola et al., 2005, 2010). Tissue type, developmental stage and various 
external signals determine the IF content of cells, thus indicating distinct and specialized 
functions for different IF proteins. Indeed, although IFs are characteristically resistant to 
mechanical forces and provide cells with mechanical resilience, they are involved in cell 
signaling (reviewed by Pallari and Eriksson, 2006b). IF proteins specifically interact with 
critical signaling determinants, thereby perhaps enabling the cell type and 
developmental stage-specific regulation of signal transduction. The physiological 
importance of IF proteins is reflected by the fact that mutations in IF genes have been 
linked to a significant amount of human pathologies (reviewed by Omary, 2009). During 
the writing process of this thesis, discovered IF mutations were associated with 89 
human diseases according to Human Intermediate Filament Database (Szeverenyi et 
al., 2008, http://www.interfil.org). IF-associated diseases affect a broad range of tissues 
with clinical symptoms varying from skin fragility and liver malfunction to neuronal 
defects, muscular debility and premature aging (Omary, 2009). These human diseases 
as well as different mouse models have had a great impact on the knowledge of IF 
properties and functions.  
 
 
1.1 The diverse family of intermediate filament proteins 
 
The family of IF proteins is composed of 73 unique gene products. Hence, this large 
multimember family belongs to the 100 largest gene families in humans (Omary, 2009). 
The expression of IF proteins is representative for a broad range of metazoans (Kim and 
Coulombe, 2007). The absence of IF network in plants and fungi is hypothesized to stem 
from their tough and rigid cell wall providing structural support (Herrmann et al., 2009). 
More simple metazoans often express a limited number of IF proteins, for example 
nematode Caenorhabditis elegans has 12 genes encoding IF proteins in its genome 
(Carberry et al., 2009). Instead, in higher vertebrates the number of IF genes has 
multiplied during evolution.     
 
IF proteins are grouped into five different sequence homology classes (Table 1). The 
largest number of IF proteins is categorized as type I and type II keratins expressed in 
epithelial cells (reviewed by Moll et al., 2008). In addition, significant amount of keratins 
represent hair follicle specific epithelial keratins and hair keratins (Moll et al., 2008). At 
least one type I and one type II keratin is expressed in each cell type as keratins form 
obligate heteropolymers. Among the most studied keratins are K8 and K18, the major IF 
proteins in single-layered epithelia found in a variety of organs including liver, kidney, 
pancreas, lung, and gastrointestinal track. K8/K18 are coexpressed with or without 
K7/K19/K20 depending on the cell type. Keratinocytes from stratified epithelia express 
K1/K5/K10/K14, K5/K14 being preferentially expressed in basal keratinocytes and 
K1/K10 typifying suprabasal keratinocytes in the upper layers of skin. The expression of 
K6/K16/K17 is triggered in epidermal injuries (Moll et al., 2008).    
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IF 
protein 
type 
 
Proteins 
 
Primary cell/tissue type 
 
I 
 
K9-K28 
K31-K40 
 
 
Epithelial cells 
Hair  
II K1-K8 
K71-K77 
K81-K86 
 
Epithelial cells  
Epithelial cells 
Hair 
III Vimentin 
GFAP 
Desmin 
Peripherin 
Syncoilin 
 
Mesenchymal cells, lens 
Glia cells 
Muscle 
PNS 
Muscle, CNS, PNS 
IV NF-L, NF-M, NF-H 
-internexin 
Nestin 
Synemin 
 
CNS, PNS 
CNS 
Neuroepithelial cells, muscle 
Muscle, CNS 
V Lamins A/C 
Lamins B1, B2 
 
Nuclear lamina of all cells 
Nuclear lamina of all cells 
VI BFSP1, BFSP2 Lens 
             Table 1. The IF protein family. 
 
 
The expression of type III IF protein vimentin defines the cells of mesenchymal, 
endothelial and hematopoietic origin (reviewed by Ivaska et al., 2007). Muscular 
cytoskeleton is typified by the type III IF protein desmin (reviewed by Capetanaki et al., 
2007). Glial fibrillary acidic protein (GFAP) and peripherin, expressed in the astrocytes of 
central nervous system (CNS) and in the nerve cells of peripheral nervous system (PNS) 
respectively, are also categorized to type III IF proteins (reviewed by Liem and Messing, 
2009). GFAP is known to have splice variants, one of them, GFAP-, defining a distinct 
population of CNS astrocytes giving rise to adult neural stem cells (Roelofs et al., 2005). 
Syncoilin is the most recently identified type III IF protein characterized by three isoforms 
which are generated through exon splicing (Kemp et al., 2009). Syncoilin is expressed in 
muscle tissue (Kemp et al., 2009) as well as in both CNS and PNS (Clarke et al., 2010). 
 
The neurofilament (NF) triplet proteins, NF-L, NF-M, and NF-H (for low, medium and 
high with respect to their molecular masses), the most abundant IF proteins in mature 
neurons, represent the type IV IF proteins (reviewed by Perrot et al., 2008). In addition to 
NFs, -internexin, nestin, and synemin are categorized as type IV proteins. -internexin 
is expressed in nervous system (Yuan et al., 2006) whereas nestin expression defines 
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neuronal and muscular progenitor cells (Lendahl et al., 1990, Sejersen and Lendahl, 
1993). Also synemin encodes three different protein isoforms through alternative splicing 
mechanism (Izmiryan et al., 2010). Synemin expression was first described in skeletal 
muscle (Granger and Lazarides, 1980) but has later been reported to occur in the cells 
of CNS during different stages of development (Tawk et al., 2003, Izmiryan et al., 2009, 
2010).  
 
Type V nuclear lamins are not present in the cytoplasm, but instead are the major 
components of the nuclear lamina, filamentous layer associated with the inner nuclear 
envelope (NE; reviewed by Dechat et al., 2008). In addition, lamins can be found in 
throughout the nucleoplasm, although in smaller quantities. A-type lamins (lamins A and 
C) are encoded by the LMNA gene through alternative splicing whereas B-type lamins 
(lamins B1 and B2) are derived from two different genes, LMNB1 and LMNB2 
respectively (Dechat et al., 2008). Lamins are found in all metazoan cells. Whereas the 
expression of B-type lamins is induced during the early phases of development, the 
expression of lamin A/C is executed while differentiation proceeds (Dechat et al., 2008). 
Type VI beaded filament structural proteins 1 and 2 (BFSP1 and BFSP2) constitute the 
IF network in the eye lens (reviewed by Perng et al., 2007, Song et al., 2009). BFSP1 
and BFSP2 are highly divergent from the other IF proteins as indicated by the sequence 
alterations and the formation of unique beaded filaments.  
 
 
1.2 Structure and assembly of intermediate filaments 
 
1.2.1 Structural features of intermediate filament proteins 
 
Albeit drastically differing in primary amino acid sequence, fibrous IF proteins share a 
common tripartite domain organization (Figure 1; reviewed by Kreplak et al., 2004, Parry 
et al., 2007, Herrmann et al., 2007, 2009). They all share the central, -helical rod 
domain flanked by the non--helical amino (N) and carboxy (C)-terminal regions. The 
highly conserved rod domain, common denominator of the IF protein family, display 
pronounced repeats of heptads, where the first and the fourth positions are occupied by 
an amino acid with hydrophobic side chain. These repeats are responsible for the 
generation of a coiled-coil dimer, the initial assembly step of IFs formed by two IF 
proteins wound around each other. The rod domain is divided into four subhelices 
termed coil 1A, coil 1B, coil 2A, and coil 2B (Kreplak et al., 2004, Parry et al., 2007, 
Herrmann et al., 2007, 2009). These are interrupted by linker domains L1, L12, and L2, 
the structures of which remain elusive. Linkers have been suggested to serve as hinges 
promoting the flexibility of a coiled-coil dimer. Stutter is a conserved sequence of four 
amino acids inserted in the coil 2B. Highly conserved sequences are pinpointed at both 
ends of the rod domain. Mutations in these highly conserved sequences inhibit the 
generation of functional IF network (Kreplak et al., 2004, Parry et al., 2007, Herrmann et 
al., 2007, 2009).  
 
Contrary to the conserved rod domain consisting of ~310 amino acids, the distal regions 
show considerable variation in both size and amino acid composition, thus contributing 
to the diversity of the IF protein family. The lengths of the N-terminal head domains vary 
from few amino acids in human nestin to 167 amino acids observed in K5. The variation 
in the C-terminal tail domains is even more pronounced as indicated by K19 with a 15 
amino acid long tail and human nestin with a tail domain longer than 1300 amino acids 
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(Herrmann et al., 2009). These less conserved domains have been suggested to be 
involved in the specific functions of individual IF proteins. The nuclear lamins are known 
to differ structurally from cytoplasmic IF proteins (Dechat et al., 2008). Within their C-
terminal tail they have a structural motif resembling immunoglobulin fold and a nuclear 
localization signal responsible for nuclear transport. Furthermore, lamins are expressed 
as pre-lamins which are subjected to modification and processing during protein 
maturation (Dechat et al., 2008).  
 
 
Figure 1. Domain organization of an IF molecule (A) and IF dimer (B). (A) The figure represents the 
prevailing model of an IF molecule. Boxes represent the four subhelices of the central rod domain, coil 1A, 
coil 1B, coil 2A, and coil 2B, whereas the grey segments denote the highly conserved sequences. Sub-
helices are separated by the linker regions L1, L12, and L2. Stutter is the conserved segment inserted in the 
coil 2B. “Head” and “tail” indicate the non--helical distal regions. (B) The model depicts the structure of a 
vimentin-like IF dimer. According to the most recent crystallographic studies, the segments termed coil 2A, 
L2, and coil 2B appear to constitute a continuous coiled-coil, coil 2, with a short paired bundle (pb) formed 
by the segments coil 2A and L2. Positively charged distal domains bend towards the more negatively 
charged rod domain (modified from Herrmann et al., 2009). 
 
 
1.2.2 Assembly of intermediate filaments 
 
The assembly of IFs is initiated when the rod domains of two IF proteins interact in a 
parallel fashion to form a coiled-coil dimer (Figure 1; reviewed by Kreplak et al., 2004, 
Parry et al., 2007, Herrmann et al., 2007, 2009). Dimers interact to form anti-parallel 
half-staggered tetramers that interact laterally to form unit-length filaments (ULFs; Figure 
2). One ULF is composed of an average of eight tetramers. After the longitudinal end-to-
end annealing of ULFs to longer filaments, occurs a phase of radial compaction when 
the filament diameter is reduced from approximately 17 nm to 10 nm due to molecular 
rearrangements. The 10 nm diameter reflects mature IFs and clarifies the origin of the 
name “intermediate filament” falling in between 25 nm diameter MTs and 9 nm diameter 
MFs. The assembly of nuclear lamins differs from the cytoplasmic IFs involving 
simultaneous lateral and longitudinal interactions between dimers with tendency to head-
to-tail interactions (Kreplak et al., 2004, Parry et al., 2007, Herrmann et al., 2007, 2009). 
Besides the numerous in vitro studies, carried out to thoroughly understand the distinct 
steps of IF assembly, IF formation has been intensively surveyed in vivo. Different 
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structural forms of IFs have been identified in cell model systems. Type III IF proteins 
have been shown to exist as non-filamentous particles, short filaments and long 
filaments (reviewed by Kreplak et al., 2004, Goldman et al., 2008). During the initial 
phases of cell spreading on substratum the IF particles are connected to short filaments 
that subsequently become linked to longer IFs. Although the exact nature of IF particles 
and short filaments is unknown it has been proposed that the non-filamentous particles 
would be composed of ULF-like precursors which, in turn, would anneal to produce 
longer filaments (Kreplak et al., 2004, Goldman et al., 2008).  
 
 
 
 
 
Figure 2. Schematic presentation of the phases of cytoplasmic IF assembly. The assembly of 
cytoplasmic IFs can be divided into three major phases. In the first phase an average of eight tetramers 
associates laterally into ULFs, followed by a second phase where ULFs and short filaments anneal 
longitudinally to longer filaments. The mature IF structure is accomplished in the third phase with the radial 
compaction of filaments (adapted from Herrmann et al., 2009). 
 
 
In contrast to most type III IF proteins assembling into homopolymers, keratins form 
obligate heteropolymers containing one acidic (type I) and one basic (type II) keratin. 
The loss of one keratin leads to the instability of the partner (Strnad et al., 2008). Type 
IV proteins nestin and synemin form filaments with type III IF proteins (Bellin et al., 1999, 
Steinert et al., 1999, Jing et al., 2007). Considering the established importance of the N-
terminus in IF assembly (Herrmann et al., 1996, Mücke et al., 2004) and the short head 
Longitudinal annealing of ULFs and short filaments
Lateral association of tetramers into ULFs
Radial compaction of extended filaments
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domains of nestin (Steinert et al., 1999) and synemin (Khanamiryan et al., 2008) it 
seems evident that nestin and synemin do not assemble into homopolymers. NF triplet 
proteins exhibit a complex assembly pattern where four IF proteins are incorporated into 
the same filament, the fourth being -internexin or peripherin (Perrot et al., 2008). The 
dissimilarities in assembly processes are expected to prevent the formation of mixed IFs 
within the cells (Herrmann et al., 2009).           
 
In addition to the amount of subunits, there are fundamental differences in the assembly 
and properties of the three cytoskeletal networks. MTs and MFs are polarized structures 
enabling vesicular transport along them whereas cytoplasmic IFs are non-polar due to 
the antiparallel interaction between dimers (Herrmann et al., 2007). The polymerization 
of MT and MF subunits, tubulin and actin respectively, occurs on both ends of the 
filaments, one end growing more rapidly than the other. IFs lengthen by end-to-end 
annealing of ULFs or longer filaments but exhibit also intercalary subunit exchange 
along the length of entire filament indicating a topologically open architecture (Colakoğlu 
and Brown, 2009). Furthermore, the ability of IFs to polymerize into filaments requires 
neither energy nor accessory cofactors contrary to MTs and MFs the dynamics of which 
are depended on nucleotide hydrolysis. Different biophysical analyses have given insight 
into the special features of IFs (reviewed by Herrmann et al., 2007, Kreplak and Fudge, 
2007). It has been long known that IFs remain highly insoluble in buffers with high salt 
concentration or ionic detergents where MTs and MFs become disassembled. Moreover, 
accumulating evidence implies that the ability of IFs to resist applied forces is increased 
compared to MTs and MFs. A phenomenon of strain stiffening has been described with 
IFs. When mechanical stress is directed to IFs, filaments are not broken but instead 
become viscoelastic showing extensibility that can not be seen with MTs and MFs 
(Herrmann et al., 2007, Kreplak and Fudge, 2007). The mechanical properties of 
filaments composed of distinct IF proteins differ, thus indicating that the selection of IF 
proteins may reflect the mechanical stress experienced by the tissue (Schopferer et al., 
2009).  
 
 
1.3 Intermediate filaments maintain tissue integrity and cytoplasmic 
organization  
 
The IF network is not a separate structural entity but instead IFs appear to form a 
cellular framework closely connected to other cytoskeletal systems as well as to different 
structural elements and cell organelles. IF-associated proteins (IFAPs) are utilized as 
linker proteins and mediate many of these interactions (reviewed by Green et al., 2005). 
Periplakin, plectin and desmoplakin, proteins of the plakin family, are well-established in 
bridging IFs to MTs, MFs, adhesion sites, and cell organelles (Figure 3; reviewed by 
Sonnenberg and Liem, 2007). The essential functions of IFs, abilities to maintain the 
integrity of the cells and tissues and to provide organization for cell interior, are 
dependent on IF interactions.  
 
IFs interact closely with different cell membrane structures. Keratins are tethered to 
desmosomes, complexes at cell-cell junctions, and to hemidesmosomes, cell-
substratum contacts. Desmosomes utilize Ca2+-dependent adhesion molecules, 
desmogleins and desmocollins for cell-cell interaction. The tails of these proteins 
associate with plakoglobin and plakophilin, both of which, in turn, interact with the plakin 
family members linking keratin cytoskeleton to the junctions. At hemidesmosomes 
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plectin connects keratin filaments to integrins (reviewed by Sonnenberg and Liem, 2007, 
Green and Simpson, 2007). Keratin interactions to cell membrane structures are 
important in the formation of a well-anchored network stabilizing epithelial tissues. This 
became evident when the symptoms of the skin blistering disease epidermolysis bullosa 
simplex (EBS) were realized to derive form mutations in epidermal K5 and K14 
(Coulombe et al., 1991, reviewed by Pekny and Lane, 2007, Coulombe et al., 2009). As 
a consequence of these mutations, the most severe ones enhancing keratin 
aggregation, skin keratinocytes are extremely fragile and the patients suffer skin 
blistering. Stretch induced aggregation of K14 bearing EBS-mutation was connected to a 
subsequent collapse of cell-cell and cell-substratum contacts (Russell et al., 2004). 
Hence, the interactions with adhesion structures seem to define the capacity of keratins 
to resist and distribute the forces of mechanical stress throughout the epithelial tissue 
(Green and Simpson, 2007). Considering the general properties of IFs, being extended 
and strong although flexible, IFs can be stated ideal for providing mechanical resilience 
to cells and tissues (Goldman et al., 2008). 
 
 
 
Figure 3. Hypothetical cell depicting the role of IFs in tissue stability and cytoplasmic organization. 
The three cytoskeletal systems, MTs, MFs and IFs, are connected to each other by IFAPs. IFs are anchored 
to desmosomes at cell–cell junctions and hemidesmosomes at cell–matrix junctions. The transmembrane 
proteins mediating the association between the neighboring cells and with the extracellular matrix (ECM) are 
cadherins and integrins, respectively. In addition, IFs are coupled to the NE and lamins through IFAPs and 
lamin/NE-binding proteins. IFs anchor cell organelles, mitochondria and the Golgi apparatus, as well as work 
as a regulatory scaffold for vesicular transport systems. (ER, endoplasmic reticulum; MTOC, microtubule-
organizing center; modified from Herrmann et al., 2007.) 
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In cardiac muscle desmin is tethered to intercalated discs, adhesion structures 
connecting the adjacent cells in myocardium (reviewed by Capetanaki et al., 2007). 
Desmin filaments seem to regulate the cellular organization rather comprehensively by 
integrating key elements of muscle tissue. Distinct plectin isoforms anchor desmin to 
costameres, protein complexes on muscle plasma membrane, and to myofibrils, thereby 
connecting the cell membrane and the contractile apparatus (Konieczny et al., 2008). 
Synemin is similarly tethered to adhesive structures, but instead of binding to IFAPs, the 
long C-terminal tail of synemin interacts directly with vinculin and talin localized on 
costameres as well as with -actinin at Z-discs (Bellin et al., 1999, Sun N et al., 2008a, 
2008b). These interactions of synemin have been suggested to strengthen the 
association of desmin/synemin heteropolymers to costameres. As desmin integrates the 
functional elements of muscle tissue and is suggested to participate in the transmission 
of contractile forces, it is no surprise that desmin mutations lead to severe malfunctions, 
cardiac and skeletal myopathies (reviewed by Paulin and Li, 2004, Goldfarb and 
Dalakas, 2009). 
 
IFs extend from the NE throughout the cytoplasm to the cell membrane. The outer 
nuclear membrane protein nesprin-3 associates with plectin, thereby enabling the 
anchorage of IFs to the NE (Wilhelmsen et al., 2005). As plectin mediates the IF 
interactions to cell-cell and cell-matrix junctions (Bhattacharya et al., 2009) this finding 
proposes that by utilizing IFAPs, IFs connect the nucleus and cell adhesion sites. The 
ablation of A-type lamins, important regulators of NE organization, led to a loss of 
nesprin-3 from the NE and disturbances in vimentin filaments (Houben et al., 2009), 
hence demonstrating the functional link between the cytoplasmic IFs and the nuclear 
lamina. The anchorage of nucleus to the cytoskeleton and cell membrane has been 
stated to protect nuclei from external mechanical forces, mediate mechanotransduction, 
i.e. a process where mechanical stimuli evokes cellular signals, and modulate the 
reorientation of nucleus during cell migration (Dechat et al., 2008, Houben et al., 2009).  
 
An important function of IFs is to maintain the internal organization of cells through 
interactions with cell organelles. Furthermore, accumulating data points to the role of IFs 
as important regulators of organelle topography, shape and function. Mitochondria have 
been functionally linked to the IF network. The ablation of desmin causes a 
hyperproliferation of mitochondria together with abnormal positioning, morphological 
alterations and reduced respiration rate, the effects being most prominent in cardiac 
muscle (Milner et al., 2000). Likewise vimentin filaments are depicted to interact with and 
regulate the morphology and cellular distribution of mitochondria (Tang et al., 2008). 
Also K8 knockout (KO) hepatocytes are characterized with abnormalities in 
mitochondrial morphology, distribution and function (Tao et al., 2009). Thus far it is not 
clear how IFs interact with mitochondria, although plectin has been proposed to mediate 
the interaction (Konieczny et al., 2008). In addition, the reasons for altered mitochondrial 
functions remain obscure. IFs have been speculated to provide structural support for the 
mitochondrial membrane or balance mitochondrial fission and fusion or, alternatively, 
regulate the functionality of mitochondria through protein targeting to the mitochondrial 
membrane (Capetanaki et al., 2007). Among IF interacting cell organelles is also the 
Golgi apparatus which has been shown to associate with vimentin IFs through an 
interaction between vimentin and Golgi-associated enzyme formiminotransferase 
cyclodeaminase (FTCD; Gao and Sztul, 2001). Ectopically expressed FTCD colocalizes 
with vimentin IFs causing Golgi fragmentation and association of Golgi elements along 
vimentin. Moreover, in vimentin downregulated cells the polarization of Golgi complex 
towards the direction of migration was reported to be disturbed, further indicating the 
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ability of vimentin to affect the Golgi apparatus (Phua et al., 2009). In addition, the loss 
of an intact keratin network in epithelial cell lines due to the expression of K18 where 
arginine 89 has been mutated to cysteine (R89C) incurred the redistribution of Golgi 
(Kumemura et al., 2004). However the relevance of keratin-Golgi association has been 
questioned as no apparent Golgi abnormalities are present in hepatocytes and 
colonocytes in K8 KO or K18 R89C transgenic mice (Toivola et al., 2005).     
 
Cytoplasmic IFs have also been implicated in vesicular transport. Besides the interplay 
between IFs and the endo-lysosomal sorting machinery (discussed in section 2.3) IFs 
have been depicted to regulate the distribution of melanosomes. K5 plays a role in the 
transfer of melanosomes from melanocytes to the upper layers of epidermis as 
exemplified by a hyperpigmentation disorder, Dowling-Degos disease, arising from a K5 
mutation (Planko et al., 2007). In addition, the dynamic changes observed in vimentin 
networks in Xenopus laevis melanophores in response to hormone stimulation have 
been associated with the distribution of melanosomes to the cell periphery (Chang et al., 
2009). It was suggested that vimentin, forming a cage-like network around melanosomes 
would coordinate the melanosome movements and that modulation of vimentin filaments 
would be prerequisite for the subcellular transfer of melanosomes. To summarize, IFs 
are connected to a variety of cellular elements, hence being essential in integrating 
tissues, providing mechanical resilience and controlling intracellular organization. 
 
 
1.4 Dynamic nature of intermediate filaments    
 
Although IFs are essential in stabilizing tissues and providing subcellular organization, 
they are far from static structures. The dynamic nature of IFs can be observed on 
multiple levels ranging from the variable expression patterns of IF proteins to the rapid 
structural modifications on mature IFs.   
 
1.4.1 Physiological and pathological expression patterns of intermediate filament 
proteins 
 
The expression patterns of IF proteins are strictly regulated. Distinct IF networks typify 
particular cell and tissue types (Table 1), but the transcription of IF genes can vary 
according to the developmental stage or in response to stress or injury. For example, a 
transition in cellular IF content occurs during the maturation of neurons when vimentin 
and nestin present in neuronal progenitor cells are gradually replaced by NFs (Yabe et 
al., 2003). Similarly desmin displaces nestin and vimentin during muscle development 
(Sejersen and Lendahl, 1993). In epidermis the keratinocytes switch their IF gene 
expression while moving from the proliferative basal cell layer to the postmitotic 
suprabasal cell layer during epidermal differentiation (Moll et al., 2008). K5/K14 in basal 
keratinocytes are changed to K1/K10 in suprabasal cells in the upper layers of skin. 
These changes in the IF expression most probably reflect the altered environmental 
conditions and cellular requirements to which cells can answer by modulating the IF 
network. Considering the widespread functions of IFs in providing mechanical resilience 
(section 1.3) and mediating the signal transduction (section 2), modifications in the IF 
network appear a practical mechanism to adapt to novel conditions.     
 
Tissue regeneration is depicted in several context to correlate with alterations in the 
expression of IF proteins. For instance, the expression of K6 and K16 is rapidly induced 
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in keratinocytes at the skin wound edge. The importance of K6/K16 is suggested to stem 
from their ability to provide the keratinocytes for adequate plasticity required for 
migration to wound area and mechanical strength to survive in wounded tissue (Wong 
and Coulombe, 2003). In certain situations, the IF genes upregulated following an injury 
are the ones transcribed during the early stages of development. Vimentin and nestin 
are replaced by GFAP in maturating astrocytes, but their expression can be switched on 
upon CNS injuries, when astrocytes form a glial scar at the site of injury (Pekny et al., 
1999). Similarly, enhancement in the expression of vimentin and nestin occurs in kidney 
podocytes in response to nephrosis (Zou et al., 2006) and in skeletal muscle following 
an injury (Vaittinen et al., 2001). This could reflect the enhanced capability of progenitor-
type cells to survive in injured tissue and mediate regeneration. Furthermore, several 
forms of stress ranging from mechanical stress and heat to viral infections and toxins are 
known to upregulate either resident or de novo IF proteins in multiple tissues (reviewed 
by Toivola et al., 2010). The ablation of IF proteins depicted in regenerative processes 
including vimentin, GFAP and K6/K16, has been demonstrated to compromise the 
response to stress or injury (Eckes et al., 2000, Wong and Coulombe, 2003, 
Wilhelmsson et al., 2004). Therefore, the transition of cellular IF content can be a clear 
advantage for cells to survive in challenging environment.  
 
1.4.2 Assembly dynamics of intermediate filaments 
 
In addition to the variable expression patterns of IF proteins, the assembly of IFs in vivo 
is a highly dynamic process, non-filamentous IF particles/precursors displaying 
seemingly motile behavior. Upon cell plating, vimentin precursors become rapidly 
transported to the peripheral regions of spreading cells where they are gradually 
converted first to shorter filaments (squiggles) and then to longer filaments (Prahlad et 
al., 1998). The distribution of vimentin precursors and squiggles within the cells is 
dependent on the MT network and involves an interaction between vimentin and kinesin, 
motor protein responsible for the anterograde transport (Prahlad et al., 1998). The 
proper assembly and maintenance of the type III IF networks requires bidirectional MT-
dependent transport, hence relying also on the dynein/dynactin-mediated retrograde 
movements (Helfand et al., 2002). During neurite outgrowth dynein-binding protein 
Ndel1 facilitates the interaction of vimentin with dynein-complexes (Shim et al., 2008). 
This interaction seems particularly important during axon regeneration when 
cytoskeleton is being remodeled (Toth et al., 2008). Similarly to the type III IFs, the 
motility of type IV IFs in neurons is regulated by the MT system and molecular motors 
(Yabe et al., 1999, 2000, Prahlad et al., 2000, Shah et al., 2000, Helfand et al., 2003a).  
 
As the three cytoskeletal systems closely cooperate, it is not surprising that disturbing 
MFs impedes the motility of vimentin precursors (Yoon et al., 1998). Interestingly, it 
seems that the intracellular movements of different IF precursors are differentially 
regulated. The mobility of keratin squiggles is slower, predominantly directed to cell 
interior and less dependent on MTs than what detected with vimentin precursors (Yoon 
et al., 2001, Wöll et al., 2005). Instead, keratin precursors are abundant at focal 
adhesion in lamellipodia from where they migrate inwards along MFs subsequently 
elongating to longer assembly intermediates to become integrated into the peripheral 
keratin network (Windoffer et al., 2006, Kölsch et al., 2009). These observations indicate 
that IF polymerization can be spatially regulated by means of IF precursor transport and 
the formation of IF assembly intermediates can be restricted to specific cellular 
compartments, such as adhesive structures, hence probably enhancing cytoskeletal 
adjustment during cell migration (Windoffer et al., 2004, 2006, Kölsch et al., 2009). An 
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intriguing way of cells to regulate the local IF content is the dynamic cotranslation 
described for peripherin. Peripherin mRNA-containing particles move along MT tracks 
while protein synthesis can be initiated when the particles stop and peripherin becomes 
cotranslationally assembled into IF precursors (Chang et al., 2006). These translational 
units are suggested to concentrate the IF protein synthesis and IF polymerization to 
specific cellular compartments.    
 
1.4.3 Turnover and remodeling of intermediate filaments 
 
After being constructed, IF networks are exposed to constant turnover and remodeling. 
In late 1980s it started to become evident that a small portion of IF proteins/precursors 
remains in unpolymerized soluble pool within the cells (reviewed by Eriksson et al., 
1992, 2009). IFs, previously considered extremely static structures, were discovered to 
undergo dynamic subunit exchange i.e. a process where polymerized IF subunits are 
being replaced by soluble IF proteins/precursors which become incorporated into the 
existing IF network. Moreover, IFs were reported to be subjected to remarkable 
reorganization during differentiation, stress and pathological situations (for example 
Tokuyasu et al., 1984, Perry et al., 1985, Liao et al., 1995, reviewed by Toivola et al., 
2010). Important insight into the dynamic nature of IFs was obtained from the studies 
showing the mitotic disassembly of IF network. IFs undergo marked structural changes 
during cell division ranging from the almost total disassembly of nuclear lamina 
(reviewed by Foisner, 1997) to less dramatic reorganization of cytoplasmic IFs around 
the mitotic apparatus (reviewed by Chou et al., 2007). Furthermore, various motile 
processes, many of them associated with alterations in cell morphology, are 
characterized by IF remodeling. For example in lymphocytes, profound changes in 
vimentin filaments have been presented to occur upon lymphocyte transmigration across 
the vascular endothelium (Nieminen et al., 2006). The continuous subunit exchange and 
the structural modulation of the IF network require an efficient regulatory mechanism that 
can be specifically activated depending on the ongoing physiological process.   
 
1.4.4 Phosphorylation as a regulator of intermediate filament dynamics 
 
A distinguishing feature of IFs is their tight regulation by posttranslational modifications, 
phosphorylation being the most prominent. The initial observations of IF protein 
phosphorylation were made more than 30 years ago when NFs (Pant et al., 1978) and 
keratins (Sun and Green, 1978) were described to undergo this modification. Nearly a 
decade later phosphorylation of vimentin was reported to cause the disassembly of 
vimentin filaments in vitro (Inagaki et al., 1987). Thereafter IF phosphorylation has been 
extensively studied and phosphorylation has been demonstrated to be the main 
regulator of IF assembly, organization and turnover (reviewed by Omary et al., 2006, 
Pallari and Eriksson, 2006a). IF phosphorylation is a key feature of multiple cellular 
activities, such as mitosis, tissue development and cell motility, all of which are 
characterized by significant modifications in IF structure (Table 2). The phosphorylation-
mediated reorganization of IF network enables the cell division (Foisner, 1997, Sihag et 
al., 2007). Nestin phosphorylation is a prerequisite for the reorganization of nestin 
filaments upon myoblast fusion (Sahlgren et al., 2003) whereas the phosphorylation of 
NFs regulates their transport and organization in maturating axons (reviewed by Sihag et 
al., 2007, Perrot et al., 2008). The phosphorylation of vimentin controls the vesicular 
trafficking of integrins to the cell membrane, thereby regulating the directional motility of 
the cell (Ivaska et al., 2005). 
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Phosphorylation seems to be exclusively targeted to the head and tail domains of IF 
proteins, as exemplified by numerous in vitro and in vivo studies (Omary et al., 2006, 
Pallari and Eriksson, 2006a). The most likely reason for this specificity is the limited 
accessibility of kinases to the central rod domain (Omary et al., 2006). Moreover, the N- 
and C-terminal regions showing variability in both length and amino acid sequence are 
assumed to be responsible for the specific functions of IF proteins. N-terminus is also 
recognized as an important mediator of IF assembly and filament strength (Herrmann et 
al., 1996, Mücke et al., 2004). For example, the N-terminal head domain of vimentin 
contains a number of positively charged arginines. Hence, the N-terminus has been 
suggested to bend towards the highly negatively charged rod domain, thereby enabling 
the lateral aggregation of tetramers (Kreplak et al., 2004). It could be estimated that a 
switch in the N-terminal charge due to phosphorylation might hamper the ULF formation, 
thus inflicting filament disassembly. Indeed, the remarkable preference of N-terminal 
phosphorylation in IF disassembly has become evident from numerous pieces of work 
(reviewed by Pallari and Eriksson, 2006a). C-terminal phosphorylation of IFs is less 
general and has been implicated, in terms of structural influences, mainly with IF 
proteins having divergent distal regions, such as nestin (Sahlgren et al., 2001, 2003), or 
different assembly behavior, such as lamins (Heald and McKeon, 1990). Today it is 
known that the phosphorylation patterns of IF proteins are relatively complex, individual 
phosphorylation sites having context-dependent roles.   
 
Mitosis is not the only physiological process during which IF phosphorylation and 
subsequent reorganization can be detected (Table 2). Different forms of stress and 
exposure to toxic compounds enhance keratin phosphorylation (Liao et al., 1997, Toivola 
et al., 2002) although the purpose of phosphorylation is not necessarily related to 
structural modifications on filaments. Instead, keratin IFs have been hypothesized to 
work as phosphate sponges protecting cells from excess of stress-associated kinase 
activity (Omary et al., 2006). Mechanical shear stress of lung alveolar epithelial cells is 
reported to cause phosphorylation-dependent disassembly of keratin IFs (Ridge et al., 
2005). However, when only a moderate shear stress was applied to cells for a short 
period of time, phosphorylation was noticed to be associated with bundling of keratin 
filaments into thicker tonofibrils, hence indicating that phosphorylation can also reinforce 
IFs and possibly enhance the ability of cells to resist mechanical stress (Flitney et al., 
2009). Furthermore, phosphorylation affects IF dynamics by regulating IF protein 
turnover and selective degradation. GFAP is discovered to undergo more rapid turnover 
when the N-terminal phosphorylation sites are mutated to alanine (Takemura et al., 
2002). Similarly, hyperphosphorylation is reported to protect K18 from caspase-
dependent degradation (Ku and Omary, 2001). K18 and the binding partner K8 are 
targeted to ubiquitylation and proteosomal degradation with the help of which, for 
example, the imbalance in K8/K18 protein levels can be corrected (Ku and Omary, 
2000). Phosphorylation of K8 on serine 74 (S74; according to the new nomenclature, 
Omary et al., 2009) was observed to have a stabilizing effect yet following shear stress 
the same phosphorylation site triggered the ubiquitylation and proteosomal degradation 
of K8 in alveolar epithelial cells (Jaitovich et al., 2008). Differences in susceptibility for 
ubiquitylation might stem from different cell types or biological processes determining the 
enzymes in the ubiquitin-proteasome pathway.  
 
When referring to IF phosphorylation, one has to remark that phosphorylation can also 
have outcomes not related to structural remodeling or protein turnover. Importantly, IF 
phosphorylation is known to regulate the interactions between IFs and different signaling 
determinants, thus having an influence on signal transduction (Table 2, reviewed by 
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Hyder et al., 2008). Moreover, several IF kinases have been demonstrated to interact 
with IF substrates. These interactions have often functional consequences that can be 
observed as a sequestration-based regulation of the kinases (Omary et al., 2006, Pallari 
and Eriksson, 2006b). 
 
 
 
IF property or function 
affected by phosphorylation 
 
 
Examples 
 
IF assembly-state and organization  
 
Solubilization and structural remodeling of IF network during 
mitosis, stress, differentiation etc (Foisner, 1997, Sahlgren et al., 
2003, Ridge et al., 2005, Omary et al., 2006, Sihag et al., 2007) 
 
Keratin bundling during moderate shear stress (Flitney et al., 2009) 
 
 
IF transport and cellular localization 
 
Transport of NFs from the cell soma to axons (Sihag et al., 2007, 
Perrot et al., 2008) 
 
 
IF turnover Protection of  IF proteins form proteosomal and caspase-
dependent degradation (Ku et al., 2000, Ku and Omary, 2001, 
Takemura et al., 2002) 
 
Targeting of keratins to proteasomes (Jaitovich et al., 2008)  
 
 
IF-mediated protein sequestration 
and targeting 
IF-mediated sequestration of 14-3-3 proteins (Ku et al., 1998a,  
Tzivion et al., 2000, Kim et al., 2006) 
 
Association of IFs with kinases and other signaling molecules (Sin 
et al., 1998, Ku et al., 2004, Chou et al., 2009) 
 
Vimentin-dependent trafficking of integrins to the cell membrane 
(Ivaska et al., 2005) 
 
 
Ability of IFs to protect cells from 
apoptosis 
Keratin-dependent protection of cells from stress-induced kinase 
activity (Ku et al., 2007) 
 
 
Table 2. IF phosphorylation regulates a variety of IF properties and functions. Examples related to the 
IF signaling functions are discussed in section 2 (modified from Omary et al., 2006). 
 
 
2 Intermediate filaments as versatile signaling platforms 
 
Until the last decade, IFs were considered mainly as structural proteins. However, the 
functional versatility of IF protein family has been revealed by multiple studies pointing to 
the role of IFs in sequestration-based regulation of signaling determinants. The 
extensive IF network distributed from the NE throughout the cytoplasm to the cell 
membrane provides an enormous surface area to be utilized as a scaffold for various 
proteins (Goldman et al., 2008). Furthermore, the highly dynamic nature of IFs, at the 
level of both expression and assembly, makes IFs ideal signaling factors. Disassembly 
of filaments can have tremendous effect on the signaling determinants regulated by the 
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IF scaffold. In response to developmental, stress-related or regenerative signals IF 
network can be replaced or supplemented with other IF proteins, more suitable to the 
prevailing needs in terms of signal transduction. Hence, the purpose of the multimember 
IF protein family could be explained by the demand of specialized regulatory elements 
for distinct physiological processes.  
 
 
2.1 Intermediate filaments regulate cell death and survival pathways 
 
2.1.1 Intermediate filaments control multiple components in apoptotic machinery  
 
The ability of IFs to help cells to tolerate stress extends beyond their role as structural 
support against mechanical forces, since emerging evidence imply that IFs provide 
resistance against apoptotic stimuli. Diverse molecular mechanisms of IF-dependent 
cytoprotection have been described, many of them relating to the regulation of cell death 
and survival pathways. An entity of IF-regulated signaling determinants is composed of 
proteins associated with apoptotic death receptor pathways (Figure 4). The IF-mediated 
regulation governs proteins from the level of receptors to the downstream executioners 
of apoptosis, caspases.  
 
Alterations in keratin IFs in liver have been demonstrated to render mice more prone to 
Fas-mediated liver damage (Ku et al., 2003). Fas receptor was linked to the IF network 
when a failure in Fas receptor targeting to the cell membrane was observed in K8 KO 
hepatocytes (Gilbert et al., 2001). The ablation of K8/K18 IFs leads to an increased 
density of Fas receptor at the cell membrane suggesting a role for K8/K18 in modulating 
the Fas receptor distribution. K8/K18 filaments have been reported to bind also the 
cytoplasmic domain of tumor necrosis factor (TNF) receptor 2 (TNFR2; Caulin et al., 
2000). The lack of K8/K18 in epithelial cells increases their sensitivity towards TNF-
induced cell death (Caulin et al., 2000). K8/K18-deficient cells show higher activities of c-
Jun N-terminal kinase (JNK) and nuclear factor kappa enhancer binding protein (NFκB) 
when treated with TNF indicating that K8/K18 IFs modulate the TNF-induced signaling 
(Caulin et al., 2000) although the detailed mechanism remains still uncharacterized. 
 
IFs appear critical also for the formation of death inducing signaling complex (DISC) at 
death receptors. K18 has been proposed to regulate the recruitment of TNFR1-
associated death domain protein (TRADD) to activated TNFR1 as overexpressed K18 is 
able to attenuate TNF-induced apoptosis through the sequestration of TRADD (Inada et 
al., 2001). K17 modulates TNF-signaling through similar TRADD scaffolding in skin 
keratinocytes (Tong and Coulombe, 2006). Interestingly, the transition to the stage of 
catagen, apoptosis-driven involution in the hair growth cycle, when distinct hair follicle 
cells are eliminated in a TNF-dependent manner, is premature in K17 KO mice resulting 
hair cycling defect and alopecia (Tong and Coulombe, 2006). DISC formation is more 
prominent also in K8 KO hepatocytes as indicated by the increased recruitment of Fas-
associated protein with death domain (FADD) and procaspase-8 to Fas receptor upon 
stimulation (Gilbert et al., 2008). In addition, K8/K18 filaments have been established to 
bind to death receptor-associated caspase-8 inhibitor, cellular FLICE-inhibitory protein 
(c-FLIP; Gilbert et al., 2004). c-FLIP has a major influence on apoptotic response as it, 
by being recruited to DISC, can restrain the caspase-8 activation. Moreover, c-FLIP is 
known to act as a platform for Raf-1, an upstream regulator of the extracellular signal-
regulated kinase (ERK) pathway (Kataoka et al., 2000). Consequently, the drastic 
reduction of c-FLIP in K8 KO cells (Gilbert et al., 2004) could partially explain the 
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increased caspase activity and weaker Fas-induced antiapoptotic ERK signaling in K8 
KO hepatocytes (Gilbert et al., 2001, 2004, 2008).  
 
As dramatic cytoskeletal disassembly is associated with apoptotic cell death, the 
proteolytic processing of IF proteins including K18 (Caulin et al., 1997), vimentin (Byun 
et al., 2001), and desmin (Chen et al., 2003) by caspases is not surprising. The 
caspase-mediated cleavage of IF proteins seems in fact influential for the progress of 
apoptosis as caspase-resistant vimentin and desmin attenuate programmed cell death 
(Belichenko et al., 2001, Panagopoulou et al., 2008). Interestingly, IFs have been 
established to provide an additional regulatory mechanism for caspase activation. The 
interaction between K8/K18 and death effector domain containing DNA binding protein 
(DEDD) creates a platform for caspase-3, thus bringing caspase-3 into close proximity of 
K8/K18-associated caspase-9 and facilitating the caspase activation (Lee et al., 2002, 
Dinsdale et al., 2004). As a further support, the interaction between keratin filaments and 
DEDD has been depicted to correlate with apoptotic sensitivity (Schutte et al., 2006). 
However, the close relationship between IFs and caspase activation does not reflect 
merely the role of IFs in amplifying the caspase cascade and, thus apoptosis. Keratin 
inclusions, resulting from the caspase cleavage of K18 and the collapse of K8/K18 
filaments at later stages of apoptosis, sequester proapoptotic factors, including active 
caspases, DEDD, and TRADD (Dinsdale et al., 2004). The isolation of the components 
of apoptotic machinery is likely to modify the apoptotic program. eIF3k, a subunit of 
eukaryotic translation initiation factor 3 complex, has been observed to interact with K18 
and promote the mobilization of active caspase-3 from K8/K18 inclusions by inhibiting 
the association between K18 and caspase-3 (Lin et al., 2008). The depletion of eIF3k 
attenuates apoptosis in epithelial cells demonstrating the importance of keratin 
inclusions as regulators of caspase availability (Lin et al., 2008). Moreover, K18 as a 
major caspase-3 substrate has been proposed to reduce the proteolysis of other 
caspase-3 target proteins, thereby partially explaining the increased susceptibility of 
K8/K18-deficient tissues to apoptosis (Leifeld et al., 2009).   
 
The susceptibility of keratin-deficient cells to death ligand-induced apoptosis is shown in 
various contexts. The predisposition of K8/K18 to regulate Fas- versus TNF-mediated 
apoptosis seems highly cell-type specific. Whereas the exquisite respond to Fas is 
typical for liver with a modulated K8/K18 network (Ku et al., 2003, 2007), the significant 
embryolethality described in certain K8 KO strains is due to TNF-dependent apoptosis 
triggered in placental trophoblasts (Jaquemar et al., 2003). TNF has been implicated in 
various physiological processes in placenta ranging from the turnover to invasion of 
trophoblasts (reviewed by Haider and Knöfler, 2009). This emphasizes the need for 
keratins in responding to TNF-evoked apoptotic challenge during embryogenesis. The 
increased susceptibility to TNF-induced apoptosis is also detected among keratinocytes 
bearing a K14 mutation leading to a rare ectodermal dysplasia, Naegeli-Franceschetti-
Jadassohn syndrome, characterized by abnormal apoptotic activity in the epidermal cell 
layer (Lugassy et al., 2008).  
 
To conclude, keratin filaments seem to critically modulate death receptor signaling 
cascades preventing the unwarranted and too intense induction of apoptosis (Figure 4). 
So far such a comprehensive regulation of the apoptotic machinery has not been 
published with other cytoplasmic IF proteins. The observations defining IFs as regulators 
of mitochondria (Milner et al., 2000, Tao et al., 2009), prompt to investigate also the 
possible functions of IFs in the intrinsic, mitochondrial pathway of apoptosis. In fact, the 
reduced capacity of mitochondria to resist increased cellular Ca2+ levels in desmin KO 
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cardiomyocytes can be overcome by the overexpression of antiapoptotic mitochondrial 
membrane protein Bcl-2 (Weisleder et al., 2004). More recently the morphological 
alterations and disturbed intracellular distribution of mitochondria in keratin-deficient 
hepatocytes were shown to correlate with increased sensitivity to Ca2+-induced 
permeability of mitochondria and increased release of cytochrome c (Tao et al., 2009). 
However, it is worth remembering that these features can also arise from the ability of 
IFs to mechanically stabilize the mitochondrial structure and, thus to regulate the 
cytochrome c release, initiating the intrinsic apoptotic pathway. 
 
 
Figure 4. Generalized view on the apoptotic pathways affected by IF-mediated protein sequestration. 
The association of death ligands to death receptors induces the anchorage of TRADD and FADD to 
receptors. These adaptor molecules facilitate the binding of procaspase-8, the activation of which induces 
the caspase cascade. c-FLIP inhibits the procaspase-8 processing, thus impairing the caspase activation, 
and promotes the antiapoptotic ERK activity through Raf-1. TNF receptor associated factor 2 (TRAF2) 
mediates through the regulation of IB kinase (IKK) the activation of NFB. Same receptor complex 
promotes the JNK activation which enhances the transcription of proapoptotic genes and inhibits Bcl-2. The 
members of the Bcl-2 family regulate the intrinsic pathway of apoptosis by controlling mitochondrial 
permeability. The antiapoptotic Bcl-2 inhibits cytochrome c release whereas the proapoptotic Bad 
translocating to the mitochondria following death signal promotes the release of cytochrome c. Bad 
translocation is inhibited by survival factors inducing the phosphorylation of Bad that leads to its cytosolic 
sequestration. In response to DNA damage, p53 induces the transcription of proapoptotic Bax and PUMA. 
Upon release from mitochondria, cytochrome c binds to apoptotic protease activating factor 1 (APAF1) 
forming apoptosome which enables the caspase-9 activation. DEDD creates a platform for caspase-3 
facilitating its activation and amplifying caspase cascade. Proteins directly regulated with IFs are written with 
bigger and bolder font whereas the proteins showing functional consequences upon IF ablation are written 
with bigger font. 
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2.1.2 Apoptosis-modulating signaling is affected by intermediate filaments 
 
Although the execution of apoptosis is dependent on the extrinsic receptor-mediated and 
intrinsic mitochondrial pathways terminating to caspase activation, the apoptotic process 
is regulated by a wide range of other signaling proteins (Figure 4). The family of 
mitogen-activated protein kinases (MAPKs) plays an important role in determining the 
response of cells to apoptotic stimuli, stress, and injuries. K8 has been demonstrated to 
sequester pro-apoptotic JNK activity upon Fas receptor stimulation (He et al., 2002). The 
interaction with K8/K18 filaments may hold JNK from phosphorylating nuclear targets, 
such as c-Jun (He et al., 2002). The scaffolding properties of IFs have also been linked 
to the ERK pathway enhancing cell survival. The ability of IF precursors to become 
transported along MTs is employed in an elaborate manner upon nerve injury, when 
soluble vimentin subunits enable the transport of phosphorylated ERK (pERK) from the 
site of axonal lesion to the nerve cell body (Perlson et al., 2005). pERK is linked to 
importin-β and dynein-mediated retrograde transport by means of vimentin that 
simultaneously sterically protects pERK from dephosphorylation (Perlson et al., 2005, 
2006). The utilization of vimentin as a long-distance messenger provides an explanation 
for the specific increase in vimentin abundance upon nerve injury. Recently elevated 
ERK activity was linked to increased resistance of basal keratinocytes expressing severe 
EBS mutation to mechanical stress-induced apoptosis in comparison to wild type (WT) 
keratinocytes (Russell et al., 2010). This observation further emphasizes the altered 
apoptotic response in the presence of disturbed keratin network. In addition, K8 is known 
to associate with inactive Raf-1, the major upstream regulator of the ERK pathway (Ku et 
al., 2004). Upon stress Raf-1 is released from keratin IFs in association with Raf-1 
activation and K18 phosphorylation indicating a keratin-dependent regulatory 
mechanism for Raf-1 and ERK activities (Ku et al., 2004).  
 
Tumor suppressor protein p53 ensures that damaged cells become destroyed by 
apoptosis by enhancing the expression of proapoptotic genes. The ability of vimentin to 
associate with p53 (Nishio and Inoue, 2005, Yang et al., 2005) represents another 
paradigm on the involvement of IFs in the regulation of cell death and survival. 
Treatment with proteasome inhibitor was observed to induce a vimentin-dependent 
sequestration and accumulation of p53 to the cytoplasm of rheumatoid arthritis synovial 
fibroblasts (cells causing cartilage destruction in the joints of rheumatoid arthritis 
patients, Yang et al., 2005). This sensitized fibroblasts to TNF-related apoptosis inducing 
ligand (TRAIL)-induced apoptosis as the caspase-mediated degradation of vimentin 
caused a nuclear translocation of all the accumulated p53, thus highlighting the potent 
effect of vimentin on p53.  
 
2.1.3 Intermediate filaments as buffers of cellular stress signals 
 
Extensive work with a variety of mouse and cell culture model systems has proven the 
essential role of simple epithelial keratins in protecting tissues against various toxin-
related stresses. The abundance of keratins, targets of stress-associated kinases, can 
be utilized during toxin exposure to absorb unwarranted kinase activity underlining the 
multitude of mechanisms of keratins to regulate stress-induced signal transduction.  
 
K8 and K18 become phosphorylated during different forms of cell stress (Liao et al., 
1995, 1997, Tao et al., 2003). In addition, the hyperphosphorylation of K8/K18 
determines the human liver disease progression (Toivola et al., 2004b). A clue to the 
physiological role of stress-mediated K8/K18 phosphorylation was obtained from studies 
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showing that the mutation of S53 to alanine (S53A; according to the new nomenclature, 
Omary et al., 2009) in K18 eliminating phosphorylation on this particular site predisposes 
transgenic mice to hepatotoxic injury (Ku et al., 1998b). This indicates that keratin 
phosphorylation could have a protective effect. Although the exact role of stress-induced 
keratin phosphorylation is not entirely solved the existing theory defines keratin filaments 
as phosphate sponges or buffers absorbing redundant kinase activity. This is suggested 
to prevent the stress-associated kinases to regulate the activity of phosphorylation-
dependent proapoptotic proteins (Ku et al., 2007, Toivola et al., 2010). Mutations in 
K8/K18 have been described to pose a risk for liver diseases with multiple etiologies 
(reviewed by Omary et al., 2002, 2009). The first direct evidence that one of the most 
common mutations, glycine 62 to cysteine (G62C; according to the new nomenclature, 
Omary et al., 2009) in K8, predisposes to liver damage was got when the transgenic 
mice overexpressing K8 with this mutation were revealed to be more prone to liver injury 
and apoptosis than WT mice (Ku and Omary, 2006). Moreover, the G62C-mutation 
dramatically inhibited K8 phosphorylation at S74, which is known to be targeted by the 
stress-activated protein kinases. G62C-mutation was suggested to interfere with the 
ability of S74 to serve as a phosphate substrate, thereby exposing other proteins for 
increased phosphorylation and, consequently, promoting the progress of apoptosis (Ku 
and Omary, 2006). The ability to modulate apoptosis by shunting kinase activity may 
concern several type II keratins. The motif akin to S74 in K8 is conserved in esophageal 
K4 as well as in epidermal K5 and K6 that equally become phosphorylated during stress 
(Toivola et al., 2002).  
  
Hyperphosphorylation of K8/18 has been observed to mediate the formation of Mallory-
Denk bodies (MDBs), cytoplasmic inclusions characteristic to alcoholic and non-alcoholic 
liver diseases (reviewed by Zatloukal et al., 2007, Ku et al., 2007, Strnad et al., 2008). In 
addition to hyperphosphorylated keratins, chaperones and sequestosome 1/p62 are the 
major constituents of MDBs. Despite being prominent morphological features indicating 
hepatocellular injury, it is still unknown whether the formation of MDBs is deliberate and 
what the significance of MDBs is. Although MDBs could be expected to disturb protein 
folding and degradation due to the isolation of respective cellular machineries, MDBs 
seem not to have any apparent toxic effect and disappear upon recovery when keratin 
network reassembles. Hence, it has been postulated that MDBs could protect 
hepatocytes by sequestering toxic and harmful compounds (Zatloukal et al., 2007, Ku et 
al., 2007). Considering the effect of apoptotic keratin inclusions to caspase availability, 
IF inclusions could have specific, sequestration-based functions rather than being mere 
bystanders. Furthermore, some unexpected pieces of work have revealed increased 
resistance of cells bearing inclusion-promoting mutations in their IF genes to apoptosis 
compared to WT cells (Schietke et al., 2006, Russell et al., 2010). How IF inclusions 
affect death and survival signaling is among the IF-related questions to be answered. 
 
In summary, IFs act as survival-promoting cell elements regulating various steps in 
apoptotic signal transduction through protein sequestration and attenuation of the stress-
induced kinase activity (Figure 4). Further supporting the antiapoptotic function of IFs, 
the ablation of IF network often coincides with increased apoptotic sensitivity. 
Considering that also mechanical forces applied to either epithelial, endothelial (vascular 
flow) or myogenic cells (contraction) can stimulate apoptotic signals, it remains obscure 
whether the non-mechanical functions were the primary functions of IFs or arose as a 
secondary effect of mechanical resistance (Pekny and Lane, 2007).  
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2.2 Impact of intermediate filaments on tissue growth and regeneration 
 
Although the stress-related features of IFs are extensively studied, substantial amount of 
research has focused on describing the IF functions in cell growth and proliferation. The 
ablation of IF proteins has been presented to modulate the proliferation rate of cells both 
positively (Paramio et al., 2001, Reichelt and Magin, 2002) and negatively (Pan et al., 
2008) elucidating the ability of IFs to regulate the growth-related signaling cascades.  
 
K10, the major type I keratin in postmitotic suprabasal keratinocytes, has been proposed 
to have antiproliferative features as the expression of K10 inhibits cell growth in a variety 
of epithelial cell lines (Paramio et al., 2001). The negative impact on cell cycle 
progression seems to stem from the deregulation of phosphatidylinositol 3-kinase (PI3K) 
pathway through a direct sequestration of Akt and atypical protein kinase C  (PKC) by 
the K10 N-terminus (Paramio et al., 2001). Mice expressing K10 in basal keratinocytes 
under the promoter of K5 are characterized by impaired Akt and PKC activities in skin, 
decreased epidermal proliferation and reduced probability to skin carcinogenesis 
(Santos et al., 2002). Interestingly, the ablation of K10 in mice induces hyperproliferation 
in basal cells expressing K5/K14 but not in suprabasal keratinocytes (Reichelt and 
Magin, 2002). Instead of Akt, increased MAPK activity observed in K10 KO epidermis 
was suggested to explain the induction of proliferation (Reichelt et al., 2004). Against 
what could be expected, the papilloma formation was decreased in K10 KO mice, 
probably due to accelerated cell turnover in K10 KO epidermis (Reichelt et al., 2004). 
These results indicate that a multitude of factors affect the outcome of K10 modulation in 
vivo. Increased Akt activation has also been detected in K8 KO hepatocytes along with 
more efficient G1/S transition (Galarneau et al., 2007). However, rather than a keratin-
dependent regulation of Akt, this was estimated to reside from the K8/18-mediated 
regulation of receptor for activated C kinase 1 (RACK1)/plectin-complex acting as a 
platform for growth signals, although no direct interaction between K8/18 and 
RACK1/plectin-complex was presented.  
 
14-3-3 proteins are a family of abundant cellular proteins that play key roles in the 
regulation of central physiological activities, including cell growth and proliferation, 
through interactions with a number of signaling determinants (Figure 5; reviewed by 
Bridges and Moorhead, 2005, Mhawech, 2005, Hermeking and Benzinger, 2006, Tzivion 
et al., 2006). IFs have been illustrated important regulators of 14-3-3. Phosphorylated 
vimentin sequesters 14-3-3 from another 14-3-3 binding protein Raf whose catalytic 
activity is dependent on 14-3-3 interaction (Tzivion et al., 2000). Phosphorylated K18 
interacts with 14-3-3 during the G2/S/M phases of the cell cycle (Liao and Omary, 1996). 
The N-terminal S34 of K18 (according to the new nomenclature, Omary et al., 2009) has 
been demonstrated to mediate the interaction (Ku et al., 1998a). Given that 14-3-3 
proteins are known to regulate the G2 to M phase checkpoint through their interaction 
with the phosphatase Cdc25 (Hermeking and Benzinger, 2006), it was hypothesized that 
keratin network might affect the cell cycle. Indeed the mitotic progression was disturbed 
in K8 KO hepatocytes, lacking the K8/18 network (Toivola et al., 2001), as well as in 
hepatocytes from a transgenic mouse overexpressing K18 with a mutated 14-3-3 binding 
site (S34A; Ku et al., 2002). 14-3-3 displayed nuclear sequestration both in K8 KO liver 
cells and in K18 S34A transgenic hepatocytes, compared to its normally rather diffuse 
cytoplasmic localization, thus indicating that IFs are necessary to control the subcellular 
localization of 14-3-3 and prevent the uncontrolled and harmful interactions between 14-
3-3 and Cdc25 in the nucleus (Toivola et al., 2001, Ku et al., 2002).  
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In addition to cell proliferation, IF/14-3-3 interactions have been implicated in 
determining cell size. 14-3-3, an epithelial isoform, associates with K17 in a 
phosphorylation-dependent manner (Kim et al., 2006). The expression of K17 is rapidly 
increased in epithelial cells at the skin wound edges. Mouse skin keratinocytes lacking 
K17 are depicted with smaller size than WT keratinocytes, depressed protein translation 
and delayed wound closure (Kim et al., 2006). These defects have turned out to be due 
to disturbed anchoring of 14-3-3 in the cytoplasm, where it is needed to stimulate the 
mammalian target of rapamycin (mTOR) signaling pathway controlling protein synthesis 
and cell growth, hence pointing to the demand of K17/14-3-3 interaction during 
regeneration (Kim et al., 2006). Phosphorylation of T9 and S44 in the N-terminal domain 
of K17 was delineated to mediate this interaction (Kim et al., 2006). More recently mTOR 
signaling defects were observed in mouse embryos where the entire type II keratin 
cluster had been deleted (Vijayaraj et al., 2009). These embryos, dying at embryonic day 
9.5 (E9.5) because of severe growth retardation, suffer mislocalization of glucose 
transporters GLUT1 and GLUT3 at the apical membrane of the yolk sac, increased 
activation of mTOR inhibiting AMP kinase due to limited glucose and, hence, reduced 
mTOR activity and protein synthesis. The authors proposed a role for keratin IFs in the 
regulation of glucose availability and cell growth prior to the formation of placenta when 
the embryo is still dependent on the yolk sac (Vijayaraj et al., 2009). 
 
 
Figure 5. Simplified scheme of cellular events controlled by 14-3-3 with examples of 14-3-3-regulated 
proteins. FOXO, Forkhead box protein O; p130Cas, p130 Crk-associated substrate; TSC2, Tuberous 
sclerosis protein 2 (Bridges and Moorhead, 2005, Mhawech, 2005, Hermeking and Benzinger, 2006, Tzivion 
et al., 2006.) 
 
 
Similarly to the expression of K17 depicting skin injuries, the specific upregulation of 
GFAP and vimentin is a hallmark of reactive astrocytes in CNS injuries. The ablation of 
these IF proteins leads to attenuated reactive gliosis (astrocyte activation) at the initial 
stages of neurotrauma although the later posttraumatic regeneration is improved 
suggesting that reducing reactive gliosis may actually have profound effects 
(Wilhelmsson et al., 2004, Sihlbom et al., 2007). It is noteworthy that the expression of 
14-3-3is induced in reactive gliosis and is less pronounced in GFAP/vimentin-depleted 
astrocytes (Sihlbom et al., 2007). Although 14-3-3 has been established to associate 
with GFAP and vimentin in astrocytes (Satoh et al., 2004, Li et al., 2006), it remains to 
be elucidated whether the reduced 14-3-3 protein levels are directly due to deficiencies 
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in the IF network. Moreover, no apparent changes in cell proliferation in response to 
neuronal injury was detected in GFAP/vimentin KO reactive astrocytes (Pekny et al., 
1999), but instead a reduced hypertrophy of cellular processes in individual 
GFAP/vimentin KO astrocytes after CNS trauma was evident (Wilhelmsson et al., 2004). 
Whether this reflects a link between 14-3-3 and cell growth is still unanswered. The 
symptoms of GFAP/vimentin KO mice upon nerve injury could also be explained by the 
changes in endothelin-1 signaling. Endothelin-1, a peptide mediating the vascular tone, 
has been perceived as a potent regulator of reactive gliosis acting through endothelin B 
receptor (ETBR; Gadea et al., 2008). The remarkable colocalization between 
GFAP/vimentin filaments and ETBR in astrocytes and the disturbed distribution of ETBR 
in GFAP/vimentin double KO reactive astrocytes in brain ischemia suggest a direct, IF-
dependent regulation of ETBR (Li et al., 2008). Endothelins are known to inhibit the 
astrocyte gap-junctional communication (AGJC). A less efficient AGJC block indicating 
enhanced distribution of signals over long distances was observed in IF-deficient 
astrocytes raising the possibility that disturbed endothelin signaling could be the 
explanation for the more prominent response to CNS trauma and increased infarct size 
in GFAP/vimentin KO mice (Li et al., 2008).       
 
The importance of glial GFAP has been discerned also in the injuries of peripheral 
axons. Delayed nerve regeneration in GFAP KO animals arises from the reduced 
proliferation of Schwann cells, glia of the PNS which normally mediate the axonal 
regrowth (Triolo et al., 2006). GFAP and vimentin were observed to interact with integrin 
v8 and 51 respectively and, moreover, GFAP was discovered to be an important 
regulator of fibrin-v8-ERK1/2 pathway controlling Schwann cell proliferation after 
injury (Triolo et al., 2006). Thus, the mechanisms of IF-mediated regulation of cell growth 
and proliferation appear highly cell type and context-dependent. Moreover, the ability of 
K18 to attenuate estrogen receptor  (ER)-mediated signaling through the anchorage 
of LPR16, a protein interacting with and regulating the transcriptional activity of ER, 
and, thereby to inhibit the estrogen-stimulated cell cycle progression (Meng et al., 2009), 
further highlights the versatile mechanisms of IFs to regulate cell proliferation and tissue 
growth through protein scaffolding.       
 
 
2.3 Intermediate filaments contribute to cell homeostasis through protein 
targeting   
 
Apart from being essential for stress tolerance and tissue growth, IFs have been 
depicted important in maintaining the cellular homeostasis. Through protein targeting 
and sequestration IFs regulate cell polarity, cell membrane complexes taking care of 
cellular nutrition as well as vesicular trafficking affecting the cell membrane composition.  
 
Tissue homeostasis is dependent on epithelial polarization since the correct localization 
of various proteins/protein complexes either to the apical or basal compartment is critical 
for their functionality. Prominent apical distribution of keratins in single-layered 
epithelium and keratin-dependent protein sequestration have been illustrated important 
for the establishment and maintenance of epithelial polarity (Oriolo et al., 2007b). 
Keratin-mediated scaffolding of a component of -tubulin ring complex, GCP6, a protein 
functioning at MTOCs, improves the enrichment of MTOCs to the apical domain (Oriolo 
et al., 2007a). This is essential for the capping of MT minus-ends directed towards the 
apical part of the cell and the stabilization of MT network which by providing a 
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mechanism for protein transport governs an important aspect of epithelial polarization. 
Furthermore, apical keratin filaments form a ternary complex with the chaperone Hsp70 
and the regulator of cellular asymmetry, atypical PKC (Mashukova et al., 2009). Keratin 
scaffold was suggested to be essential for both the chaperone-mediated rescue of 
inactive PKC from proteosomal degradation and the phosphorylation-dependent 
reactivation of PKC. This mechanism would maintain the appropriate levels of functional 
PKC in epithelial cells (Mashukova et al., 2009). Albatross is a protein located in apical 
junctional complexes which separate the apical and lateral membranes of epithelial cells, 
thereby preventing mislocalization of membrane proteins and assisting cell polarization. 
K8/18 filaments have been shown to promote the formation of apical junctional 
complexes by sequestering and stabilizing Albatross protein (Sugimoto et al., 2008). 
 
In addition to the establishment of epithelial polarity, IFs have been linked to the 
functionality of diverse cell membrane proteins. This function of IFs is well reflected by 
the disturbed signal transduction originating at the β-adrenergic receptors (βARs) and 
reduced lipolysis in vimentin-depleted adipocytes (Kumar et al., 2007). In response to 
catecholamine stimulation, βARs recruit Src kinase to stimulate the ERK cascade which 
leads to the release of stored fatty acids. Vimentin is proposed to constitute a regulatory 
structure at the receptor enabling efficient signal transmission (Kumar et al., 2007). 
Similarly the reduction of sodium-glucose cotransporter SGLT1 in the membrane lipid 
rafts and the decreased sodium-glucose transport specify vimentin KO renal proximal 
tubular cells (Runembert et al., 2002). A significant colocalization of vimentin and SGLT1 
on the membrane of WT tubular cells suggests a vimentin-mediated incorporation of 
SGLT1 into rafts. The importance of vimentin in the sodium-glucose transport was 
highlighted when the specific vimentin re-expression in proximal tubular cells upon renal 
ischemia was shown to be essential for the localization of SGLT1 and the restoration of 
sodium-glucose cotransporter activity and, hence the prevention of glucosuria 
(Runembert et al., 2004). Furthermore, severe problems in electrolyte transport have 
been detected in the distal colon of K8 KO mice suffering colitis and chronic diarrhea 
(Toivola et al., 2004a). Altered localization and impaired function of ion transporters 
observed in K8 KO colon renders IFs as important regulators of the internal ion 
equilibrium, although no direct association between the ion transporters and keratins 
was detected (Toivola et al., 2004a).   
 
Endo-lysosomal sorting machinery is critical for the determination of protein content of 
the cell membrane but participates also in the maintenance of cell homeostasis through 
the regulation of protein degradation. IFs have been proven to modulate the vesicular 
transport machinery, thereby affecting the distribution and degradation of proteins. AP-3 
is an adaptor protein complex regulating the packing and coating of vesicles delivering 
proteins from endosomes to late endosomes and lysosomes. Vimentin regulates the 
distribution of AP-3 and the sorting of the AP-3 binding proteins (Styers et al., 2004). 
Desmin has been demonstrated to bind through myospryn to the biogenesis of 
lysosome-related organelles complex 1 (BLOC-1) which, according to its name, 
regulates the biogenesis of lysosome-related organelles such as melanosomes 
(Kouloumenta et al., 2007). The N-terminal domain of desmin is responsible for 
myospryn sequestration and, therefore, in desmin KO neonatal cardiomyocytes 
myospryn is diffused throughout the cytoplasm contrary to the normal perinuclear 
localization. Due to the colocalization of myospryn with lysosomal markers in WT 
cardiomyocytes and the juxtanuclear aggregation of lysosomes in desmin KO cells, the 
authors rationalized that desmin-mediated regulation of myospryn and BLOC-1 could 
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enable the biogenesis and positioning of lysosomes and lysosome-related organelles 
(Kouloumenta et al., 2007). Furthermore, vimentin serves as a reservoir for the 
synaptosome-associated protein SNAP23, a member of SNAP receptor (SNARE) 
protein family (Faigle et al., 2000). SNAP23 participates in the formation of SNARE 
complex mediating cell membrane fusion upon exocytosis. In addition, evidence has 
been presented that the ablation of GFAP and vimentin in astrocytes affects the 
directional mobility and trafficking of vesicles (Potokar et al., 2007, 2010). This indicates 
that IFs could have profound influence on the storage and release of various neuroactive 
compounds from astrocytes. Taken together, the scaffolding function of IFs appears 
critical for the proper subcellular localization of a variety of proteins. In addition, IFs 
seem to have a pronounced control over the vesicular trafficking system, affecting cell 
and tissue homeostasis in many ways. 
 
 
2.4 Nuclear signaling functions of intermediate filaments 
 
Among the most important cellular activities is protein synthesis. In addition to the 
keratin-mediated regulation of mTOR pathway, affecting the activities of S6 protein 
kinase and eukaryotic initiation factor 4E, and the ability of epithelial keratins to regulate 
translation by binding to eukaryotic elongation factor-1 subunit  (Kim et al., 2007), IFs 
display specific control over nuclear activities including gene transcription. Lamins, IFs of 
the NE, have been elucidated to function as scaffolds for a variety of nuclear proteins 
and, in addition, to regulate chromatin organization (Figure 6; reviewed by Dechat et al., 
2008, Andrés and González, 2009).  
 
Nuclear lamins have been shown to interact with chromatin either directly or indirectly 
through various lamin-binding proteins. The importance of lamins in chromatin regulation 
is reflected by disturbances in heterochromatin organization and epigenetic changes in 
heterochromatin due to modulated histone methylation in lamin-deficient or mutated cells 
(Dechat et al., 2008). Although the details require further dissecting, this function of 
lamins has been postulated to explain some aspects of laminopathies, a broad range of 
diseases leading either to myodystrophy, lipodystrophy, neurodystrophy or premature 
aging (Dechat et al., 2008). Studies with amphiregulin (AR), a member of epidermal 
growth factor (EGF) family, provide an example of lamin-mediated protein sequestration 
affecting chromatin (Isokane et al., 2008). AR is synthesized as a transmembrane 
protein (pro-AR) the transactivation of which requires ectodomain shedding. The induced 
transactivation is partial and the remaining pro-AR is endocytosed, proteolytically 
processed and translocated to the inner NE where it becomes anchored to A-type 
lamins. Targeting of pro-AR to the NE induces heterochromatin assembly and 
suppresses the gene expression (Isokane et al., 2008). More recently A-type lamins 
were suggested to repress transcription when anchored to the close proximity of gene 
promoters probably due to the relocalization of promoters to nuclear periphery, area 
depicted with heterochromatin and reduced gene activity (Lee et al., 2009). B-type 
lamins have been detected to tether testis-specific gene clusters to the NE and repress 
the transcription of genes in these clusters (Shevelyov et al., 2009). The derepression of 
clusters is associated with their detachment from the NE, hence indicating that lamins 
provide a mechanism to silence multigenic regions (Shevelyov et al., 2009). However, 
the model of repressed gene expression at the nuclear periphery has been criticized to 
be oversimplified as also opposite results have been presented (reviewed by Takizawa 
et al., 2008). Microenvironment at the NE has been stated to play a key role in gene 
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silencing but the molecular mechanisms of reduced transcription at the nuclear periphery 
still remain elusive (Takizawa et al., 2008). 
 
Several studies have implicated lamins in the regulation of transcription factors, cell 
cycle regulator retinoblastoma protein (Rb) being one of the most studied. The 
nucleoplasmic complexes of lamin A/C and lamin-binding protein LAP2 promote the 
nuclear localization of Rb through sequestration (Markiewicz et al., 2002). Loss of these 
complexes leads to hyperphosphorylation of Rb, dissociation of transcription factor E2F 
from Rb, increased expression of E2F target genes and inefficient cell cycle arrest 
(Naetar et al., 2008). Indeed, lamins seem essential for the regulation of Rb 
phosphorylation as the lamin A/C scaffold has been proposed to facilitate the interaction 
between protein phosphatase 2A (PP2A) and Rb (Van Berlo et al., 2005). The activation 
of PP2A in response to transforming growth factor-1 (TGF-1) signaling is followed by 
the dephosphorylation of Rb. Thus, lamins appear to enable an important switch in the 
regulation of cell proliferation and tissue turnover. Furthermore, lamins have been shown 
to protect Rb from proteosomal degradation (Johnson et al., 2004).    
 
 
 
Rb is not the only proliferation-related transcription factor regulated by lamins. Type A 
lamins have been elucidated to affect Activator protein-1 (AP-1) dependent transcription 
by sequestering c-Fos to the NE through a direct interaction with bZIP region of c-Fos 
(Ivorra et al., 2006). bZIP is essential for c-Fos heterodimerization with other AP-1 family 
members, such as c-Jun, and, thus for AP-1 activity. In fact, ectopic expression of lamin 
A induces growth arrest (Ivorra et al., 2006). Later on the lamin A scaffold has been 
found to mediate the mitogen-induced AP-1 activation. Activated ERK1/2 interacts with 
lamin A and phosphorylates c-Fos which subsequently becomes released from the NE 
allowing the rapid transcription of AP-1 regulated genes (González et al., 2008). The 
regulation of transcription concerns also B-type lamins. Octamer transcription factor 1 
(Oct-1) modulates both developmental processes and stress response. Lamin B1-
dependent sequestration of Oct-1 to the nuclear periphery has turned out significant for 
gene expression and resistance to oxidative stress (Malhas et al., 2009). This interaction 
may also play a role in aging as reactive oxygen species (ROS) are involved in aging 
process (Malhas et al., 2009).  
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Figure 6. Schematic picture of 
the organization of nuclear 
lamina and the scaffolding 
functions of lamins. Filamentous 
layer of nuclear lamins associates 
with the inner NE. In addition, 
lamins can be found in throughout 
the nucleoplasm. Lamins regulate 
heterochromatin and a broad 
range of transcription factors 
through their scaffolding ability. 
Examples of lamin-interacting 
proteins are covered in the text.  
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The initiation of A-type lamin expression correlates with the progress of differentiation. 
Intriguingly, several muscular dystrophies are known to reside from mutations in the 
LMNA gene (Worman and Bonne, 2007). The ablation of lamin A in myoblasts impairs 
the exit of myoblasts from the cell cycle upon mitogen withdrawal and hampers 
myogenic differentiation, suggesting that compromised muscular regeneration would 
contribute to the generation of muscular dystrophies (Frock et al., 2006). MyoD, a key 
regulator of muscle differentiation, has been implicated as a lamin A binding protein 
(Bakay et al., 2006). During myogenesis, hypophosphorylated Rb recruits histone 
deacetylase 1 (HDAC1) from MyoD, the activity of which is promoted by acetylation (Puri 
et al., 2001). Based on a microarray analysis of muscle biopsies it was suggested that 
these key signaling events of myogenic differentiation leading to MyoD acetylation would 
occur on the lamin scaffold, hence providing a molecular mechanism for the defects in 
lamin A-depleted muscle (Bakay et al., 2006). In addition to myogenic factors, an 
interaction between lamin A and an adipocyte transcription factor sterol response 
element binding protein 1 has been described (Lloyd et al., 2002). Deregulation of this 
interaction may have profound effect on laminopathies affecting the subcutaneous 
adipose tissue (Maraldi et al., 2008). 
 
Nuclear lamina regulates also gene activity by affecting the transcriptional machinery. 
The disruption of the lamina by the overexpression of mutated lamin is associated with 
the accumulation of TATA binding protein (TBP) to lamin aggregates and to reduced 
transcriptional activity of RNA polymerase II indicating that lamins can serve as a 
scaffold for transcription complex (Spann et al., 2002). In summary, lamins can be stated 
to function as a docking platform for nuclear proteins (Figure 6), thus providing a 
mechanism to regulate nuclear signals and gene expression. Furthermore, the lamin-
binding NE proteins interacting with transcriptional regulators further expand the network 
of nuclear signals affected by the lamina (Andrés and González, 2009).         
 
 
2.5 Intermediate filaments as mediators of cell motility 
 
It is well established that IFs regulate cell migration and it is becoming increasingly 
evident that the ability of IFs to function as protein platforms is utilized in determining the 
motile and adhesive properties of cells. Migrational defects observed in vimentin KO 
animals during wound healing (Eckes et al., 1998, 2000) and the numerous examples 
illustrating the concurrence of enhanced migration and vimentin expression (for example 
Mendez et al., 2010) render vimentin the most studied IF protein in terms of migration. 
Vimentin has been described to accumulate to focal adhesions, associate with integrins 
and form structures sharing features of both actin-tethering focal adhesions and keratin-
containing hemidesmosomes termed vimentin associated matrix adhesions (reviewed by 
Ivaska et al., 2007). Vimentin seems to critically regulate the size and distribution of 
adhesion sites (Tsuruta and Jones, 2003) and the strength of cell adhesion 
(Bhattacharya et al., 2009). This is exemplified by the reduced ability of vimentin-
depleted endothelial cells to resist flow-induced mechanical forces due to their inability to 
maintain the adhesion to substratum (Tsuruta and Jones, 2003).  
 
Vimentin associates with cell adhesion receptors, integrins, plectin being depicted to 
function as a linker protein (Gonzales et al., 2001, Homan et al., 2002, Kreis et al., 
2005). The interplay between vimentin and integrins is bidirectional. Integrin 3 has been 
presented to regulate the recruitment of vimentin to focal adhesion, thus ensuring the 
adequate strength of adhesion (Bhattacharya et al., 2009), whereas vimentin has been 
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shown to modulate the integrin content on the cell membrane. Integrin internalization 
followed by subsequent recycling back to the plasma membrane is an important 
mechanism for cells to regulate the speed and directionality of migration (Caswell and 
Norman, 2006). Vimentin is demonstrated to associate with integrin 1 containing 
vesicles (Ivaska et al., 2005). This interaction is released by the PKC-mediated 
phosphorylation of vimentin head domain that enables the recycling of the endocytosed 
integrin 1 to the membrane and promotes cell motility. An actin cross-linking protein 
filamin A is suggested to co-operate with vimentin in integrin 1 trafficking during cell 
adhesion and spreading (Kim H et al., 2010a, 2010b). Filamin A interacts with PKC and 
vimentin and mediates the PKC-dependent vimentin phosphorylation and, thereby the 
cell membrane translocation of integrin 1. The importance of vimentin in the regulation 
of adhesion molecules is further highlighted by a report showing that vimentin IFs are 
crucial for the attachment of lymphocytes to the vascular endothelium and the 
transcellular migration of lymphocytes through endothelial cells (Nieminen et al., 2006). 
The perturbations observed with vimentin KO mice were presented to stem from the 
decreased amounts of integrin 1 on lymphocytes and intercellular adhesion molecule 1 
and vascular cell adhesion molecule 1 on endothelial cells. Furthermore, the clear 
leakiness of vimentin KO endothelium (Nieminen et al., 2006) may reflect impaired 
integrin-cell matrix binding known to induce microvessel leakiness (Wu, 2005). The role 
of vimentin in integrin downstream signaling has not been addressed although the 
adaptor protein p130Cas serving as a protein platform at focal adhesions associates 
with vimentin network (Wang et al., 2007). Furthermore, an important organizer of focal 
adhesions, Rho-kinase, is sequestered by vimentin filaments (Sin et al., 1998). Vimentin 
phosphorylation by Rho-kinase and subsequent IF collapse is associated with the 
release of Rho-kinase from vimentin and translocation to the cell periphery. This implies 
that vimentin scaffold could participate also to the transport of adhesion-related signals 
originating at the cell membrane. 
 
Anterior-posterior polarization is an important phenomenon occurring in migrating cells. 
Vimentin has been implicated as a regulator of Scrib, a protein linked to polarized 
migration (Phua et al., 2009). In addition to prominent interaction, vimentin was detected 
to protect Scrib from proteosomal degradation. Importantly, the downregulation of 
vimentin and Scrib led to very similar disturbances in directed migration and cell-cell 
adhesion, thereby suggesting that IF-Scrib association is a prerequisite for the function 
of Scrib in adhesion and migration (Phua et al., 2009).    
 
Although extensively studied, vimentin is not the only IF protein linked to cell adhesion 
and migration. Synemin localizes to the leading edge of migrating cells and affects the 
MF dynamics (Uyama et al., 2006, Pan et al., 2008). Indeed, synemin was recently 
reported to interact with zyxin, focal adhesion associated protein affecting MF assembly 
and the migratory properties of cells (Sun et al., 2010). K6/K16/K17 become expressed 
upon epidermal injuries at the wound edge and are involved in the healing process, 
dependent on rapid mobilization and increased migration of keratinocytes (Mazzalupo et 
al., 2003, Wong and Coulombe, 2003). K8 KO hepatocytes have been demonstrated to 
exhibit altered adhesion and spreading properties compared to WT hepatocytes 
(Galarneau et al., 2007). This was suggested to be due to the increased density of 
integrin 1 at the cell membrane of K8 KO hepatocytes. Furthermore, the more rapid 
adhesion and impaired spreading of K8 KO cells on fibronectin were associated with 
modulations in the regulation of focal adhesion kinase (FAK), a key protein mediating 
integrin-induced cellular signals, and Akt (Galarneau et al., 2007). These results indicate 
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that keratins can have a control over integrins as well as the downstream effects of 
integrin ligation.  
 
 
3 Intermediate filament protein nestin 
 
The IF protein nestin was identified in 1990 when Lendahl and colleagues were 
searching for the protein recognized by the antibody Rat.401, specifically targeting the 
proliferative cells in developing neural tube. They named their discovery according to its 
expression to neuroepithelial stem cell protein, nestin. With the proteome information 
from developing CNS Lendahl and colleagues (1990) wished to shed light on the 
molecular mechanisms of stem cell differentiation into neurons and glia. During the past 
20 years nestin has been widely used as a marker for the stem and progenitor cells of 
various tissues but its functional importance is only recently starting to become evident.  
 
 
3.1 Expression of nestin  
 
3.1.1 Nestin in developing and regenerating central nervous system  
 
The expression of nestin in developing CNS follows a strict temporal pattern since the 
expression appearing as early as E7-E8 in the emerging neural tube is rapidly declining 
when development proceeds (Dahlstrand et al., 1995). In rat cerebrum, representing an 
early developing part of brain, nestin expression peaks at E16 whereas in later 
developing cerebellum the amount of nestin mRNA is at the highest at postnatal day 5 
(P5; Lendahl et al., 1990). By P9 the expression of nestin is downregulated in both 
compartments. In addition, nestin expression determines the neuronal and glial 
progenitor cells in sympathetic ganglia of mouse PNS where the expression of nestin is 
at the highest at P1 and becomes gradually downregulated by P18 (Shi et al., 2008). In 
the adult brain nestin defines the neuronal stem cells in subventricular and subgranular 
zones (Lagace et al., 2007). In mature neurons nestin is displaced by NFs and 
peripherin whereas in mature glia cells GFAP is the major IF protein. Specific 
upregulation of nestin expression occurs upon regeneration of injured CNS. Nestin 
expression increases in reactive astrocytes forming a glial scar shortly after the spinal 
cord or optic nerve injuries in rats (Frisén et al., 1995). Similarly, the optic nerve lesion in 
mouse eye increases nestin expression in astrocytes (Wohl et al., 2009). In addition, 
increased nestin expression correlates with increased proliferation in the progenitor cells 
of hippocampal subgranular zone following cerebral ischemia (He et al., 2005). 
Detection of nestin in the temporal neocortex of patients with intractable epilepsy equally 
indicates accelerated gliosis and neurogenesis (Wang et al., 2009). Taken together, the 
expression of nestin defines both the developing and regenerating CNS. 
 
3.1.2 General mechanisms of myogenesis – nestin in myogenic tissue 
 
Skeletal muscles emerge from the paraxial mesoderm during early embryogenesis. 
Paraxial mesoderm first separates into segments, cell clusters called somites. The 
somites are further specialized when cells that retain the expression of transcription 
factors Pax3 and Pax7 form the dermomyotome. An important step of muscle 
development, the generation of myotome, is initiated when progenitor cells determined 
to myotome precursors migrate beneath the dermomyotome. These myotome precursor 
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cells become myoblasts while they downregulate Pax3 and upregulate myogenic 
regulatory factors (MRFs). Myoblasts are withdrawn from the cell cycle and 
subsequently fuse to form multinucleated myofibers. Pax3 and Pax7 positive cells from 
the eventually disintegrating dermomyotome migrate to the myotome and proliferate 
extensively prior to the generation of myofibers, thereby expanding the emerging muscle 
tissue. A portion of these Pax3 and Pax7 positive cells gives rise to satellite cells 
responsible for muscle regeneration in adult tissue (reviewed by Francis-West et al., 
2003, Shi and Garry, 2006, Grefte et al., 2007).   
 
The regulatory cascade directing myogenesis is composed of MRFs (Figure 7). This 
family of basic helix-loop-helix transcription factors, including MyoD, Myf5, myogenin and 
Mrf4, plays a central role in myogenesis (Shi and Garry, 2006). MyoD, Myf5 and Mrf4 
are required by the precursor cells to adapt the myogenic fate whereas MyoD, myogenin 
and Mrf4 determine the terminal differentiation. In addition, the myocyte-specific 
enhancer factor 2 (MEF2) regulatory factors, belonging to the MADS-box family of 
transcription factors, are depicted crucial for muscle generation and coordinate gene 
expression at all stages of development (Sandmann et al., 2006). Paired-box 
transcription factors Pax3 and Pax7 seem equally essential for myogenesis. They are 
required for the delamination and migration of myogenic progenitor cells from the 
dermomyotome as well as to the entry of progenitor cells to myogenic program 
(reviewed by Buckingham and Relaix, 2007). Furthermore, Pax deficiency compromises 
cell proliferation and survival. The permanent cell cycle withdrawal of myoblasts 
committed to differentiate is accomplished with cyclin-dependent kinase inhibitors (CKIs) 
p18, p21 and p27 (Myers et al., 2004). In addition, secreted signaling molecules, such as 
Wnt, Notch and Sonic hedgehog, are known to be involved in muscle development 
(Francis-West et al., 2003, Buckingham, 2006). 
   
 
 
Figure 7. Simplified schematic presentation of myogenic differentiation. Mesodermal progenitor cells 
are committed to the myogenic lineage. Myoblasts fuse to multinucleated myotubes which then mature to 
myofibers. The progress of differentiation is critically regulated by the presented regulatory factors. 
 
 
An important feature of adult skeletal muscle is the ability to self-regenerate following an 
injury (reviewed by Shi and Garry, 2006, Grefte et al., 2007). New skeletal muscle 
emerges from myogenic precursor cells called satellite cells residing beneath the 
basement membrane of muscle fibers. The expression of different growth factors is 
enhanced at the site of injury leading to the activation of quiescent satellite cells and 
their transformation into myoblasts. The myoblasts proliferate and upregulate MRFs. 
Following the downregulation of Pax3 and Pax7 myoblasts are committed to differentiate 
and either fuse to the damaged myofibers or fuse to form new multinucleated myofibers, 
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thereby repairing the injured muscle. An essential feature of satellite cells is the 
capability of self-renewal which maintains the number of satellite cells during the rounds 
of regeneration and normal tissue turnover (Shi and Garry, 2006, Grefte et al., 2007). 
During aging, the regeneration is increasingly ineffective and the amount of satellite cells 
declines due to impaired proliferative capacity.     
 
Nestin is expressed in developing skeletal (Sejersen and Lendahl, 1993) and cardiac 
muscle (Kachinsky et al., 1995). In the developing rat limbs nestin can be observed at 
E11 in mesenchymal cells (Wroblewski et al., 1996). When embryo development 
proceeds to E15-E18 the expression of nestin is concentrated to muscles (Sejersen and 
Lendahl, 1993, Wroblewski et al., 1996) to become downregulated by P21 (Sejersen and 
Lendahl, 1993). In embryonic mouse cardiomyocytes the expression of nestin is 
extremely transient and can be detected only at E9-E10 (Kachinsky et al., 1995). In adult 
skeletal muscle the overall nestin expression is low except the specific accumulation of 
nestin to the restricted sarcoplasmic regions, myotendinous and neuromuscular 
junctions (NMJs; Vaittinen et al., 1999). The specific transcription of nestin at the NMJs 
has been confirmed by in situ hybridizations (Kang et al., 2007).  
 
While comparing muscle biopsies from patients with Duchenne/Becker muscular 
dystrophy or myositis to biopsies from healthy donors, nestin immunoreactivity was 
detected in a subset of muscle fibers from all the patients (Sjöberg et al., 1994a). Later 
on it became obvious that nestin, vimentin and desmin are expressed in regenerating 
skeletal muscle, the expression dynamics resembling closely those observed during 
muscle differentiation (Vaittinen et al., 2001). This indicates that the differentiation of 
activated satellite cells proceeds equivalently to embryonic muscle precursors (Vaittinen 
et al., 2001). As a result of denervation of adult skeletal muscle the expression of nestin 
increases and nestin becomes spatially distributed from NMJs (Vaittinen et al., 1999). 
During reinnervation nestin distribution is restored implying that the innervation status of 
muscle fibers determiners the nestin localization and expression in fully developed 
skeletal muscle (Vaittinen et al., 1999). However, in another study the denervation of 
muscle was associated with the disappearance of nestin immunoreactivity in muscle 
fiber (Kang et al., 2007). Instead, a striking increase in nestin transcription in the 
Schwann cells covering the nerve terminals was observed (Kang et al., 2007). In 
infracted cardiac muscle nestin positive, myocyte-like cells have been detected to 
encircle the ischemically damaged area (Scobioala et al., 2008, Béguin et al., 2009). In a 
hypothetical model small progeny of nestin expressing cardiac stem cells gives rise to 
cardiac progenitor cells but whether these cells eventually differentiate with potential to 
repair the damaged tissue is currently unknown (Scobioala et al., 2008, Béguin et al., 
2009). Nestin expression is evident also in developing and regenerating vascular smooth 
muscle cells (Oikawa et al., 2010). To conclude, the expression patterns of nestin in 
muscle tissue closely resemble its expression in CNS being prominent during both 
development and regeneration. 
 
3.1.3 Nestin determines the developing and regenerating cells of various tissues 
 
After the initial findings of nestin expression in CNS and muscle, nestin has been shown 
to be enriched in a multitude of cell and tissue types during development and 
regeneration. These include developing testis (Fröjdman et al., 1997), developing eye 
(Yang et al., 2000), developing and injured tooth (About et al., 2000), developing 
pancreas (Selander and Edlund, 2002), and hair follicle stem cells (Amoh et al., 2009). 
The expression of nestin has also been observed in the endothelial cells of newly formed 
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blood vessels in developing embryo and regenerating infracted myocardium (Mokrý et 
al., 2004). The latter example, representing neovascularization of postnatal tissue, points 
out another regenerative process characterized by nestin expression. In addition, 
endothelial nestin has been depicted in developing kidney, where nestin is transiently 
expressed in glomerular endothelial cells (Chen et al., 2006, Bertelli et al., 2007).   
 
Although mostly typifying progenitor cells, nestin expression has been detected to 
persist in the podocytes of mature glomeruli in adult kidney (Chen et al., 2006, Bertelli et 
al., 2007). Moreover, the evident upregulation of nestin is accompanying kidney injuries. 
Upon puromycin aminonucleoside-induced nephrosis, an experimental podocyte injury 
model, nestin expression in podocytes increases (Zou et al., 2006). An antibody-
mediated destruction of the mesangium, the inner layer of glomerulus, represents 
another kidney injury model. In response to antibody treatment mesangial reserve cells 
start to proliferate and migrate to repair the destroyed mesangium. De novo expression 
of nestin occurs while mesangial cells move to the proliferative phase and start 
regeneration (Daniel et al., 2008). Nestin is present also in a variety of cell types in adult 
pancreas although the expression of nestin seems very heterogeneous (Street et al., 
2004). Whether nestin can be used as marker for adult pancreatic stem cells and 
whether these cells can be utilized in the production of -cells destroyed at the 
pancreatic islets of Langerhans in diabetes has been under investigation for a decade. 
Recently it was shown that the depletion of nestin in pancreatic duct stem cells hampers 
their differentiation into insulin producing cells but the mechanism stays unclear (Kim SY 
et al., 2010)      
 
Cancer and progenitor cells share many features including enhanced proliferation, 
survival and motility. Soon after the initial characterization of nestin in the CNS, nestin 
was observed to be expressed in brain tumors, especially in gliomas exhibiting 
malignant behavior (Tohyama et al., 1992). It was proposed that nestin, depicting 
various CNS tumors of neuroectodermal origin, could define the tumors originating from 
neuronal progenitor cells (Dahlstrand et al., 1992a). More recently nestin has been 
offered as a marker for tumors originating from stem cells (for example Sellheyer et al., 
2009) although the exact role of these stem cell-like cancer cells in tumor initiation and 
progression is still under a debate. In addition, nestin has been suggested to serve as a 
molecular link between tissue regeneration, dependent on the activation of progenitor 
cells, and cancer risk (Kleeberger et al., 2007). Hitherto the expression of nestin has 
been shown to determine tumors of various origin including gastrointestinal stromal 
(Tsujimura et al., 2001), testicular (Lobo et al., 2004), odontogenic (Fujita et al., 2006), 
prostate (Kleeberger et al., 2007), pancreatic (Kawamoto et al., 2009), thyroid (Yamada 
et al., 2009), and mammary gland tumors (Liu et al., 2010).  
 
3.1.4 Regulation of nestin expression 
 
A great amount of work has been aimed at characterizing the factors regulating nestin 
expression. The second intron of the nestin gene is known to be essential for the 
expression of nestin in CNS whereas the first intron, containing E box motifs possibly 
recognized by MRFs, regulates nestin expression in muscle precursors (Sejersen and 
Lendahl, 1993). The transcription factors of SOX and POU families have been indicated 
important in the production of nestin mRNA in developing CNS (Tanaka S et al., 2004). 
Thyroid transcription factor-1, regulating forebrain organogenesis, is another potential 
candidate for nestin expression (Lonigro et al., 2001). In highly malignant neuroblastoma 
cells N-Myc appears as a putative regulator of nestin expression as it binds to the 
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second intron (Thomas et al., 2004). The second intron of the human and mouse nestin 
genes also contains a binding site for CBF-1, the activity of which is regulated by the 
Notch signaling (Shih and Holland, 2006). Indeed, in K-ras-induced mouse models of 
glioblastoma multiforme, the expression of nestin correlates with the Notch activation. 
Notch signaling also appeared important for the maintenance of nestin immunoreactivity 
in neuronal stem cell line (Mellodew et al., 2004). Following transplantation to the rats 
undergone striatal lesion or co-culture on primary hippocampal slices, the amount of 
nestin in these stem cells was rapidly reduced due to proteosomal degradation. The 
reduction of nestin represented an early event in the progress of neuronal differentiation 
and was reversed by the ectopic expression of Notch intracellular domain (Mellodew et 
al., 2004). Fairly little data is available considering the regulation of the first intron of 
nestin but in murine systems it has been shown to contain a consensus sequence for 
Wilms’ tumor suppressor 1 (WT1), specifically concentrated to the developing and 
mature podocytes (Chen et al., 2006). However, in another publication showing similar 
expression patterns for nestin and WT1 in developing kidney, developing epicardium, 
and coronary vessels, WT1 was suggested to affect through intron 2 (Wagner et al., 
2006).  
 
Growth factors have been indicated in the regulation of nestin expression in several 
contexts. An insulin-like growth factor has a promoting effect on nestin expression during 
myogenesis (Wroblewski et al., 1996). In cultured mesangial cells platelet-derived 
growth factor (PDGF) has been indicated to stimulate nestin expression (Daniel et al., 
2008). Similarly in cultured vascular smooth muscle cells the expression of nestin is 
positively regulated by PDGF and EGF the downstream effectors being ERK and Akt 
(Oikawa et al., 2010). In another study the binding of thrombin to G protein coupled 
receptor (GPCR) induced a transactivation of EGF receptor in vascular smooth muscle 
cells leading to ERK-dependent nestin production (Huang YL et al., 2009a). 
Interestingly, the expression of thrombin-specific GPCR is upregulated in arteries 
following balloon injury which could indicate the injury-associated expression of nestin 
(Huang YL et al., 2009a). The positive effect of thrombin to cell proliferation and nestin 
expression has also been detected in cultures of radial glia isolated from embryonic 
cerebellum (Wautier et al., 2007). In dental pulp cells and odontoblasts bone 
morphogenic protein 4 seems responsible for nestin expression (About et al., 2000). 
 
 
3.2 Structural features of nestin 
  
Due to the remarkable differences in the nestin transcript compared to the gene products 
of other IF proteins identified by 1990, nestin was categorized as a novel type VI IF 
protein (Lendahl et al., 1990). However, more elaborate characterization of the human 
nestin gene revealed that the intron-exon structure resembled closely NFs (Dahlstrand 
et al., 1992b). Hence, nestin has been later included into the type IV IF proteins. 
Relatively high variation can be observed when comparing the sequences of the C-
terminal tails of human and rodent nestin indicating that the nestin gene is undergoing a 
dynamic evolution (Dahlstrand et al., 1992b, Steinert et al., 1999, Herrmann et al., 2009)  
 
Nestin polymerizes in vitro with vimentin and -internexin (Steinert et al., 1999). In 
vimentin deficient primary astrocytes nestin appears unable to form filaments with 
residual GFAP further corroborating the prominent predisposition of nestin to assemble 
into filaments with vimentin (Eliasson et al. 1999). In myogenic cells nestin colocalizes 
with vimentin and desmin filaments (Sjöberg et al., 1994b) but the ability to assemble 
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into filaments with desmin has not been investigated. According to in vitro studies, nestin 
assembles with vimentin at an optimal molar ratio of 1:4 (Steinert et al., 1999). Nestin 
has been proposed to form heterodimers with vimentin and -internexin but the details of 
the integration of the heterodimers to the IF network remain to be investigated (Steinert 
et al., 1999). As indicated in section 1.2.2, the short N-terminal domain of nestin (11 
amino acids) is the presumable explanation for the inability of nestin to form 
homopolymers. However, the long, highly charged C-terminal domain of nestin (1300-
1600 amino acids) containing glutamate-rich repeats has equally been suggested to 
interfere the IF assembly (Steinert et al., 1999). Indeed, also the C-terminal 
phosphorylation of nestin on threonine 316 (T316) by Cyclin-dependent kinase 1 (Cdk1) 
has been associated with the mitotic disassembly of nestin filaments (Sahlgren et al., 
2001). Question regarding whether this peculiar C-terminal domain of nestin is oriented 
parallel to filament or protrudes from the IF core, similarly to the C-terminal tails of NFs 
(Perrot et al., 2008), has not been answered yet.   
 
 
3.3 Functional importance of nestin 
 
At the time nestin was identified, IFs were considered mainly as structural proteins. 
Hence, nestin was hypothesized to support the progenitor cells encountering structural 
challenges due to increased proliferation, migration or morphological remodeling 
occurring during developmental processes such as neurulation (Lendahl et al., 1990). 
This hypothesis was supported by the observations revealing a prominent accumulation 
of nestin mRNA at the proliferating regions of developing CNS (Dahlstrand et al., 1995). 
Nestin containing IFs were also speculated to possess faster polymerization kinetics 
suitable for undifferentiated cells in the phase of active proliferation (Sejersen and 
Lendahl, 1993).  
 
In 2003 Chou and coworkers reported that nestin actually promotes the disassembly of 
vimentin filaments during mitosis. Transient transfection of nestin caused a formation of 
non-filamentous vimentin aggregates in mitotic cells where vimentin normally retained its 
filamentous pattern while reorganizing around the mitotic apparatus. The disassembly of 
vimentin correlated with the increased phosphorylation of S55 in vimentin head domain 
indicating that nestin/vimentin heterofilaments could be more prone to phosphorylation 
(Chou et al., 2003). Due to the short N-terminus of nestin, possibly incapable for 
intrafilament interactions, vimentin modifications could perhaps have a more prominent 
effect on the filament structure (Chou et al., 2003). Thereafter, postulates have been 
presented that the expression of nestin would render vimentin filaments less stable, 
thereby alleviating mitosis in fast proliferating endothelial cells (Mokrý et al., 2004), 
mesangial cells (Daniel et al., 2008) and EGF-treated vascular smooth muscle cells 
(Huang YL et al., 2009a). Recently the RNAi-mediated downregulation of nestin was 
reported to suppress the proliferation of neuronal progenitor cells (Xue and Yuan, 2010). 
The mitotic vimentin/nestin aggregates seem also to have a functional role as they have 
been detected to sequester insulin-degrading enzyme (IDE) and modulate its activity 
(Chou et al., 2009). It was suggested that nestin would turn vimentin more accessible for 
IDE by facilitating the IF disassembly and vimentin phosphorylation, critical denominator 
of the IDE interaction. However, further research is required to clarify the physiological 
significance of this phenomenon.    
 
Referring to their previous studies with the rapidly moving non-filamentous IF particles 
(Helfand et al., 2003b), Chou and colleagues (2003) presented a hypothesis that the 
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exceptionally long C-terminal tail of nestin could be utilized in transporting of “cargo” 
molecules. Asymmetric cell division giving rise to two daughter cells with different 
properties plays an important role in the development of CNS. Hence, the nestin-
mediated filament disassembly and the motility of vimentin/nestin particles could take 
part into the distribution of cellular factors to daughter cells (Chou et al., 2003). 
Intriguingly, the asymmetric distribution of nestin during the division of neuronal 
progenitor cells has been reported to regulate cell fate. Prostate apoptosis response-4 
(Par-4) positive daughter cells are committed to ceramide-induced apoptosis whereas 
the nestin positive daughter cells survive to again divide or differentiate (Bieberich et al., 
2003). This may have profound effects in neuronal stem cell transplantation as the 
ceramide-treatment of neuronal cultures to be transplanted reduces the number of Par-
4-positive cells showing increased tendency towards teratoma formation (Bieberich et 
al., 2004). In mitotic neuroepithelial cells of avian embryos, nestin ortholog transitin 
regulates the asymmetric distribution of Numb, a regulator of the Notch signaling, 
through a direct interaction (Wakamatsu et al., 2007). Transitin besides segregates but 
also stabilizes Numb, thereby affecting the proliferation and differentiation of 
neuroepithelial cells. Due to species-specific differences in the nestin C-terminal domain, 
however, it remains elusive whether this kind of regulation occurs in human or rodents 
(Wakamatsu et al., 2007). In fact, in mouse cortical progenitor cells derived from E13 
cortex undergoing active neurogenesis, Numb was efficiently segregated to the nestin 
negative cell, although in progenitor cells derived from E10 cortex the divergent 
distribution of Numb and nestin was not as evident (Shen et al., 2002). Recently, nestin-
mediated protein sequestration has been linked even more closely to cellular signal 
transduction. Nestin has been shown to serve as a cytoplasmic anchor to unliganded 
glucocorticoid receptor (GR; Reimer et al., 2009). The interaction between nestin and 
GR is prominent in embryonic brain as well as in embryo-derived cell cultures and 
hypothesized as an important regulatory mechanism in embryogenesis as nuclear 
accumulation of GR enforces cell cycle arrest. Hence, nestin plays an important function 
as a subcellular organizer affecting critical cell fate decisions.  
 
Although the early theory suggested an important role for nestin in cells undergoing 
morphological remodeling (Lendahl et al., 1990), nestin has not been notably associated 
with the structural features of cells. However, at the NMJs nestin has been shown to be 
associated with the junctional elements beneath the postsynaptic receptors (Kang et al., 
2007). Moreover, nestin filaments are oriented towards the costameres and synaptic 
nuclei because of which nestin has been assumed to provide mechanical stability and 
molecular organization for NMJs (Kang et al., 2007). In podocytes the downregulation of 
nestin is associated with the impaired formation of podocyte processes that normally 
form a network wrapping the capillaries and control the filtration of material from blood to 
Bowman's capsule as primary urine (Chen et al., 2006). As podocytes are presented to 
have a mechanical role in preventing the outward ballooning of the vessel, nestin 
network might be important in the maintenance of the functionality of podocytes (Chen et 
al., 2006). Whether nestin works solely on mechanical level stabilizing the podocyte 
structure or regulates, for example, mechanotransduction requires further studies.     
 
Despite several studies indicating that nestin regulates proliferation during both 
physiological processes and cancer (Thomas et al., 2004), nestin was reported not to 
affect the growth rate of prostate cancer cells (Kleeberger et al., 2007). Therefore, the 
authors presented that nestin might permit rapid proliferation but would not always be 
required for it. Instead, they provided evidence that nestin is essential for the migration 
of prostate cancer cells as well as to the formation of prostate cancer metastases after 
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xenografting in vivo, hence confirming the long-term speculations regarding nestin as a 
regulator of migration (Kleeberger et al., 2007). Moreover, nestin expression has been 
observed to correlate with lymph node metastasis in a subset of breast cancers not 
responding to hormonal therapies (Liu et al., 2010) and become accumulated in the 
invasive tumor cells at the periphery of gliomas (Strojnik et al., 2007). However, in 
patients with non-small cell lung cancer nestin expression was associated with 
lymphangiogenesis which could also explain the increased lymph node metastases and 
indicate the versatility of nestin-mediated effects in cancer metastasizing (Chen Y et al., 
2010). Related to the motile properties of cells, a formin-family protein Fhos2 has been 
proposed to interact with nestin (Kanaya et al., 2005). An actin-organizing protein Fhos2 
inducing stress fibers, localizes to nestin IFs in embryonic brain and heart but more 
studies are required to understand the biological importance of this interaction.  
 
In developing cortex, the IFs of neuronal progenitor cells, nestin and vimentin, have 
been proposed to affect the migration of neuronal progenitors away from the ventricular 
zone (Miyata and Ogawa, 2007). IFs were suggested to participate in the twisting of the 
pial processes of neuronal progenitors directed towards the outer surface of developing 
brain, thereby enabling a spring-like mechanism catapulting the cells away from the 
ventricular zone. This was dependent on the loss of ventricular contact and the transition 
of bipolar progenitor cells to unipolar. The involvement of IFs was based on the fact that 
the treatment with a phosphatase inhibitor known to induce IF disassembly severely 
impaired the pial processes. This novel mechanism was suggested to be utilized during 
the initial stages of migration whereas the more conventional modes of neuronal 
migration would govern the later cortical development (Miyata and Ogawa, 2007). 
Interestingly, in cortical progenitor cells nestin is expressed in radially elongating G1 
phase cells to become downregulated at the G2-M phase (Sunabori et al., 2008). 
Whether this is associated with the twisting of processes remains uncertain. Considering 
a report showing that the depletion of nestin does not hinder isolated kidney mesangial 
cell to migrate (Daniel et al., 2008), the role of nestin in cell migration seems highly 
context-dependent, similarly to the role of nestin in proliferation. Taken together, nestin 
seems influential for the cellular features typical for stem/progenitor cells, such as 
abilities to proliferate, migrate, and tolerate stress. Moreover, nestin may also play a role 
in defining the commitment of cells to differentiate. These findings place nestin at the 
crossroads of cell fate and indicate that nestin could function as a cellular signpost 
(Figure 8).   
 
 
 
 
proliferation
differentiation?
nest+
nest-
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Figure 8. Nestin at the crossroads of 
cell fate. Nestin expression appears to 
coordinate the features and properties of 
progenitor cells.  
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4 Cyclin-dependent kinase 5 as a key determinant in  
development and disease 
 
Cyclin-dependent kinase 5 (Cdk5) was identified in 1992 by virtue of its close sequence 
homology to Cdk1 (Hellmich et al., 1992, Lew et al., 1992, Meyerson et al., 1992). 
However, it became soon apparent that unlike the other members of the Cdk family, 
Cdk5 is not activated by cyclins and exhibits functions not related to cell cycle regulation. 
During almost two decades of research Cdk5 has been described to regulate a variety of 
proteins by phosphorylating serines and threonines with proline immediately 
downstream. Cdk5 has been implicated both in development and disease affecting a 
plethora of cellular activities including neuronal migration, synaptic transmission as well 
as neuronal death and survival.  
 
 
4.1 Regulation of Cdk5 
 
4.1.1 The regulatory subunits of Cdk5 
 
Consistently to the other Cdks, Cdk5 has no enzymatic activity prior to the association 
with a regulatory protein. Distinct protein activators p35 and p39, showing no significant 
homology to cyclins, have been described to associate with and regulate the activity of 
Cdk5 (Tsai et al., 1994, Tang et al., 1995). p35 and p39 exhibit stringent expression 
patterns being heavily concentrated on postmitotic neurons (Tsai et al., 1994, Tang et 
al., 1995). Contrary to the perinatally lethal Cdk5 KO mice, discussed in detail in further 
sections, KO mouse model for p35 was revealed viable and fertile although displaying 
Cdk5 KO-like defects in CNS and increased tendency towards seizures (Chae et al., 
1997). This indicates that p39 can possibly compensate some functions of p35. p35/p39 
double KO mice, phenotypically indistinguishable from Cdk5 KO mice, confirmed that 
p35 and p39 were the main physiological activators of Cdk5 in CNS (Ko et al., 2001). 
Intriguingly, evidence has been presented that in bovine brain Cdk5/p35 would reside in 
a macromolecular complex containing possible inhibitory proteins (Lee KY et al., 1996). 
This indicates that the regulation of Cdk5 activity may extend beyond the interaction 
between Cdk5 and the activator proteins. An interesting feature of p35 and p39 is the N-
terminal myristoylation which promotes the association of the Cdk5/p35 and Cdk5/p39 
complexes with the cell membrane (Patrick et al., 1999, Kusakawa et al., 2000). In fact, 
although Cdk5 activated by either p35 or p39 is also present and has substrates in the 
cytoplasm and nucleus, approximately one third of Cdk5 substrates is membrane 
proteins or proteins associated with the cell membrane (Asada et al., 2008).  
 
4.1.2 Phosphorylation of the Cdk5/p35 complex 
 
The kinase activity of mitotic Cdks is negatively modulated by phosphorylation at T14 
and tyrosine 15 (Y15). However, the activity of Cdk5 seems to increase when Cdk5 
becomes phosphorylated at Y15 by c-Abl (Zukerberg et al., 2000) or Fyn (Miyamoto et 
al., 2008). Phosphorylation of T160/161 activates the mitotic Cdks but phosphorylation of 
the equivalent site on Cdk5 (S159) was suggested to sterically hinder the association 
between Cdk5 and p35 (Tarricone et al., 2001). CKIs seem not to have a prominent 
effect on Cdk5 activity (Lee MH et al., 1996).  
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The activation of Cdk5 launches an autoregulatory feedback loop in which the Cdk5-
mediated phosphorylation of p35 results in ubiquitylation and proteosomal degradation 
of the activator protein (Figure 9; Patrick et al., 1998). Intriguingly, the phosphorylation of 
this Cdk5-specific site, T138 on p35, has been depicted to protect p35 from calpain-
mediated processing to a more stable activator protein p25 (Kamei et al., 2007, 
discussed in 4.3.1). This negative feedback signal, limiting Cdk5 activity, highlights the 
tight regulation of Cdk5. On the other hand, a report depicting the phosphorylation-
dependent stabilization of p35 further underlines the precise regulation of Cdk5 activity. 
PKC belonging to the family of novel PKCs was observed to phosphorylate and 
stabilize p35 in cortical neurons and positively regulate the radial migration of postmitotic 
neurons in a p35-dependent manner (Zhao et al., 2009). Besides modulating the stability 
of p35 (Patrick et al., 1998), the Cdk5-mediated phosphorylation of p35 has been 
reported to induce the activation and dissociation of Cdk5/p35 from the cell membrane in 
perinatal brain (Sato et al., 2007).  
 
 
4.2 Established roles of Cdk5 in development and tissue homeostasis 
 
4.2.1 Cdk5 is required for the development of central nervous system 
 
The formation of cerebral cortex starts when the preplate, the first layer of postmitotic 
neuronal cells is split into a superficial marginal zone and a deeper subplate layer. 
Thereafter, the generation of cortex proceeds in an orchestrated fashion with inside-out 
layering of migrating cells when the newly born neurons migrate past the earlier cell 
layers towards the marginal zone. The expression of Cdk5 and its associated kinase 
activity have been described to substantially increase when the developing nerve cells 
are withdrawn from the cell cycle and be prominent in postmitotic migrating neurons 
(Tsai et al., 1993). With the help of Cdk5 KO mice, the essential role of Cdk5 in CNS 
development has started to emerge (Ohshima et al., 1996). The lack of Cdk5 leads to 
the disruption of neuronal layering in cortex and late embryonic or perinatal death. The 
inability of newborn cells to migrate through the layers of earlier generated neurons 
leading to inverted laminar organization points to the essential function of Cdk5 in nerve 
cell migration during corticogenesis (Gilmore et al., 1998). Similarly, the cerebellar layers 
are disrupted upon Cdk5 depletion (Ohshima et al., 1999). Thereafter, Cdk5-dependent 
regulation has been presented to govern the motility of several neuronal cell types 
including interneurons (Rakić et al., 2009) and oligodendrocyte precursors (Miyamoto et 
al., 2008). 
 
Consistently with the proposed role of Cdk5 in migrating neurons, many of its identified 
substrates are cytoskeletal or cytoskeleton-associated proteins essential for the 
Figure 9. Autoregulatory feedback loop 
controlling Cdk5 activity. Cdk5-mediated 
phosphorylation of p35 on T138 reduces the 
stability of p35 by inducing p35 ubiquitylation 
and proteosomal degradation as well as 
suppresses the calpain-dependent cleavage of 
p35 to a more stable activator protein, p25, thus 
determining Cdk5 activity. 
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neuronal cytoarchitecture (Table 3). Cdk5 is depicted as an important regulator of MT 
and MF dynamics. Somal translocation is a mode of neuronal migration where the 
extension of the leading process is followed by nuclear translocation, nucleokinesis, and 
the retraction of the trailing process. The dynamic regulation of MFs is essential for 
correct neuronal migration as the extension of the leading process requires actin 
treadmilling. The accumulation of Cdk5/p35 to actin rich growth cones (Nikolic et al., 
1996) and the association of p39 with actin cytoskeleton (Humbert et al., 2000) hinted at 
the possibility of Cdk5 affecting MF structure. Cdk5 has been implicated as an effector of 
small GTPases involved in MF dynamics as it regulates Pak1 activity in a Rac-
dependent manner (Nikolic et al., 1998). Identification of the Cdk5-p27 pathway was 
among the first direct evidences of the Cdk5-dependent regulation of MF binding 
proteins and MF dynamics in migrating neurons (Kawauchi et al., 2006). Cdk5-mediated 
phosphorylation was described to regulate the stability of p27, thus enabling the p27-
mediated inhibition of Rho-kinase and suppression in the phosphorylation of actin-
binding protein cofilin. Non-phosphorylated cofilin is active and able to control the MF 
reorganization (Kawauchi et al., 2006). Cdk5-mediated phosphorylation reduces also the 
ability of scaffolding protein Neurabin-1 to associate with MFs (Causeret et al., 2007) 
and, thereby, to affect the dynamics of MF network.  
 
 
Protein Outcome Reference 
 
Pak-1 
 
 
MF dynamics 
 
Nikolic et al., 1998 
p27 
 
Cofilin-mediated MF reorganization Kawauchi et al., 2006 
Neurabin-1 
 
MF dynamics Causeret et al., 2007 
Ndel1 
 
Dynein-mediated nuclear translocation along MT 
tracks 
Niethammer et al., 2000, Sasaki et 
al., 2000 
 
FAK 
 
Stabilization of MT fork Xie et al., 2003 
DCX 
 
MT dynamics Tanaka T et al., 2004 
NF-H, NF-M Transport of NFs to axons and formation of 
axonal NF structures 
Shetty et al., 1993, Sun et al., 
1996, Sihag et al., 2007, Perrot et 
al., 2008 
 
Table 3. Summary of Cdk5-regulated proteins controlling neuronal cytoarchitecture. Cdk5 regulates 
the dynamics of all the three cytoskeletal networks in developing CNS by regulating a variety of proteins.    
 
 
Nucleokinesis is greatly dependent on the MT network which in association with the 
centrosome guides the transport of the nucleus towards the leading process (reviewed 
by Marin et al., 2010). Among Cdk5 substrates is Ndel1, a protein found in complexes 
with dynein and Lis1 (Niethammer et al., 2000, Sasaki et al., 2000). This finding is of 
particular interest as dynein-mediated retrograde transport has been implicated in 
nuclear translocation (Marin et al., 2010). Considering that Ndel1 and Lis1 have the 
capacity to affect dynein localization and that the inhibition of Ndel1 phosphorylation 
causes aberrant neurite morphology together with Ndel1 redistribution, it was speculated 
that Cdk5 plays a role in regulating the association between Ndel1 and dynein and, thus 
the dynein-based nuclear transport (Niethammer et al., 2000, Sasaki et al., 2000). In 
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addition, several factors, critical for the polymerization and stability of MTs, are known 
Cdk5 targets. FAK has been depicted essential for the stabilization of MTs between the 
centrosome and the nucleus. Phosphorylation of FAK at S732 by Cdk5 is critical for the 
enrichment of FAK at MTs and the sustainability of the fork-like MT structure without 
altering FAK activity (Xie et al., 2003). Cells overexpressing FAK S732A mutant loose 
the synchrony in nuclear movements, indicating that the MT fork links the nucleus and 
the centrosome, thereby enabling nucleokinesis. Strikingly similar cortical malformations 
in MT-associated doublecortin (DCX) mutated mice and Cdk5 KO mice prompted 
researchers to investigate the possible functional link between Cdk5 and DCX. Indeed, 
the Cdk5/p35 complex and DCX were observed to colocalize in the regions of 
developing brain containing migrating neurons (Tanaka T et al., 2004). The Cdk5-
mediated phosphorylation of DCX at S729 decreased the ability of DCX to bind and 
stabilize the MTs, thereby affecting MT dynamics (Tanaka T et al., 2004). The drastic 
effects of Cdk5 ablation on cell migration could also stem from the disturbed regulation 
of cell-cell adhesion as Cdk5 by phosphorylating -catenin is able to disrupt the 
interaction between -catenin and N-cadherin, hence inhibiting adhesion (Kwon et al., 
2000). 
 
The cytoskeletal effects of Cdk5 in neurons extend beyond neuronal migration. The 
phosphorylation of NFs, IFs present in postmitotic neurons, is prominent in axons that 
have reached their targets and are forming synapses (reviewed by Sihag et al., 2007, 
Perrot et al., 2008). Phosphorylation is believed to modulate the transport of NFs from 
the cell soma to axons by regulating the interaction of NFs to MT motors. In addition, the 
formation of cross-bridges between NFs and other axonal structures, expanding the 
axonal caliber and conduction velocity, is affected by NF phosphorylation. NF-H and NF-
M containing numerous KSP-repetitions in their C-terminal tails are heavily targeted by 
Cdk5 (Shetty et al., 1993, Sun et al., 1996). Therefore, it is presumable that Cdk5 could 
govern at least some aspects of NF modulation in neurons, although also other kinases, 
such as MAPKs, have been presented to phosphorylate NFs. However, the 
accumulation of phosphorylated NFs to cell bodies was observed to occur also in the 
cortical neurons of Cdk5-deficient mice (Ohshima et al., 1996). This was suggested to 
reside from a kinase cross-talk where the loss of Cdk5 activity would affect the 
functionality of other kinases including MAPKs (Kesavapany et al., 2004).  
 
Despite that Cdk5 was initially shown not to promote the cell cycle progression, today it 
seems that Cdk5 has a general role in inhibiting the cell cycle in postmitotic neurons as 
well as in other cell types. The prominent nuclear localization of Cdk5 in cycling neurons 
is lost upon the cell cycle reentry triggered by stress or neurodegeneration (Zhang J et 
al., 2008). Recently the mechanism of Cdk5 to prevent the cell cycle progression was 
revealed not to stem from the kinetic functions of Cdk5 but rather from the ability of Cdk5 
to sequester the cell cycle regulatory protein E2F1 (Zhang et al., 2010). The Cdk5/p35 
complex was shown to hinder the association between E2F1 and cofactor DP1, thereby 
blocking the expression of cell cycle genes. The interaction between Cdk5/p35 and 
E2F1 relied solely on p35 with p25 and p39 showing no effect (Zhang et al., 2010).  
 
Cdk5 has also been examined in adult neurogenesis. Although neurogenesis in adult 
brain is rare, it has been demonstrated to occur at the subventricular zone of lateral 
ventricles and at the subgranular zone of adult hippocampal dentate gyrus. In postnatal 
brain Cdk5 is essential for the migration of neuronal progenitors from the subventricular 
zone along the rostral migratory stream to the olfactory bulb, where they differentiate into 
neurons (Hirota et al., 2007). The cellular niches for neuronal progenitor cells in embryo 
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and adult organism are drastically different as in adult brain the newborn neuronal cells 
need to integrate into the preexisting system. Cdk5 has been demonstrated critical for 
the proper migration, neurite extension and synapse formation of hippocampal dentate 
granule cells in adult brain (Jessberger et al., 2008). 
 
4.2.2 Synaptic functions of Cdk5 in central nervous system  
 
Synaptic transmission enables the communication between neurons and the 
functionality of an organism. The connectivity is established by the reorganization of 
cytoskeletal elements leading to the formation of dendritic spines. Synaptic plasticity 
means that the efficacy of transmission is affected by the experience and is, therefore, 
thought to underlie the memory formation. Cytoskeletal dynamics enabling the changes 
in dendritic spine shape are essential for synaptic plasticity. Cdk5 has been observed to 
be enriched in synapses and phosphorylate synaptic proteins at both presynaptic and 
postsynaptic compartments, hence possessing widespread synaptic functions (reviewed 
by Angelo et al., 2006).  
 
Cdk5 has been indicated to be involved in neurotransmitter release and recycling. For 
example, through the phosphorylation of voltage-dependent calcium channels, Cdk5 
disturbs the formation of vesicle-associated protein complex at the channels, thereby 
impairing the Ca2+-triggered exocytosis of synaptic vesicles and neurotransmitter release 
(Tomizawa et al., 2002). Cdk5 targets also proteins related to clathrin-dependent 
endocytosis including dynamin I and amphiphysin I (Tan et al., 2003, Tomizawa et al., 
2003), through which it can affect the recycling of synaptic vesicles. In addition to these 
examples, a variety of Cdk5 substrates involved both in exo- and endocytosis has been 
characterized (Angelo et al., 2006). However, according to the results gathered from 
distinct CNS compartments, Cdk5 seems to regulate these processes both negatively 
and positively. Thus, thorough understanding of the functions of Cdk5 in vesicle 
dynamics requires further investigations. An important aspect of efficient synaptic 
transmission is the proper clustering of neurotransmitter receptors at the postsynaptic 
membrane. Cdk5-mediated phosphorylation has been described to regulate the 
clustering of a scaffold protein, postsynaptic density-95 (PSD-95, Morabito et al., 2004). 
Since PSD-95 is coupled to N-methyl-D-aspartic acid (NMDA) receptors, this could 
represent one mechanism of Cdk5 to modulate synaptic plasticity. In fact, the Cdk5-
mediated phosphorylation of PSD-95 inhibits the binding of Src to PSD-95, thereby 
hampering the Src-dependent phosphorylation and endocytosis of NMDA receptors 
(Zhang S et al., 2008). Furthermore, structural remodeling of dendritic spines is relevant 
for synaptic plasticity. Cdk5 has been proposed to be influential for the modifications 
occurring in spine structure due to its ability to modulate the MF network occupying 
dendritic spines (Cheung et al., 2006, Lai and Ip, 2009). In addition to the surveys on 
molecular level, several in vivo studies have pointed to the role of Cdk5 in synaptic 
modulation and cognitive functions such as learning and memory (Cheung et al., 2006). 
 
4.2.3 Cdk5 in skeletal muscle 
 
Although Cdk5 activity is most prominent in postmitotic neurons, Cdk5 and p35 
transcripts are also present in developing skeletal muscle (Philpott et al., 1997). During 
the differentiation of the C2 myoblast cell line Cdk5 exhibits dynamic changes in terms of 
protein amount and kinase activity both peaking when myoblasts fuse to multinucleated 
myotubes (Lazaro et al., 1997). The importance of Cdk5 in the progress of myogenesis 
was indicated by the enhanced differentiation following the ectopic expression of Cdk5 
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whereas the dominant negative form of Cdk5 (dnCdk5) significantly hampered the 
process. However, the increased Cdk5 activity alone was not able to shift the 
proliferative myoblasts to differentiation phase which means that additional myogenesis 
promoting cues are required (Lazaro et al., 1997). The results obtained with C2 
myoblasts are consistent with the observations indicating that dnCdk5 disrupts muscle 
patterning and hampers the expression of myogenic regulatory proteins in Xenopus 
laevis embryos (Philpott et al., 1997). Furthermore, the expression of both Cdk5 and p35 
increases in muscle as a consequence of nerve denervation (Fu et al., 2002) and 
necrotizing muscle injury (Sahlgren et al., 2003) implying that muscle regeneration, 
resembling embryonic myogenesis, may equally benefit from Cdk5 activity. 
Unfortunately, despite these interesting discoveries, the development, regeneration, and 
morphology of muscle tissue in Cdk5 KO mice has never been thoroughly addressed.  
 
Very little is known about the myogenic targets of Cdk5. In our earlier studies we have 
observed that the expression pattern of nestin corresponds to the expression and 
activation of Cdk5 during myogenic differentiation and regeneration (Sahlgren et al., 
2003). Indeed, we have identified nestin to be a specific Cdk5 substrate (Sahlgren et al., 
2003). During the fusion of C2C12 myoblasts to multinucleated myotubes Cdk5 
phosphorylates nestin at T316, thereby increasing the amount of unpolymerized nestin 
and enabling the reorganization of nestin filaments into parallel fibers. Most importantly, 
we have shown that nestin forms a scaffold for Cdk5/p35 where the activation of Cdk5 
regulates the release of the Cdk5/p35 complex from nestin filaments (Sahlgren et al., 
2003). The latter conclusion was based on the increased interaction between nestin and 
p35 in differentiating myoblasts upon Cdk5 inhibition. Cdk-like kinase Pctaire1 is another 
muscle-specific Cdk5 substrate (Cheng et al., 2002). Pctaire1 specifically interacts with 
p35 and is activated by Cdk5 but the exact functions of Pctaire1 as well as the Cdk5-
dependent regulation remain obscure. In addition to nestin reorganization, myoblast 
elongation and fusion are characterized by the remodeling of MFs (O'Connor et al., 
2008, Nowak et al., 2009) and MTs (Straube and Merdes, 2007). Although it is tempting 
to speculate, it is currently not known if Cdk5 serves to regulate these cytoskeletal 
modifications similarly than in migrating neurons. Besides the cytoplasmic effects of 
Cdk5, the rapid nuclear compartmentalization of Cdk5 detected shortly after the 
induction of differentiation is alluding to nuclear substrates (Lazaro et al., 1997). Whether 
Cdk5 regulates the cell cycle in postmitotic myoblasts remains to be explored. 
 
Specific accumulation of Cdk5 is characteristic for NMJs (Sahlgren et al., 2003). It has 
been demonstrated to regulate the expression of acetylcholine receptors (AChRs) which 
ensure the synaptic transmission at the NMJs (Figure 10; Fu et al., 2001). A trophic 
factor neuregulin (NRG) is essential for the induction of proper synaptic gene 
expression. It functions through ErbB receptors to activate the downstream ERK 
signaling pathway leading to the transcription of AChR subunits at the NMJs. Cdk5/p35 
complexes with ErbB receptors and phosphorylates ErbB3 in response to NRG (Fu et 
al., 2001). The inhibition of Cdk5 activity attenuated ErbB activation, induction of the 
downstream cascade and the expression of AChRs (Fu et al., 2001). Consistently, the 
ErbB2 and ErbB3 phosphorylation and ErbB activity were reduced in embryonic Cdk5 
KO muscles although no similar reduction of AChR transcription was observed in vivo, 
probably due to redundant signaling mechanisms (Fu et al., 2005). However, the 
ablation of Cdk5 led to a disturbed clustering of AChRs, loss of Schwann cells and 
increased neurotransmission, depicting the versatile functions of Cdk5 in directing the 
formation and functionality of NMJs (Fu et al., 2005). The generation of the postsynaptic 
apparatus is initiated by means of muscle-intrinsic mechanisms before the muscle 
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becomes innervated (Lin et al., 2005). The nerve-derived agrin and acetylcholine (ACh) 
are utilized either to stabilize the postsynaptic apparatus or disperse the AChR clusters 
that have not been innervated respectively. Cdk5 has been presented to be activated by 
ACh agonists and to be required for the dispersion of the AChR clusters, hence 
explaining the larger AChR clusters detected in Cdk5 KO muscle (Lin et al., 2005).  
 
 
Figure 10. Cdk5 at the NMJs. Activation of Muscle-specific kinase (MuSK) receptor complex by agrin 
induces the clustering of AChRs at the NMJs. MuSK together with NRG and ErbB receptors triggers the 
expression or NMJ components, including AChR, in the nuclei located directly beneath the NMJs (Schaeffer 
et al., 2001). NRG induces Cdk5 activation, which is necessary for ErbB activation, thereby constituting a 
positive feedback loop where an increase in Cdk5 activity further activates ErbB receptors (Lee and Tsai, 
2001). ACh and agrin provided by motor nerves serve as a negative and positive signal for NMJs 
respectively. It is proposed that agrin is not diffuse enough to overcome the dispersion effect of ACh in 
receptor clusters that are not apposed by a nerve terminal (Lin et al., 2005). Dispersion of the clusters far 
from nerve terminals is Cdk5-dependent. 
 
 
4.2.4 Cdk5 is expressed in a multitude of cell types 
 
Cdk5 was originally identified in CNS but has thereafter been observed in diverse cell 
types including Sertoli cells, lens cells, kidney podocytes and pancreatic -cells, 
although the expression is described moderate compared to CNS (Rosales and Lee, 
2006, Bertelli et al., 2007). Nevertheless, the importance of Cdk5 for the functionality of 
these cell types is obvious. Cdk5 has been implicated in glucose metabolism as it 
regulates the insulin secretion in pancreatic -cells (Wei et al., 2005b) and glucose 
uptake in adipocytes (Lalioti et al., 2009). Expression of Cdk5 is prominent also in 
various types of cancer (Rosales and Lee, 2006). Considering the similarities between 
the formation of metastasis and cortical development in terms of cell migration, the 
influence of Cdk5 on the motile properties of prostate cancer cells was challenged. Cdk5 
was delineated as governing the migration of prostate cancer cells in both cell culture 
and xenograft model systems (Strock et al., 2006). Apparent defects in MT organization 
were observed upon Cdk5 inhibition (Strock et al., 2006). Another survey with 
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glioblastoma cells presented Cdk5 as a positive upstream regulator of Akt and cell 
invasion stemming from the ability of Cdk5 to promote the GTPase activity of PI3K 
enhancer, a regulator of Akt pathway (Liu et al., 2008). The potent effect of Cdk5 on cell 
motility has been examined in a variety of cell models. Using Chinese hamster ovary 
cells Huang C and coworkers (2009) revealed the involvement of Cdk5 in talin stability 
and focal adhesion assembly. The Cdk5-mediated phosphorylation of talin head domain 
inhibited the binding of E3 ubiquitin ligase Smurf1 to talin, hence protecting talin from 
degradation. As the talin head domain, generated through calpain-mediated cleavage, 
has an essential role in integrin activation, Cdk5 provides a mechanism to stabilize focal 
adhesions and to set an optimal rate for cell migration (Huang C et al., 2009).       
 
 
4.3 Deregulation of Cdk5  
 
In addition to the pivotal role of Cdk5 in development, several lines of evidence indicate 
that aberrant Cdk5 activity contributes to neurodegenerative disorders. The calpain-
mediated generation of p25 from p35 has been revealed to be responsible for the 
deleterious functions of Cdk5. The disease-associated formation of the Cdk5/p25 
signaling complex reflects the requirements for tight regulation of Cdk5 activity.  
 
4.3.1 Characteristics of p25  
 
p25 is a proteolytic cleavage product of p35 generated by activated calpains (Kusakawa 
et al., 2000). Contrary to the short-lived p35 with a half-life less than 20 minutes, p25 is 
not readily degraded and has approximately two or three times longer half-life (Patrick et 
al., 1998, 1999). Moreover, this C-terminal cleavage product of p35 lacks the 
myristoylation signal located in the N-terminus of p35 (Patrick et al., 1999, Kusakawa et 
al., 2000) which increases the accumulation of the Cdk5/p25 complex into the cytoplasm 
and nucleus. Hence, it is no surprise that the prolonged activity of Cdk5 associated with 
the deregulation of subcellular localization has detrimental effects to cells. The active 
role of Cdk5/p25 in promoting cell death was published in two papers showing an 
increased amount of p25 in dying neurons (Kusakawa et al., 2000) and the induction of 
apoptosis in neuronal cultures following the overexpression of Cdk5 and p25 (Patrick et 
al., 1999). Dephosphorylation of T138, a Cdk5-specific phosphorylation site on p35, 
renders p35 more susceptible to calpain-mediated cleavage (Figure 8; Kamei et al., 
2007). This particular site is phosphorylated in prenatal but not in adult brains and might 
function as a critical regulatory mechanism preventing the generation of p25 during 
development. Interestingly, the mutation of T138 to alanine stabilizes the short-lived p35 
(Patrick et al., 1998) which could indicate that the rapid degradation of phosphorylated 
p35 would explain the inability of calpains to target it (Kamei et al., 2007). p29 is 
indicated as a cleavage product of the other Cdk5 activator protein, p39 (Patzke and 
Tsai, 2002b), but less research has been aimed at to characterize the functions of p29.    
 
4.3.2 The Cdk5/p25 signaling complex in neurologic diseases 
 
The pathological hallmarks of Alzheimer’s disease (AD) are the accumulation of -
amyloid (A) peptides to extracellular amyloid plaques and the generation of intracellular 
neurofibrillary tangles composed of hyperphosphorylated tau (reviewed by Cruz and 
Tsai, 2004). The resulting neuronal death and the loss of neurons incur the symptoms of 
AD, cognitive and motor dysfunction. Today the calpain-mediated cleavage of p35 to 
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p25 is known to play a significant role in the pathogenesis of AD. Cdk5/p25 is able to 
influence the processing of -amyloid precursor protein (APP) to A as Cdk5 
transcriptionally regulates the APP cleaving enzyme (Wen et al., 2008) and the Cdk5-
mediated phosphorylation of APP increases the secretion of A (Cruz and Tsai, 2004). 
Furthermore, the Cdk5/p25 complex efficiently hyperphosphorylates microtubule-
associated protein tau reducing the ability of tau to bind MTs, thus causing MT 
destabilization and aggregation of tau to neurofibrillary tangles (Patrick et al., 1999, Cruz 
et al., 2003). Combined with the Cdk5/p25-mediated pronounced phosphorylation and 
disassembly of the NF network (Patrick et al., 1999), Cdk5/p25 induces rather 
comprehensive cytoskeletal disruption in neurons. The generation of transgenic mice 
producing p25 has confirmed that the cytoskeletal disturbances stemming from the 
hyperactive Cdk5 are similar to neurodegenerative diseases, including AD, thus linking 
p25-induced enhanced Cdk5 activity even more solidly to disease pathologies 
(Ahlijanian et al., 2000). In addition to AD, the deregulation of Cdk5 has been implicated 
in other neurodegenerative disorders including Amyotrophic lateral sclerosis, 
Parkinson´s disease and ischemia (Patzke and Tsai, 2002a, Cruz and Tsai, 2004). 
 
4.3.3 Influence of Cdk5/p25 on apoptotic responses  
 
The conversion of p35 to p25 has been shown to be triggered by a variety of neurotoxic 
conditions including oxidative stress (Strocchi et al., 2003), exposure to A peptides 
(Lee et al., 2000), glutamate-induced excitotoxicity (Tang et al., 2005), ischemia (Wang 
et al., 2003) and ER stress (Saito et al., 2007). Neurotoxic insults often trigger neuronal 
apoptosis in many neurological disorders. Therefore, in defining the etiology of 
neurodegenerative diseases, efforts have been devoted to understand the Cdk5/p25-
induced cellular perturbations leading to apoptotic cell death. During the past years Cdk5 
activity has been shown to modulate the functionality of several proteins during 
neurotoxicity-induced apoptosis (Figure 11). For example, the regulation of survival-
promoting molecular machinery can have drastic effects on cell fate. The 
phosphorylation of transcription factor MEF2 by Cdk5/p25 induces the caspase-
dependent MEF2 degradation, hence inhibiting the transcriptional activity and the ability 
of MEF2 to protect cells from apoptosis (Gong et al., 2003, Tang et al., 2005).  
 
Neuronal stress often coincides with the reactivation of cell cycle regulators. However, 
the cell cycle reentry of postmitotic neurons under cell stress leads to cell death with no 
signs of cell division. In addition, DNA damage has been associated with various 
neurodegenerative conditions. Although the mechanisms, how the cell cycle reentry or 
DNA damage affect the progress of neuronal cell death, are still somewhat unclear, 
these processes seem to have an active role in neuronal apoptosis (reviewed by Kim 
and Tsai, 2009). Cdk5 has been implicated to participate in the regulation of both 
apoptotic cell cycle activity and DNA damage. The phosphorylation of Rb by the 
Cdk5/p25 signaling complex accompanied with the upregulation of E2F-responsive 
genes is among the earliest events of neuronal cell death (Hamdane et al., 2005).  
 
The aberrant induction of p25 has been described to result in double-strand DNA breaks 
(Kim et al., 2008). p25 was found to interact with the catalytic domain of HDAC1 and 
inhibit the enzymatic activity of HDAC1 although the detailed mechanism remains 
elusive (Kim et al., 2008). The acetylation decreases the ability of histones to bind to 
DNA leading to hampered chromatin compaction, increased susceptibility to DNA breaks 
and deregulated gene expression. Apurinic/apyrimidinic endonuclease 1 (Ape1) is 
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essential for the repair of DNA damaged by oxidative stress or genotoxic compounds. 
Cdk5 was recently illustrated to phosphorylate Ape1 on T232, thereby reducing Ape1’s 
endonuclease activity and promoting the accumulation of DNA damage leading to 
neuronal death (Huang et al., 2010). Remarkably, the Cdk5/p25-mediated 
phosphorylation of Ape1 was detected to be more deregulated as it was not affected by 
the interaction between the kinase complex and Ape1 similarly than the Cdk5/p35-
mediated phosphorylation of Ape1 (Huang et al., 2010). The PI3K-like kinase ATM 
(ataxia telangiectasia mutated) coordinates the downstream DNA-damage responses by 
activating the p53 tumor suppressor protein which induces the expression of death 
related target genes such as puma and bax. The treatment of neuronal cells with DNA-
damaging agents induces rapid induction in Cdk5 activity and the Cdk5-mediated 
phosphorylation of ATM at S749 which is required for ATM activation (Tian et al., 2009). 
The attenuation of this pathway prevents the transcription of proapoptotic p53 target 
proteins and protects neurons from cell death (Tian et al., 2009). p53 is reported also to 
be a direct Cdk5 substrate. In response to genotoxic or oxidative stress the Cdk5-
mediated phosphorylation disrupts the interaction between p53 and Hdm2, an E3 
ubiquitin ligase of p53, thereby stabilizing p53 (Lee et al., 2007). Moreover, the Cdk5-
mediated phosphorylation promotes the acetylation and transcriptional activity of p53, 
leading to the increased expression of proapoptotic p53 target genes stimulating the 
intrinsic mitochondrial pathway of apoptosis (Lee et al., 2007).  
 
 
Figure 11. Cdk5/p25-mediated neurodegeneration. Generation of p25 is linked to neurodegenerative 
disorders and can be triggered by a variety of neurotoxic insults. The Cdk5/p25 complex induces severe 
perturbations in the functionality of several proteins, thereby evoking apoptotic cell death (modified from Ikiz 
and Przedborski, 2008).  
 
 
Oxidative stress resulting in mitochondrial dysfunction contributes to the early phases of 
AD. Similarly, the treatment of neuronal cells with glutamate or A leads to the 
accumulation of ROS and mitochondrial depolarization. Cdk5 has been uncovered to 
inhibit the activities of peroxidases, peroxiredoxin I and II, through phosphorylation (Sun 
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KH et al., 2008). Thus, the attenuation of Cdk5 activity reduces the amount of 
accumulating ROS and prevents the mitochondrial damage. As the mitochondrial 
depolarization leads to an increase in the intracellular Ca2+ levels, the authors suggested 
that this would further strengthen the initial death-promoting Cdk5/p25 signal (Sun KH et 
al., 2008). To sum up, the Cdk5/p25 complex seems to have prominent proapoptotic 
effect residing from aberrant regulation of a variety of proteins. However, it remains to be 
explored whether Cdk5/p25 promotes distinct cell death cascades depending on the 
type of stress or the type of tissue where the hyperactivation occurs.  
 
Contrary to the seemingly neurotoxic functions of Cdk5/p25 summarized in figure 11, 
Cdk5 has also been implicated as a regulator of neuronal survival. For example, 
although a transient activation of ERK1/2 is beneficial for proliferation and differentiation, 
sustained ERK1/2 activation seems to have detrimental effect in neurons. The Cdk5-
dependent inhibition of MEK1, an upstream activator of ERK1/2, promotes cell survival 
in cortical neurons (Zheng et al., 2007). Moreover, the Cdk5/p35-mediated 
phosphorylation suppresses the activity of proapoptotic JNK3 (Li et al., 2002) whereas 
the Cdk5-mediated phosphorylation of Bcl-2 promotes the antiapoptotic functions of Bcl-
2 in neurons (Cheung et al., 2008). Antiapoptotic functions of the Cdk5/p35 complex 
extend also to non-neuronal cells as Cdk5/p35 has been described to protect podocytes 
from cell death (Brinkkoetter et al., 2010). These results underline the critical role of 
Cdk5 in life and death decisions emphasizing that moderate Cdk5 activity may enhance 
survival during developmental processes. The cleavage of p35 to p25 resulting in a 
prolonged activation together with an aberrant subcellular distribution and nuclear 
accumulation of Cdk5 could define a mechanism through which the activity of Cdk5 turns 
pathological (O’Hare et al., 2005). This accentuates the need for a strict regulatory 
machinery for Cdk5 to prevent unwarranted and harmful activity.  
 
4.3.4 Surprising cognitive benefits of the Cdk5/p25 complex 
 
p25 overexpressing mouse models have been widely utilized in surveying the 
pathogenesis of AD. Intriguingly, the transient expression of p25 in mice was discovered 
to have unexpected effects as it did not cause neurodegeneration as was the situation 
with the prolonged overexpression of p25, but instead improved learning and memory 
(Fischer et al., 2005). These effects correlated with increased hippocampal long term 
potentiation (LTP), NMDA receptor signaling, dendritic spine density and the number of 
synapses. In contrast, the prolonged production of p25 led to a reduction in the number 
of synapses and impaired the formation of new memories (Fischer et al., 2005). These 
observations led to a hypothesis that limited amount of p25 would be produced during 
aging to compensate for the loss of Cdk5 activity and facilitate cognitive functions, hence 
ameliorating the early memory defects. However, the exposure to AD risk factors would 
increase the amount of p25 over the critical threshold and invert eventually the situation 
detrimental (Fischer et al., 2005). Similar results was achieved with two mouse strains 
overexpressing low levels of p25, although a prominent sexual dimorphism with only 
females showing improved learning was detected (Ris et al., 2005). These interesting 
results suggest that the calpain-mediated generation of p25 does not automatically lead 
to neuronal death but the tightly controlled generation of p25 can actually be beneficial 
under certain circumstances. 
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5 An overview of the regulation and functions of protein  
kinase C  
 
PKC was originally observed to be related to, but distinct from, the other members of 
the PKC family (Ono et al., 1989). Hence, it was classified into the atypical subfamily of 
PKCs (aPKCs) together with PKC/ (PKC is the mouse homolog of human PKC). The 
major difference between the PKC subfamilies, conventional (cPKC), novel (nPKC) and 
atypical PKCs, is the mechanism of activation (reviewed by Hirai and Chida, 2003, 
Moscat et al., 2009). Contrary to the cPKCs and nPKCs, the activation of aPKCs does 
not require Ca2+ or diacylglycerol, but is still dependent on the release of the 
pseudosubstrate (PS) sequence from the substrate-binding cavity and the 
phosphorylation of the kinase domain. Lipid components, such as phosphatidylinositol 
(3,4,5)-trisphosphate, are presented to enable the release from PS-induced 
autoinhibition whereas 3-phosphoinositide-dependent protein kinase 1 (PDK1), a 
downstream effector of PI3K, is depicted to phosphorylate the kinase domain of PKC 
(Figure 12). The PB1 domain is a conserved protein interaction module present in the N-
terminus of PKC and responsible for many of the PKC interactions. PKC has been 
implicated to complex with adaptor proteins, such as p62/sequestosome 1 and Par-
proteins modulating PKC activity and the outcome of PKC-dependent signal 
transduction (reviewed by Etienne-Manneville and Hall, 2003a, Hirai and Chida, 2003, 
Moscat et al., 2009).  
 
 
 
Figure 12. Regulatory domains of aPKCs. Through the N-terminal protein interaction domain, PB1, as 
well as the zinc finger domain (ZF) PKC interacts with adaptor proteins. PDK1 targets the C-terminal 
catalytic domain whereas lipid components mediate the release from PS-dependent autoinhibition. In 
contrast to cPKCs and nPKCs. aPKCs lack the Ca
2+
-binding C2 domain and have only one ZF domain. 
These structural differences may explain the divergent mechanisms of PKC activation (modified from 
Moscat et al., 2009). 
 
 
The involvement of PKC has been established important for a variety of signaling 
cascades, for example MAPK pathway (Diaz-Meco and Moscat, 2001, Cohen et al., 
2006). It has also been found to function in insulin signaling and glucose uptake. 
Through phosphorylation PKC modulates the ability of insulin receptor substrates to 
transmit the signal from insulin receptors (Ravichandran et al., 2001, Moeschel et al., 
2004, Lee et al., 2008) whereas through MF remodeling PKC regulates the 
translocation of glucose transporter 4 containing vesicles to the cell membrane (Liu et 
al., 2006). In addition, PKC is depicted to promote the activity of p70 ribosomal S6 
kinase (p70S6K) which in response to mitogenic stimuli controls the translational 
machinery (Romanelli et al., 1999). Furthermore, PKC participates in the regulation of 
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NFB activation. It has been reported to enable the interaction between NFB complex 
and transcriptional coactivator CBP by phosphorylating the RelA subunit in NFB 
complex as well as to enhance the activation of IKK through phosphorylation (Lallena et 
al., 1999, Duran et al., 2003).  
 
Interestingly, PKC has been characterized to act as a mediator of diverse 
developmental processes. It affects the nerve growth factor-induced differentiation of 
PC12 pheochromocytoma cells (Wooten et al., 1994, 1999). Overexpression of PKC 
enforces an erythroid phenotype in leukemic cells suggesting that PKC might promote 
also erythropoiesis (Mansat-De Mas et al., 2002). Moreover, PKC expression has been 
shown to correlate with the morphological alterations in differentiating melanocytes (Kim 
JH et al., 2010) and in neonatal myocardial tissue (Centurione et al., 2003). In the former 
model PKC was documented to regulate neurite extension whereas the latter effect 
was suggested to result from PKC-dependent modulation of cell growth and apoptosis. 
PKC KO mice have provided additional insight into the developmental functions of 
PKC as these mice display a delay in the development of secondary lymphoid organs: 
lymph nodes, Peyer’s patches and spleen (Martin et al., 2002). PKC is also important 
for B-cell proliferation and survival and the ablation of PKC results in reduced B-cell 
numbers in secondary lymphoid organs (Martin et al., 2002). In addition, the 
differentiation of PKC-deficient Th2 cells is compromised further emphasizing the 
developmental functions of PKC (Martin et al., 2005).  
 
aPKCs have been presented to critically regulate cell polarization, an essential cellular 
event underlying various developmental processes. The complexes between aPKCs and 
Par-proteins have been implicated in the regulation of MT organization, thus assisting 
the establishment of cell polarity, important for the asymmetric cell division and cell 
migration (Etienne-Manneville and Hall, 2003a). For example, the chemotaxis of 
macrophages is critically regulated by PKC (Guo et al., 2009) and the migration of 
astrocytes is affected by the PKC/Par-6 complex determining the reorientation of 
centrosome towards the direction of cell elongation (Etienne-Manneville and Hall, 2001). 
The latter was later reported to occur as a result of the PKC-mediated phosphorylation 
of Glycogen synthase kinase 3 (GSK-3) leading to the inhibition of GSK-3 activity 
(Etienne-Manneville and Hall, 2003b). This reduced the ability of GSK-3 target protein 
adenomatous polyposis coli to interact with the plus ends of MTs, hence affecting MT 
organization. Consistently in migrating cerebellar granule neurons the PKC/Par-6 
complex localizes to the centrosome and regulates the dynamics of MT network, thereby 
enabling the coordinated movement of the centrosome prior to the somal translocation of 
the nucleus (Solecki et al., 2004). An accumulation of Aurora A around the centrosome 
in elongating neurites has been depicted to result from PKC-mediated phosphorylation 
of Aurora A (Mori et al., 2009). The activated Aurora A phosphorylates Ndel1 and 
facilitates MT extension into neurite processes. These results place PKC in a central 
role in the regulation of cell migration. 
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OUTLINE OF THE STUDY 
 
 
The concept of IFs as regulatory scaffolds for signaling determinants had been recently 
introduced when this PhD thesis work was conducted in autumn of 2003. Previous work 
in our laboratory, focused on determining the phosphorylation-mediated regulation of the 
IF protein nestin, had revealed besides Cdk5 as a specific nestin kinase but also a 
strong interaction between nestin and the Cdk5/p35 signaling complex. Therefore, the 
emphasis of my PhD studies was to investigate whether nestin functions as a scaffold 
for the Cdk5/p35 complex affecting the cellular events involving Cdk5 activity. We sought 
to define how nestin affects the key features of Cdk5 and p35, including the kinase 
activity, the subcellular localization, and the proteolytic processing of p35. In addition, by 
addressing the potential role of nestin as a regulator of the Cdk5/p35 signaling complex, 
we pursued to obtain novel information about the cellular functions of nestin of which 
very little was known at that time. Furthermore, the importance of phosphorylation in the 
regulation of IF organization and turnover, prompted us to investigate whether Cdk5 
regulates the stability and turnover of its own scaffold. To answer these challenges we 
decided to utilize two different model systems characterized by the nestin expression 
and Cdk5 activity, the hydrogen peroxide (H2O2)-triggered oxidative stress in neuronal 
progenitor cells and the differentiation of myoblasts to multinucleated myotubes.  
 
The mechanisms regulating Cdk5 activity have been extensively studied in neuronal 
context. However, despite the specific activation of Cdk5 in the developing and 
regenerating muscle as well as at the NMJs, the regulation of Cdk5 in myogenic tissue 
has never been thoroughly addressed. We endeavored to shed light on the upstream 
regulatory cascades directing the activation of Cdk5 in differentiating myoblasts. 
 
The aims of this thesis were: 
 
 To investigate the dynamic crosstalk between nestin and the Cdk5/p35 signaling 
complex in model systems characterized by Cdk5 activity; neuronal stress and 
myogenic differentiation.  
 To identify the regulatory mechanism controlling the activation of Cdk5 in 
differentiating myoblasts. 
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EXPERIMENTAL PROCEDURES 
 
 
1 Cell culture  
 
1.1 Maintenance of cell lines (I-III) 
 
All the cell lines used were maintained in a humidified 5% CO2 atmosphere at 37ºC. 
ST15A neuronal progenitor cell line is isolated from the neonatal rat cerebellum 
(Frederiksen et al., 1988). These cells can be induced to differentiate towards neuronal 
or glial cell type but in our experiments ST15A cells were grown under conditions 
keeping them in proliferative progenitor cell-like state. ST15A cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM, Sigma) supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-Glutamine, and antibiotics (penicillin and streptomycin).  
 
C2C12 cell line is a subclone from a mouse myoblast cell line established from the thigh 
muscle of adult mouse (Yaffe and Saxel, 1977). This cell line was maintained in DMEM 
supplemented with 10% FBS, 2 mM L-Glutamine, and antibiotics (growth medium). 
C2C12 myoblasts provide an excellent model system to investigate myogenesis as 
these cells can be induced to differentiate and fuse to multinucleated myotubes 
expressing characteristic muscle proteins. Differentiation of C2C12 myoblasts was 
induced by mitogen removal by switching subconfluent cell cultures to DMEM 
supplemented with 1% FBS, 2 mM L-Glutamine, and antibiotics (differentiation medium). 
 
HeLa human epithelial cervical cancer cells, Cos7 monkey kidney cells, HEK293 human 
embryonic kidney cells and SW13 human adenocarcinoma cells were cultured in DMEM 
supplemented with 10% FBS, 2 mM L-Glutamine, and antibiotics. SW13 cells expressing 
vimentin in a mosaic pattern were subcloned by dilution cloning. Cell clones were 
upscaled and examined for vimentin expression by Western blotting. Vimentin-negative 
and vimentin-positive subclones were selected for experimentation.  
 
 
1.2 Isolation and culture of primary myoblasts (II, III) 
 
Cultures of primary myoblasts were established from the limb skeletal muscles of 2-day-
old wild type and vimentin KO 129/SV mice (Colucci-Guyon et al., 1994). For nestin 
downregulation studies primary myoblasts were isolated from the limb skeletal muscles 
of 2-day-old FVB-n mice. In both cases muscle tissue was minced and enzymatically 
digested by incubation in 0.2% type XI collagenase (Roche Diagnostics) and 0.1% 
trypsin at 37°C for 45 min. The resulting slurry was filtered to remove large pieces of 
tissue and rinsed with growth medium (Hams F-10 [Sigma] supplemented with 15% 
FBS, 2 mM L-glutamine, antibiotics, and 2.5 ng/ml fibroblast growth factor-β [Promega]). 
Cells were centrifuged at 1000 x g for 5 min, resuspended in growth medium, and plated 
into tissue culture dishes. After the attainment of 80% confluence, the differentiation was 
induced by replacing growth medium with differentiation medium (DMEM supplemented 
with 2% FBS, 2 mM L-glutamine, and antibiotics). 
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1.3 Experimental treatments (I-III) 
 
Oxidative stress was induced in ST15A neuronal progenitor cells by 100 M H2O2. 20 
μM Z-VAD (Sigma) was applied to H2O2-treated cells 3 h before harvesting to inhibit 
caspases whereas 10 μM MG132 (Peptide institute) was applied 6 h before harvesting 
to inhibit proteasomes. In order to inhibit Cdk5 during oxidative stress, Roscovitine 
(Calbiochem) was added to a final concentration of 10 μM 3 h after the induction of 
stress (time points 5, 6 and 8 h). For analyzing the p35 turnover the proteasome inhibitor 
MG132 and the protein synthesis inhibitor cycloheximide (CHX; Sigma) were used at 
concentrations of 20 μM and 30 µg/ml respectively for indicated time periods.  
 
To specifically inhibit the activity of PKC, C2C12 and mouse primary myoblasts were 
induced to differentiate in the presence of 15-20 M PS peptide inhibitor (PS; Myr-
SIYRRGARRWRKL; MilleGen Prologue Biotech). Scrambled peptide (Scr-P; Myr-
RLYRKRIWRSAGR) was used as a control to rule out the unspecific effects of peptide 
treatment. Both of the peptides were linked to a myristoyl group to facilitate the transport 
through the cell membrane. Calphostin C was used to specifically inhibit the cPKCs and 
nPKCs. The PKC inhibitor chelerythrine (Calbiochem) was used at a concentration of 5 
M. For detecting the role of Cdk5 in myogenic differentiation C2C12 cells were treated 
with 10 M Roscovitine from the induction of differentiation. The cleavage of p35 to p25 
was analyzed by modifying the activity of calpains. Calpain activity was induced in 
C2C12, HeLa and in both vimentin-positive and negative SW13 cells by adding 10 µM 
calcium ionophore A23187 (Calbiochem). The inhibition of calpain activity in C2C12 cells 
was obtained with 15 µM calpain inhibitor III (Calbiochem). The proteasomal inhibitor 
MG132 was used at a concentration of 20 µM.   
 
The effect of NMJ-related signaling on nestin protein levels in C2C12 myotubes 
(differentiated for 96 or 120 hours) was investigated by treating the myotubes with 10 
ng/ml of recombinant rat C-terminal agrin (R&D Systems) for 16h followed by a 
treatment with 50 ng/ml of recombinant human NRG-1 extracellular domain (R&D 
Systems) for indicated times. Prior to the addition of NRG myotubes were carefully 
rinsed. To inhibit Cdk5 activity 10-20 µM Roscovitine was added to myotubes 30 min 
before the addition of NRG. Lysates were harvested 12 hours after the NRG induction.   
 
 
2 Plasmid constructs (I-III) 
 
To downregulate nestin, siRNA vector was generated using the pSUPER vector 
(Oligoengine) and the specific nestin sequence, CTCTCCCTGACTCTACTCC, according 
to the manufacturer’s protocol (Brummelkamp et al., 2002). The scrambled sequence 
that was used as a control did not correspond to any known gene in the databases and 
had the following sequence: GCGCGCTTTGTAGGATTCG. The series of GFP-tagged 
nestin deletion mutants (Figure 13) was prepared by Dr. Ying-Hao Chou (Northwestern 
University, Chicago, USA). These plasmids encoded the first 314 (nest-314), 640 (nest-
640), 1177 (nest-1177) and 1893 (nest-1893, corresponding to the full length nestin) 
amino acids of the rat glioma nestin sequence. In addition, GFP-tagged nestin mutant 
representing the last 332 amino acid residues of the C-terminal tail domain was 
constructed using the hamster nestin sequence (nest-T332). All nestin cDNAs were 
cloned into Clonetech’s pEGFP-C1 vector. 
Experimental Procedures 
61 
 
Figure 13. Schematic presentation of the nestin mutants. 
 
 
p35 and both the WT Cdk5 and dnCdk5 cloned into pcDNA3.1 His vector expressing a 
His6 tag and aXpress epitope were kindly provided by Dr. Harish Pant (National Institutes 
of Health, Bethesda, USA). HA-tagged ubiquitin was a kind gift from Dr. Dirk Bohmann 
(EMBL, Heidelberg, Germany). Myc-tagged p35 was purchased from Addgene. Point 
mutation to this vector was made using QuikChange site-directed mutagenesis kit 
(Stratagene) and confirmed by sequencing. The FLAG-tagged PKC was kindly 
provided by Dr. John Blenis (Harvard Medical School, Boston, USA). 
 
 
3 Transient transfections (I-III) 
 
ST15A, Cos7, HEK293, HeLa and SW13 cells were transiently transfected with 
electroporation. For this procedure cells were collected, resuspended in OptiMEM 
(Gibco) and placed in 0.4 cm electroporation cuvettes (BTX) where plasmid DNA had 
been added. Cells were subjected to a single electric pulse (220 V, 975 µF) using a Bio-
Rad Gene Pulser electroporator followed by dilution in DMEM supplemented with 10% 
FBS, 2 mM L-Glutamine and antibiotics. Cells were incubated for 24-48 h prior to 
experimental procedures. For ST15A transfections the following plasmid constructs were 
used: GFP-tagged nest-314, nest-640, nest-1177, nest-1893, nest-T332, pSUPER 
nestin, pSUPER scrambled, HA-tagged ubiquitin, His-tagged p35 and both WT and 
dnCdk5. Empty pcDNA3.1 and pEGFP-C1 vectors were used as controls. Cos7 cells 
were transfected equally with electroporation with the exception that OptiMEM was 
supplemented with 5% FBS. FLAG-tagged PKC and His-tagged p35 were used in Cos7 
transfections. HEK293 cells were transfected with constitutively active PKC together 
with either WT or S33A-mutated myc-tagged p35 in order to conduct in vivo 32P labeling 
and the comparison of WT and mutant p35 phosphopeptide maps. HeLa cells and SW13 
cell clones were transfected with plasmids encoding either GFP-tagged nest-640 or plain 
GFP together with WT Cdk5 and myc-tagged p35.  
 
C2C12 and mouse primary myoblasts were transfected using different commercial 
transfection reagents. In order to downregulate PKC primary myoblasts were 
transfected with 20 or 80 pmol of PKC siRNA pool (Santa Cruz Biotechnology) using 
the Lipofectamine plus reagent (Life Technologies) according to the manufacturer’s 
instructions. Scrambled siRNA was used as a control. 20 h after the transfection, 
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differentiation was induced by switching the cells to differentiation medium. The 
depletion of nestin was achieved in C2C12 and primary myoblasts using RNAi oligos 
purchased from Qiagen. Nestin RNAi and AllStars negative control RNAi were 
transfected using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s 
protocol. After 8-9 h the medium was replaced with differentiation medium or growth 
medium when aiming for MTS assay. For plasmid transfections C2C12 cells were plated 
on 12-well plates and transfected with JetPei reagent (Polyplus-transfection) according 
to the manufacturer’s instructions with a total amount of 2 µg DNA per well. 
Differentiation was induced 6-8 h following the transfection. Four double transfections 
C2C12 cells were transfected first with RNAi oligos for 6 h followed by a JetPEI-based 
transfection with dnCdk5 for additional 6 h. 
 
 
4 Microscopic analyses (I-III) 
 
For immunofluorescence analysis ST15A cells were transfected with nestin constructs 
together with Cdk5 and p35 and grown on coverslips. Following the treatment with H2O2, 
cells were washed with phosphate-buffered saline (PBS), fixed with 3% 
paraformaldehyde (PFA) for 10 min at room temperature (RT), permeabilized for 5 min 
in 0.5% Triton X-100 in PBS, and incubated for 1 h in blocking solution (1% bovine 
serum albumin [BSA] in PBS). Cells were labeled with an antibody against p35 and p25 
(C-19, Santa Cruz Biotechnology). After washes with PBS cells were incubated with 
secondary antibody, Alexa 568 (Molecular Probes), for 1 h, washed and mounted with 
80% glycerol. Images were collected using a Zeiss LSM 510 META laser scanning 
confocal microscope equipped with a Plan-Apochromat 63x/1.4 oil DIC objective. Images 
are maxprojections generated from 8-12 (0.8-1 µm thick) z-sections using Zeiss LSM 3.0 
software. Phase contrast images of H2O2-treated ST15A cells fixed with 3% PFA were 
captured with Zeiss Axiovert 200M widefield microscope. 
 
To investigate the morphological and biochemical features of differentiation C2C12 and 
mouse primary myoblasts differentiating on coverslips were fixed in 3% PFA for 10 min 
at RT and permeabilized with 0.1-0.5% Triton X-100 in PBS for 10 min at RT. Non-
specific binding sites were blocked by incubation in 1-2% BSA in PBS for 30-60 min at 
RT. Cells were subsequently stained for 1-2 h with primary antibodies against myosin 
heavy chain (MHC), nestin and p35, after which the coverslips were rinsed three times 
with PBS or with PBS containing 0.5% Triton X-100 and stained for 40-60 min with 
secondary antibodies tagged with fluorescent dyes (Alexa 488 and Alexa 568, Molecular 
Probes). Cells were washed and mounted in Vectashield (Vector Laboratories). Samples 
were visualized using a Zeiss LSM 510 META laser scanning confocal microscope.  
 
 
5 Viability and proliferation assays 
 
5.1 DAPI labeling for detection of apoptotic nuclear morphology (I) 
 
ST15A cells were transfected either with nestin constructs or with empty GFP vector and 
plated on coverslips. In order to distinguish the apoptotic cells in a population of H2O2-
treated transfected ST15A cells, cells were fixed with 3% PFA, stained with 4,6-
diamidino-2-phenylindole (DAPI; Sigma) for 1 min, washed with PBS and mounted in 
80% glycerol. The morphology of nuclei was visualized with Leica DMRE microscope 
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equipped with Hamamatsu Photonics ORCA CCD camera. Apoptotic nuclei were 
identified by the condensed chromatin and the disturbed nuclear morphology. 
 
 
5.2 MTT assay for detection of apoptosis (I) 
 
Cellular damage gradually leads to the inability of cells to provide energy for metabolic 
cell functions. Therefore, metabolic activity assays, often measuring mitochondrial 
activity, can be utilized in determining the degree of cell death. 3-(4,5-dimethylthiazole-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) is widely used to quantitate cytotoxicity. 
Yellow MTT is reduced to purple formazan by mitochondrial enzymes i.e. by the cells 
that have functional mitochondria. Control and H2O2-treated transfected ST15A cells in 
12-well plates were washed with Hepes-buffered saline solution and subsequently 
incubated for 15 min with MTT (0.5 mg/ml in Hepes-buffered saline solution) at 37°C. 
The MTT-solution was removed and the formazan product formed was solubilized in 5% 
sodium dodecyl sulfate (SDS) overnight at RT. The results were quantified 
spectrofotometrically. 
 
 
5.3 Propidium iodide labeling of apoptotic nuclei (I)  
 
The degree of apoptosis among ST15A cells incubated with 100 M H2O2 for 6 h was 
determined by flow cytometry assay of propidium iodide (PI)-stained nuclei. PI is a DNA 
intercalator that can be used to determine the DNA content within the cells. The relative 
DNA content is reduced in apoptotic cells. For the analysis both control and H2O2-treated 
cells were harvested, washed with PBS and suspended in 300 μl of hypotonic solution 
containing PI (10 μg/ml PI in 0.1% sodium citrate and 0.1% Triton X-100). Cells were 
incubated in solution overnight at 4°C and analyzed by FACSCalibur flow cytometer (BD 
Pharmingen).      
 
 
5.4 MTS assay for analysis of proliferation rate (III)  
 
Proliferating cells are metabolically more active than non-proliferating cells. Thus, 
metabolic assays are also suitable for the detection of proliferation. Nestin was 
downregulated by RNAi and the proliferation of nestin-depleted C2C12 myoblasts was 
determined by MTS assay. Equal amounts of cells transfected either with nestin RNAi or 
with scrambled RNAi were seeded on 12-well plates 24 hours after the transfection and 
cultured in growth medium for additional 24 hours. 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS; Promega) 
reagent supplemented with phenazine ethosulfate (PES; Sigma) was added to each well 
and cells were incubated for additional 1-2 h. Optical density was measured at 490 nm 
with a plate reader (Victor2, 1420 multilabel counter, Perkin-Elmer).  
 
 
6 Migration assays 
 
For wound-healing assays C2C12 myoblasts transfected with nestin RNAi oligos were 
seeded on 12-well plates and cultured until confluent monolayer. Scratch wounds were 
done using a pipette tip and washed with DMEM containing 1% FBS to remove loosely 
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held cells. Images were captured immediately after washing and following an overnight 
incubation. Transwell migration assays were performed using 6.5 mm Transwell inserts 
(Corning Incorporated) coated with polycarbonate membrane with 8.0 µm pores. The 
protocol was adapted from the study by Ödemis and coworkers (2007). For migration 
assay 50 000 control or nestin-depleted C2C12 myoblasts were placed in 100 l of 
DMEM containing 1% FBS into the inner well of the insert while the outer well was filled 
with 600 l of DMEM containing 1% FBS. Chemoattractant SDF-1 (PeproTech) was 
added to the outer well in a concentration of 10 ng/ml and the inserts were incubated for 
5 h at 37°C. The cells that had not migrated through the membrane were wiped off using 
cotton stick and the migrated cells were fixed with 3% PFA for 10 min at RT. The 
membranes were carefully removed from inserts and mounted in Vectashield containing 
DAPI. Migrated myoblasts were counted with Leica DMRE microscope. 
 
 
7 Protein analyses 
 
7.1 SDS-polyacrylamide gel electrophoresis and Western blotting (I-III) 
 
Soluble cell extracts were prepared by lysis in Laemmli sample buffer, subjected to SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose 
membrane (Protran nitrocellulose, Schleicher & Schuell) using semidry or wet transfer 
apparatus (Bio-Rad, GE Healthcare). Membranes were blocked with 5% non-fat milk in 
PBS containing 0.3% Tween-20 for 1 h at RT. Western blotting was performed using 
antibodies against nestin (BD Pharmingen), pThr-316 nestin (Sahlgren et al., 2003), 
vimentin (BD Pharmingen and V9, Sigma), GFP (JL-8, Living Colors), p35 (C-19 and N-
20, Santa Cruz Biotechnology and P9489, Sigma), Cdk5 (DC34, Biosource Invitrogen 
and C-8, Santa Cruz Biotechnology), PKC (Santa Cruz Biotechnology), poly(ADP-
ribose) polymerase (PARP; Sigma), p21 (C-19, Santa Cruz Biotechnology), p27 (C-19, 
Santa Cruz Biotechnology), myogenin (M-225, Santa Cruz Biotechnology), troponin T 
(JLT-12, Sigma), MHC (H-300, Santa Cruz Biotechnology), desmin (RD301, Santa Cruz 
Biotechnology), Ki-67 (Abcam), proliferating cell nuclear antigen (PCNA; Sigma), calpain 
1 (Cell Signaling Technology), calpain 3 (Abcam), RhoA (Santa Cruz Biotechnology), 14-
3-3 (Santa Cruz Biotechnology), Hsc70 (SPA-815, Stressgen), and actin (AC-40, 
Sigma). After washes with PBS containing 0.3% Tween-20 membranes were probed 
with horseradish peroxidase-conjugated secondary antibodies purchased from Promega, 
Southern Biotechnology and GE Healthcare. Proteins were visualized using ECL 
detection kit (GE Healthcare). 
 
 
7.2 Protein fractionation assays (I, III)  
 
To analyze the subcellular localization of p35 as a function of nestin ST15A cells were 
transfected either with p35 alone or together with nest-640. Cells were harvested and 
lysed in Triton X-100 containing fractionation buffer (25 mM Hepes [pH 7.6], 100 mM 
NaCl, 5 mM MgCl2, 5 mM EGTA, 0.5% Triton-X 100, complete protease inhibitor mixture 
[Roche]) for 30 min on ice. Cell lysates were separated into insoluble and soluble pools 
by centrifugation at 15 000 x g for 40 min at 4°C. The supernatant and the pellet 
fractions, the latter containing highly insoluble cytoskeletal and membrane-bound 
proteins were resuspended in Laemmli sample buffer and analyzed by Western blotting. 
HeLa and C2C12 cells transfected with nest-640 were fractionated in an equal manner. 
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ST15A cells were transfected with plasmids encoding p35 and Cdk5 together with either 
nest-640 or empty GFP and incubated with 100 M H2O2 for 6 h. To prepare nuclear 
enriched fractions harvested cell pellets were carefully suspended in 800 μl of buffer 
containing 10 mM Tris (pH 7.4), 10 mM NaCl, 3 mM MgCl2, 0.5 mM 
phenylmethylsulfonyl fluoride (PMSF), 2 mM dithiothreitol (DTT), and complete protease 
inhibitor mixture and incubated for 10 minutes on ice. Following incubation 0.3% of NP-
40 was added to each sample and the tubes were inverted a few times. Incubation was 
continued for an additional minute after which the samples were centrifuged at 400 x g 
for 4 min at 4ºC. Pellets were carefully washed with the buffer described above and 
centrifuged again (400 x g, 4 min, 4ºC). Recovered pellets were suspended in 150 μl of 
buffer consisting of 20 mM Tris (pH 7.4), 40 mM Na4P2O7, 5 mM MgCl2, 50 mM NaF, 100 
μM Na3VO4, 10 mM EDTA, 1% Triton-X 100, 1% SDS, and protease inhibitors, 
sonicated briefly and centrifuged at 20 000 x g for 10 min at 4ºC. Supernatants 
comprising now the nuclei were suspended in Laemmli sample buffer and subjected to 
Western blotting.    
 
 
7.3 Coimmunoprecipitation analyses (I-III) 
 
To identify the Cdk5 interaction site on nestin, ST15A cells transfected with GFP-tagged 
nestin constructs were subjected to Cdk5 immunoprecipitation. Cells were harvested, 
suspended in lysis buffer (20 mM Hepes [pH 7.4], 140 mM NaCl, 10 mM pyrophosphate, 
5 mM EDTA, 0.4% NP-40, 100 mM PMSF, complete protease inhibitor mixture) and kept 
on ice for 30 min. Lysates were lightly sonicated and centrifuged at 10 000 rpm for 10 
min at 4ºC. The supernatants were precleared with protein A-sepharose beads (Sigma), 
followed by the immunoprecipitation of Cdk5 with polyclonal anti-Cdk5 antibody (C-8, 
Santa Cruz Biotechnology) under rotation overnight at 4ºC. Immunocomplexes were 
captured with 50% slurry of protein A-sepharose at 4ºC on a rotamix for 4 h. The beads 
were collected with mild centrifugation, washed twice with lysis buffer and twice with 
PBS containing complete protease inhibitor mixture and suspended in Laemmli sample 
buffer.  
 
For analyzing the association between nestin and the Cdk5/p35 signaling complex 
during oxidative stress ST15A cells were transfected with nest-640, p35 and Cdk5 and 
treated with H2O2. At indicated time points, medium containing dead cells was discarded 
and living cells still attached to the plate were lysed in buffer containing 50 mM Tris (pH 
8.0), 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.05% SDS, 5 mM EDTA, 5 mM 
EGTA, and complete protease inhibitor mixture on ice for 30 min. Lysates were 
centrifuged at 15 000 x g for 10 min at 4°C and the supernatants were precleared with 
protein A-sepharose. Lysates were incubated with anti-p35 C-19 and N-20 antibodies 
(Santa Cruz Biotechnology) in shaking overnight at 4ºC. Immunocomplexes were 
precipitated with protein A-sepharose on a rotamix for 2 h at 4ºC and washed three 
times with the lysis buffer. Immunoprecipitated proteins were eluted from the beads by 
boiling in Laemmli sample buffer, run on SDS-PAGE and detected by Western blotting. 
The analysis of the interaction between nest-640 and endogenous Cdk5 during C2C12 
differentiation was performed using the same coimmunoprecipiation protocol with the 
exception that the cleared cell lysates were immunoprecipitated with polyclonal anti-GFP 
antibody (Living Colors, BD Biosciences) for 1 h at 4°C under rotation followed by the 
capture of immuno-complexes by protein A-sepharose beads for 4 h at 4°C.  
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To asses the effect of nestin on p35 ubiquitylation, ST15A cells were transfected with 
His-tagged p35, HA-tagged ubiquitin together with either nest-640 or empty GFP vector 
and treated with or without 20 µM MG132. Cells were lysed in lysis buffer containing 25 
mM Hepes (pH 7.4), 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 20 mM -
glycerophosphate, 20 mM para-nitro-phenyl phosphate, 1 mM PMSF, 1 mM DTT, 
complete protease inhibitor mixture, 5 µM MG132 and 20 mM N-ethylmaleimide. 
Ubiquitylated p35 was precipitated with protein G-sepharose beads (Amersham 
Biosciences) pre-coupled with anti-HA antibody (Santa Cruz Biotechnology). 
 
C2C12 and Cos7 cells were subjected to immunoprecipitation with anti-p35 and anti-
PKC (Santa Cruz Biotechnology) antibodies in lysis buffer consisting of 50 mM Hepes 
(pH 7.4), 140 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 0.4% NP-40, 10 mM pyrophosphate, 
5 mM Na3OV4, and complete protease inhibitor mixture. Cells were lysed for 30 min on 
ice and the particulate material was centrifuged at 12 000 x g for 10 min at 4°C. Protein 
concentration was measured by the Bradford assay and 800 µg of protein per lysates 
was precleared using sepharose beads. The cleared lysates were incubated with above 
mentioned antibodies and the immunocomplexes were captured with protein G-
sepharose beads and washed four times in 20 mM Hepes (pH 7.4), 2 mM EGTA, 100 
mM NaCl, 0.4% NP-40, and 1 mM DTT. Beads were finally resuspended in Laemmli 
sample buffer, boiled and analyzed by Western blotting. 
 
For immunoprecipitation of the Cdk5/p35 complex cell pellets were lysed on ice in 
immunoprecipitation buffer suitable for the Cdk5/p35 interaction analysis (50 mM Tris 
[pH 7.5], 150 mM NaCl, 1% Triton X-100, 10% glycerol, 5 mM EDTA, 5 mM EGTA, 1 
mM DTT, 1 mM PMSF, complete protease inhibitor mixture) for 30 min. Insoluble 
material was centrifuged at 15 000 x g for 10 min at 4°C after which samples were taken 
for input control. Lysates were precleared with protein A-sepharose for 1 h at 4°C and 
then incubated with anti-p35 antibody (C-19, Santa Cruz Biotechnology) for 1 h at 4°C in 
a rotamix. Protein A-sepharose beads were added and the incubation under rotation was 
continued for additional 4 h at 4°C. Sepharose beads were washed three times with 
immunoprecipitation buffer, resuspended in Laemmli sample buffer and the 
immunoprecipitated proteins were analyzed by Western blotting.   
 
 
7.4 Kinase activity assays (I, II) 
 
Cdk5 kinase activity was analyzed from H2O2-treated ST15A cells lysed in buffer 
containing PBS (pH 7.4), 1% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, 1 mM 
EGTA, 20 mM NaF, 1 mM PMSF, 0.5 mM DTT, and complete protease inhibitor mixture 
for 30 min on ice. To obtain a crude whole cell extract, samples were homogenized 8 
times with 26 G needle and centrifuged at 14 000 rpm for 15 min at 4°C. The protein 
concentration was determined using the Bradford assay and the samples were 
normalized accordingly. Cdk5 was immunoprecipitated with anti-Cdk5 antibody (C-8, 
Santa Cruz Biotechnology) and pulled down with protein A-sepharose beads. Beads 
were washed twice with lysis buffer and twice with kinase buffer (50 mM Mops [pH 7.4] 
and 5 mM MgCl2). The immunocomplexes were resuspended in 20 l of kinase buffer 
containing histone H1 (100 g/ml) as a kinase substrate and 1.2 l of ATP mix (2 l of -
32P ATP in 28 l of 2 mM cold ATP in kinase buffer) was added to start the reactions. 
Samples were incubated at 30°C for 20 min. The reactions were stopped by the addition 
of Laemmli sample buffer and boiling for 5 min. The samples were further centrifuged at 
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12 000 × g for 5 min at RT and run on SDS-PAGE. Phosphate incorporation into histone 
H1 was visualized by autoradiography. To analyze the Cdk5 activity in soluble fraction, 
ST15A cells were transiently transfected with p35 and nestin constructs, collected and 
lysed in fractionation buffer (25 mM Hepes [pH 7.6], 100 mM NaCl, 5 mM MgCl2, 5 mM 
EGTA, 0.5% Triton-X 100, complete protease inhibitor mixture) for 30 min on ice. 
Lysates were centrifuged at 15 000 x g at 4°C for 40 min and the supernatants were 
collected as soluble fractions. Immunoprecipitation of Cdk5 and kinase reaction were 
performed as described above. 
 
To measure PKC and Cdk5 activity during myoblast differentiation, PKC and Cdk5 
were immunoprecipitated from myoblasts harvested at indicated timepoints. Cells were 
lysed in buffer containing 50 mM Hepes (pH 7.4), 140 mM NaCl, 5 mM MgCl2, 5 mM 
EGTA, 0.4% NP-40, 10 mM pyrophosphate, 5 mM Na3OV4, and complete protease 
inhibitor mixture. Lysates were centrifuged at 12 000 x g for 10 min at 4°C and 
precleared with protein G-sepharose beads prior to immunoprecipitation with anti-PKC 
and anti-Cdk5 (C-8, Santa Cruz Biotechnology) antibodies in a rotamix at 4°C overnight. 
Following an incubation with protein G-sepharose beads the immunoprecipitates were 
collected by mild centrifugation and washed four times with 50 mM Hepes (pH 7.4), 5 
mM EDTA, 125 mM NaCl, 0.2% NP-40, and 1 mM DTT and twice with 50 mM Hepes 
(pH 7.4), 25 mM NaCl, and 1 mM DTT. For PKC activity assay beads were 
resuspended in PKC kinase buffer (50 mM Hepes [pH 7.4], 1 mM EDTA, 1 mM DTT, 10 
mM MgCl2) and for Cdk5 activity assay in Cdk5 kinase buffer (50 mM Tris-HCl [pH 7.4], 
5 mM MgCl2, 1mM EDTA, 1 mM DTT). Histone H1 (3 g) together with 200 µM ATP and 
10 µCi of -32P ATP was added to each sample. The reactions were allowed to proceed 
for 30 min at 32˚C (PKC) and at 25˚C (Cdk5) and were stopped by the addition of 
Laemmli sample buffer and boiling for 5 min. Samples were run on SDS-PAGE and 
subjected to autoradiography.  
 
 
7.5 In vitro protein phosphorylation and phosphorylation site identification 
(II) 
 
In vitro phosphorylation assays were performed using immunoprecipitated p35, His-
tagged p35 N-terminus (amino acids 1-120, Bioclone Inc), GST-tagged p35 C-terminus 
(amino acids 208-308, Abnova), the His-Cdk5/GST-p35 complex (Abnova), 
immunoprecipitated calpain 3 and recombinant calpain 1 (Calbiochem) as substrates. 
Immunoprecipitations were performed as described with PKC activity assay. The in 
vitro phosphorylation reactions were done in PKC kinase buffer (50 mM Hepes [pH 
7.4], 1 mM EDTA, 1 mM DTT, 10 mM MgCl2). 50 ng of recombinant human PKC 
(Upstate Biotechnology) together with 200 µM ATP and 10 µCi of 32P-ATP was added to 
each sample. The reactions were allowed to continue for 30 min at 32˚C and were 
stopped by the addition of Laemmli sample buffer and boiling. SDS-PAGE was 
subjected to autoradiography.  
 
In order to identify the PKC-specific phosphorylation sites on p35, His-tagged human 
p35 purified from Sf9 insect cells (Sakaue et al., 2005; Yamada et al., 2007) was used 
as a substrate in in vitro reaction where 3 µg of the recombinant p35 protein was 
incubated with or without 10 ng of recombinant human PKC in a buffer consisting of 50 
mM Tris-HCl (pH 7.5), 0.1% 2-mercaptoethanol, 0.1 mM EGTA, 0.1 mM sodium 
vanadate, 10 mM magnesium acetate, and 100 µM -32P ATP for 30 min at 30°C. Kinase 
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reactions were stopped by boiling in Laemmli sample buffer and the samples were 
resolved by SDS-PAGE and subjected to autoradiography. p35 bands were excised, 
reduced with DTT, alkylated with iodeacetamide, and then in-gel digested with trypsin. 
The tryptic digests were analyzed by liquid chromatography-tandem mass spectrometry 
using an LTQ-Orbitrap XL mass spectrometer (Xcalibur 2.0.7 software; Thermo Fisher 
Scientific) coupled to EASY-nLC (Proxeon). PepMap C18 trap column (0.3 x 5 mm; LC-
Packings) and PepMap C18 analytical column (0.075 x 150 mm; LC-Packings) were 
used.  
 
 
7.6 Metabolic 32P-labeling and phosphopeptide mapping (II) 
 
HEK293 cells were transfected with constitutively active PKC together with either WT 
or S33A-mutated myc-tagged p35 and let to recover for 24 h. The recovered, 
transfected cells were preincubated in phosphate-free minimum essential medium 
Eagle (MEME, Sigma) supplemented with 10% FBS, 2 mM L-glutamine and antibiotics 
for 30 minutes prior to the labelling with 0.3 mCi/ml 32P-orthophosphate (PerkinElmer) 
in MEME for 3 hours. Cells were harvested, rinsed with PBS and subjected to p35 
immunoprecipitation. Cell pellets were lysed in immunoprecipitation buffer (50 mM Tris 
[pH 8.0], 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.05% SDS, 5 mM EDTA, 5 
mM EGTA, 1 mM DTT, 0.1 mM NaOV3, 0.5 mM PMSF, 30 mM NaF, complete 
protease inhibitor mixture) for 30 min followed by centrifugation at 15 000 x g for 10 
min at 4°C. Lysates were precleared with 50% slurry of protein A-sepharose beads for 
1 h at 4°C and the cleared cell lysates were immunoprecipitated with anti-p35 antibody 
(C-19, Santa Cruz Biotechnology) under rotation overnight at 4°C. Immunocomplexes 
were captured with protein A-sepharose beads for 4 h at 4°C, washed three times with 
immunoprecipitation buffer and resuspended in Laemmli sample buffer. Samples were 
separated by SDS-PAGE followed by autoradiography with Fujifilm BAS-1800 
Bioimaging analyzer.  
 
In-gel tryptic digestions of 32P-labeled WT and S33A-mutated p35 followed by 2D 
phosphopeptide mapping were carried out as previously described (Kochin, et al., 2006). 
The labeled p35 bands were excised from the dried gel and in-gel digested overnight at 
37°C with 2 ng/μl sequencing grade trypsin (Promega) in 50 mM ammonium bicarbonate 
buffer (pH 8). Supernatants were collected, vacuum-dried and resuspended in 15 µl of 
pH 1.9 buffer (formic acid 2.3%, acetic acid 2.9%). Peptides were then separated in two 
dimensions by electrophoresis and thin layer chromatography (TLC). For the first 
dimension 15 µl of the tryptic digest was applied on a cellulose sheet (20 cm x 20 cm, 
Merck KgaA) and electrophoretically separated in pH 1.9 buffer at 750 V for 1.5 h using 
the Hunter Thin Layer Peptide Mapping System (C.B.S. Scientific). The sheet was dried 
and ascending TLC in the second dimension was performed for 13 h in a 
chromatography tank saturated with a mobile phase containing 30% water, 37.5% n-
butanol, 7.5% acetic acid, and 25% pyridine. The sheet was dried and the 32P 
phosphopeptides were visualized by autoradiography.  
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7.7 Calpain assays (II) 
 
The brains of 2-day-old FVB-n mice were isolated and homogenized in lysis buffer (20 
mM Hepes [pH 7.4], 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM EGTA), using a Teflon 
grinder (Sato et al., 2007). Each homogenate was centrifuged at 13 000 x g for 25 min at 
4˚C. Pellets were resuspended in 100 µl of lysis buffer, sonicated, and centrifuged again 
(13 000 x g, 25 min, 4˚C.). Recovered supernatants were divided into control and actual 
sample. Calpain activity was induced by the addition of 4 mM CaCl2 and the samples 
were incubated for 1 h at 37˚C. The reaction was stopped by the addition of EGTA to a 
final concentration of 10 mM and boiling in Laemmli sample buffer. C2C12 myoblasts 
transfected with WT and S33A myc-tagged p35 were treated equally to induce calpain 
activity. The processing of p35 was analyzed by Western blotting.  
 
Following a PKC-induced phosphorylation described above (without 10 µCi of 32P-
ATP), the His-Cdk5/GST-p35 complex was subjected to calpain cleavage assay using a 
commercial kit according to the manufacturer’s instructions (QIA120, Calbiochem). After 
incubation with or without recombinant calpain 1 for 5 min at RT, the reactions were 
stopped by the addition of Laemmli sample buffer. Samples were separated by SDS-
PAGE and analyzed by Western blotting. Commercial luciferase-based assay (calpain-
Glo assay, Promega) was used to monitor the calpain activity in myoblasts upon PKC 
inhibition. C2C12 cells were allowed to differentiate for 72 h in the presence or absence 
of either PS inhibitor (20 µM) or calpain inhibitor III (15 µM) and the activity of calpains 
was measured in each sample using the kit according to the manufacturer’s protocol.  
 
 
8 Statistics (I-III) 
 
Viability of H2O2-treated ST15A cells transfected with mock, dnCdk5, nest-1177, nest-
640, or cotransfected with nest-1177 and Cdk5, was analyzed by MTT assay and the 
results were presented as relative cell viability as related to the control (untreated 
population at 0 h) of each transfection. The graph represented the mean values of six 
experiments (*P<0.05). The comparisons of C2C12 differentiation and p35 degradation 
were made using GraphPad Prism software. In differentiation analyses the amount of 
MHC-positive cells was counted from 3-6 independent experiments and the results were 
presented as relative differentiation. For statistical analysis of the proliferation of nestin-
depleted myoblasts, values representing the relative proliferation were obtained from five 
independent experiments. The comparison of WT and S33A p35 processing to p25 was 
presented as normalized p25/p35 ratio. Quantification was made from the Western blots 
of three independent experiments using densitometry (ScionImage GelPlot 2). Likewise 
the quantification of p35 processing in SW13 cells was made from the Western blots of 
three independent experiments using densitometry and the obtained values were 
normalized to untreated control samples (value 1). Statistical significance was analyzed 
with unpaired Student’s t-tests for data from nestin overexpressing myoblasts whereas 
paired Student’s t-tests were performed for nestin downregulation and p35 degradation 
data and was marked by asterisks (***, P < 0.001; **, P < 0.01; *, P < 0.05 and ns, P > 
0.05). The bar graphs represent mean values and the standard errors of mean. 
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RESULTS AND DISCUSSION 
 
 
1 Nestin scaffold regulates the Cdk5/p35 signaling complex 
during oxidative stress (I) 
 
During the past decade IFs have emerged as regulatory scaffolds for a diverse range of 
signaling molecules (Pallari and Eriksson, 2006b). This intriguing ability has 
revolutionized the view on IF functions rendering IFs from solely mechanical proteins to 
active regulators of signal transduction. Earlier work from our group had described an 
association between the Cdk5/p35 signaling complex and IF protein nestin in progenitor 
cells of CNS, in differentiating myoblasts and at the NMJs (Sahlgren et al., 2003). We 
were tempted to scrutinize the role of nestin as a regulator of Cdk5/p35 and, thereby to 
further broaden the view on IFs as multifunctional signaling scaffolds. To execute our 
plans we needed a model system.   
 
Reactive oxygen species (ROS), such as free radicals and peroxides, are molecules that 
emerge due to metabolism of oxygen. Most of cellular ROS derives from normal 
metabolic reactions, for example oxidative phosphorylation, but also environmental 
pollutants and radiation can increase the amount of ROS. Since excess of ROS is 
detrimental for organisms, cells have efficient enzymes, the most well-known ones being 
superoxide dismutase, catalase, and glutathione peroxidase, to detoxify these reactive 
intermediates and to maintain the normal reducing environment within the cells. 
Oxidative stress arises from the imbalance in the generation and inactivation of ROS. 
Free radicals of oxygen are highly reactive and can damage all cellular components 
including proteins, lipids and DNA, subsequently leading to apoptotic cell death. 
Oxidative stress is a common pathogenic factor also in several neurodegenerative 
diseases (reviewed by Barnham et al., 2004). Neuronal progenitor cells have evoked 
interest due to the fact that they could provide a possible treatment for 
neurodegenerative disorders by means of regenerative therapy. Therefore, to know how 
neuronal progenitor cells behave in pathological environment and what kind of molecular 
mechanisms they exploit in responding to excess of ROS would increase the 
understanding of neuronal progenitor cell biology. Considering the death promoting 
activity of Cdk5 upon oxidative stress (Strocchi et al., 2003, Sun KH et al., 2008) and our 
findings regarding the association between nestin and the Cdk5/p35 signaling complex 
in progenitor cells of CNS (Sahlgren et al., 2003) we decided to address the functional 
importance of nestin as a regulator of Cdk5/p35 upon the exposure of neuronal 
progenitors to H2O2.  
 
 
1.1 Proteasome-mediated downregulation of nestin is associated with the 
induction of apoptosis upon oxidative stress (I) 
 
We exposed the ST15A neuronal progenitor cells to H2O2 to induce oxidative stress. 
Consistently with the current understanding of oxidative stress as a mediator of apoptotic 
cell death (Ozben, 2007), the H2O2-treatment of ST15A cells triggered apoptosis. This 
was evidenced by morphological changes, cell shrinkage and rounding, chromatin 
condensation visualized by DAPI staining (Figure 1A, I) and DNA fragmentation detected 
with PI flow cytometry assay (Supplementary figure 1, I). Most importantly, we observed 
a rapid downregulation of nestin, as already at 5-6 hours of H2O2-treatment nestin was 
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nearly completely depleted (Figure 1A, I). The downregulation of nestin seemed to 
precede the execution of apoptosis since at the time of nestin downregulation the 
cleavage of PARP or vimentin, both of which are known targets of caspase-3 (Boulares 
et al., 1999, Buyn et al., 2001), was not evident.  
 
Disassembly of the cytoskeleton is characteristic to apoptotic cell death and several IF 
proteins including vimentin, desmin and K18 are implicated as caspase targets (Caulin 
et al., 1997, Buyn et al., 2001, Chen et al., 2003). We found interesting differences both 
in the kinetics and mechanisms of downregulation of coexpressed vimentin and nestin 
forming heteropolymers. Firstly, the depletion of nestin occurred fast and was rather 
complete by the time when the cleavage of vimentin was induced and the protein 
amount of vimentin started to decline (Figure 1A, I). When examining the detached 
(apoptotic) cells, both the intact and caspase-cleaved vimentin were present whereas 
the full length nestin was almost totally absent from apoptotic cells further exemplifying 
the different kinetics of downregulation (Figure 1B, I). Similar differences between nestin 
and vimentin downregulation was observed also when programmed cell death was 
triggered in ST15A cells with the topoisomerase II inhibitor etoposide as well as in PC3 
and DU145 prostate cancer cells with TRAIL (data not shown). Secondly, the 
downregulation of nestin appeared not to be dependent on caspase activity as the 
general caspase inhibitor Z-VAD was not able to prevent the nestin downregulation 
(Figure 1C, I). Instead, nestin depletion seemed to originate from proteosomal activity 
since the treatment with the proteasome inhibitor MG132 efficiently blocked the 
downregulation of nestin. The proteasome pathway has been stated to govern the rapid 
reduction of nestin also during neuronal differentiation (Mellodew et al., 2004), a 
discovery in line with our results.       
 
 
1.2 Nestin is a survival determinant during oxidative stress (I) 
 
Considering our observations alluding to the downregulation of nestin as a prerequisite 
for the execution of cell death, we were eager to test whether the RNAi-mediated 
depletion of nestin prior to the exposure to H2O2 could affect the sensitivity of ST15A 
neuronal progenitor cells. Indeed, the depletion of nestin clearly sensitized the cells to 
oxidant-induced apoptosis as indicated by the increased amount of apoptotic cells 
among nestin-depleted cells compared to untransfected control cells or cells transfected 
with scrambled vector (Figure 2B, I). This result was further verified by using MTT cell 
viability assay and analyzing the PARP cleavage (Figure 2C-D, I). Contrary to the nestin 
silencing, the overexpression of nestin had a protective effect (Figure 3, I). The 
incidence of apoptosis as indicated by chromatin condensation was significantly lower in 
nestin overexpressing cells than in cells overexpressing empty GFP-vector. Thus, the 
rapid downregulation of nestin appears influential for the execution of oxidant-induced 
cell death. This result is in agreement with numerous studies describing enhanced cell 
death upon IF depletion (for example Caulin et al., 2000, Gilbert et al., 2001, 2004, 2008, 
Jaquemar et al., 2003, Tong and Coulombe, 2006), thereby corroborating the rather 
evident survival-promoting functions of IFs. Intriguingly, the antiapoptotic functions of 
nestin were recently highlighted in a study where the injection of nestin morpholino into 
zebrafish eggs resulted in developmental defects in the brain and eyes including 
reduced head and brain size as well as small and poorly organized eyes (Chen HL et al., 
2010). These abnormalities in embryo development turned out to derive from increased 
neuronal progenitor cell apoptosis. Hence, the concept of nestin as a potent survival 
determinant has important ramifications for understanding the regulation of cell survival, 
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not only when neuronal progenitor cells are exposed to stress but also during neuronal 
development. 
 
 
1.3 Cdk5 activity is regulated by nestin during oxidative stress (I) 
 
After establishing that nestin is downregulated during H2O2-induced apoptosis we 
wanted to confirm that Cdk5 is activated in this model system and determine whether 
Cdk5 activation correlates with nestin downregulation. Both the expression of Cdk5 
activator protein p35 and Cdk5 activity started to increase 5 hours after the induction of 
H2O2-treatement reaching the maximum at 6 hours (Figure 4A, I). By this time nestin was 
almost completely downregulated demonstrating that the elimination of nestin occurs 
before the maximal Cdk5 activity is obtained.      
 
As IFs have been determined to regulate a large number of signaling determinants 
(Pallari and Eriksson, 2006b) we wanted to delineate whether the interaction between 
nestin and Cdk5 could explain the nestin-mediated modulation of oxidant-induced cell 
death. Indeed, we detected an increase in Cdk5 activity in nestin-depleted cells upon 
H2O2-treatment compared to control cells transfected with scrambled vector (Figure 4B, 
I). This indicates that the nestin scaffold could affect the progress of H2O2-induced 
apoptosis by regulating the activation of death promoting Cdk5. Moreover, the 
expression of dnCdk5 in nestin-depleted cells reversed the sensitizing effect of nestin 
downregulation, hence suggesting that nestin is upstream of Cdk5 in the signaling 
cascade leading to oxidant-induced apoptosis (Figure 4C, I). However, the RNAi-
mediated nestin downregulation did not lead to spontaneous Cdk5-dependent apoptosis, 
although low levels of Cdk5 and p35 were estimated to be released from the IF scaffold 
to the cytoplasm (Figure 2B, I). This implies that oxidative stress provides an additional 
activation stimulus for Cdk5. In fact, an induction in the expression of Egr-1, a 
transcription factor regulating the expression of p35, is associated with oxidative stress 
and, hence, the enhanced Cdk5 activity is suggested to derive from the increased Egr-1-
mediated expression of p35 (Strocchi et al., 2003).       
 
In our previous study we had observed a colocalization of Cdk5 along nestin filaments in 
differentiating myoblasts (Sahlgren et al., 2003). The interaction was further confirmed 
by coimmunoprecipitation analysis of nestin and Cdk5/p35 from both C2C12 myoblasts 
and ST15A neuronal progenitor cells (Sahlgren et al., 2003). To investigate the Cdk5-
binding region on nestin in more detail, we utilized a series of nestin deletion mutants: 
nest-314, consisting of the short N-terminus and -helical rod domain, nest-640 and 
nest-1177, two constructs with increasing length of the C-terminal tail as well as nest-
T332, corresponding to the last 332 amino acids of the nestin C-terminus. These 
mutants differed in, besides their assembly properties, but also in their ability to 
associate with Cdk5 (Figure 5, I). According to the coimmunoprecipitation assays Cdk5 
interacted with nest-640 and nest-1177 but not with the deletion mutants representing 
the central rod domain or the far C-terminal domain, nest-314 and nest-T332 
respectively (Figure 5D and Supplementary figure 5, I). This result places the Cdk5-
binding region (amino acids 315-640) to the C-terminal domain of nestin. Compared to 
the endogenous nestin, nest-640 appeared remarkably more stable during oxidative 
stress (Figure 5C, I). This was an interesting observation suggesting that the far C-
terminal region of nestin is involved in determining nestin degradation. We were eager to 
investigate how these more stable nestin truncations, nest-640 and nest-1177, capable 
to sequester Cdk5, modulate the oxidant-induced apoptosis in ST15A neuronal 
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progenitor cells. We observed that the cells overexpressing nestin deletion mutants were 
less prone to apoptosis induced by H2O2-treatment (Figure 6, I). To illustrate that the 
protective effect was due to the deregulation of Cdk5 we did an experiment where we 
compared the viability of nest-1177 transfected cells to nestin-1177/Cdk5 double 
transfected cells after incubation with H2O2. The increased viability of nest-1177 
expressing cells was reversed by the simultaneous overexpression of Cdk5, pointing to 
the ability of nest-1177 to reduce the proapoptotic activity of Cdk5 (Figure 7A-B, I). 
Results were further strengthened by observations showing that nestin truncation nest-
640, Cdk5 and p35 formed a complex in H2O2-treated ST15A cells (Figure 7C, I).  
 
 
1.4 Nestin affects the subcellular localization, turnover and processing of 
p35 (I) 
 
The results presented above indicated that the prosurvival role of nestin would reside 
from the sequestration of the Cdk5/p35 complex and attenuation of Cdk5 activity. To 
examine in more detail the nestin-mediated regulation of Cdk5 activity, we induced an 
imbalance in the equilibrium between soluble and polymerized nestin by elevating nestin 
expression. Nestin deletion mutant nest-640 is not completely incorporated into the 
preexisting IF network composed of endogenous nestin and vimentin heteropolymerizing 
at a molar ratio of 1:4 (Steinert et al., 1999), but a fraction of nest-640 remains soluble 
increasing the soluble nestin pool within the cells (Figure 5B, I). Therefore, we 
transfected ST15A cells with nest-640 and p35 to induce Cdk5 activation, fractionated 
the harvested cell lysates, and analyzed the distribution of p35 which served as an 
indicator of the localization of activated Cdk5. In the absence of nest-640, p35 was 
localized mainly to the detergent insoluble fraction containing the cytoskeleton and cell 
membrane (Figure 8A, I). Considering the interactions between the Cdk5/p35 complex 
and endogenous, mainly filamentous nestin (Sahlgren et al., 2003) as well as the 
myristoylation-induced targeting of p35 to the cell membrane (Patrick et al., 1999, 
Kusakawa et al., 2000), this result was rather presumable. However, the transfection of 
nest-640 shifted p35 from the pelletable to soluble fraction. Moreover, Cdk5 activity was 
more intense in the detergent soluble pool when p35 was cotransfected with partially 
soluble nest-640 (Figure 8B, I). These results demonstrate the pronounced effect of 
nestin on the subcellular localization of p35 and, thereby, corroborate our assumption of 
the nestin-mediated sequestration of the Cdk5/p35 signaling complex.         
 
Different regulatory mechanisms governing Cdk5 activity have been described in the 
literature. For example, the activity of Cdk5 is regulated by a negative feedback loop 
where the Cdk5-mediated phosphorylation of p35 results in ubiquitylation and 
proteosomal degradation of p35 (Patrick et al., 1998). As nestin seemed to efficiently 
modulate the Cdk5/p35 complex through sequestration we wanted to determine whether 
the interaction between nestin and p35 could affect the turnover of p35. We transfected 
ST15A cells with nest-640, p35 and HA-tagged ubiquitin and treated the cells with the 
proteasome inhibitor MG132. It appeared that p35 was significantly less ubiquitylated 
when nestin was overexpressed (Figure 9A, I) indicating that nestin-mediated 
sequestration promotes the stability of p35. Consistently with this discovery, the half-life 
of p35 was prolonged upon the overexpression of nestin deletion mutant (Figure 9B, I).  
 
Another well-defined mechanism regulating the Cdk5 activity is the calpain-mediated 
cleavage of p35 to a more stable activator, p25, occurring during various neurotoxic 
conditions (Strocchi et al., 2003, Wang et al., 2003, Tang et al., 2005, Saito et al., 2007). 
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The generation of p25 leads to deregulated Cdk5 activity with detrimental effects. We 
detected an increase in the generation of p25 that correlated with nestin depletion and 
Cdk5 activation in terms of kinetics (Figure 7D, I) Therefore, we made an attempt to 
determine whether the nestin scaffold could have an effect on the cleavage of p35. We 
found that the overexpression of nestin in the form of nest-640 restrained the generation 
of p25 in stressed cells suggesting that the interaction with nestin protects p35 from 
calpains (Figure 7D, I). Taken together, nestin-mediated sequestration of p35 appears to 
efficiently modulate the fate of p35 by protecting it from different modes of proteolytic 
processing.  
 
What is then the mechanism underlying the nestin-mediated regulation of p35? The 
anchorage of p35 to nestin IFs could reduce the susceptibility of p35 to calpain attack 
due to sequestration of p35 away from the activated calpains or steric masking of the 
potential calpain-cleavage sites on p35. Interaction-based protection of the calpain target 
proteins is not unusual and, for example Rb has been illustrated to be protected from 
calpain-mediated cleavage by the association of serine protease inhibitor SerpinB2 to 
the calpain cleavage site of Rb (Tonnetti et al., 2008). The cytoprotective role of 
SerpinB2 in TNF-induced apoptosis was shown to stem from the elevated levels of Rb 
repressing the transcription of proapoptotic genes through a negative regulation of E2F 
family of transcription factors. On the other hand, the Cdk5-dependent phosphorylation 
of T138 on p35 has been described to reduce the susceptibility of calpain-mediated p35 
cleavage (Kamei et al., 2007). This was considered to derive either from the reduced 
affinity of calpains or selective binding of other proteins to T138-phosphorylated p35. 
Hence, alternatively, the p35 interaction with nestin could modulate the phosphorylation 
status of p35 or nestin could sequester the phosphorylated form of p35. Moreover, the 
phosphorylation of T138 was observed to facilitate the proteosomal degradation of p35, 
thereby explaining the decreased probability to become exposed to calpains (Wei et al., 
2005a, Kamei et al., 2007). On the basis of our results it could be estimated that the 
sequestration of phosphorylated p35 by nestin would both interfere with the targeting of 
phosphorylated p35 to proteasomes, thereby increasing the half-life of p35, and hamper 
the calpain-mediated generation of death-promoting p25. Phosphorylation of T138 on 
p35 has been proposed to function as a regulatory switch and the resistance of fetal p35 
to calpain-dependent cleavage to derive from the increased phosphorylation on this 
particular site (Kamei et al., 2007). In adult brain where different forms of stress can 
enhance the generation of p25, the levels of phosphorylated T138 were significantly 
reduced. Therefore, exploring the relationship between nestin expression and the 
phosphorylation of p35 on T138 as well as the ability of nestin to sequester 
phosphorylated p35 would reveal whether these regulatory mechanisms cooperate in 
protecting the developing CNS from uncontrolled Cdk5 activity.   
   
Due to the lack of an N-terminal myristoylation group, p25 is more prominently 
distributed to the cytosol and nucleus, thereby enabling spatially less restricted Cdk5 
activation (Patrick et al., 1999, Kusakawa et al., 2000). Increased nuclear localization of 
p25 has been observed in neurons in which cell death is triggered by ER stress (Saito et 
al., 2007), glutamate-induced excitotoxicity or by treatment with a DNA-damaging agent 
(O’Hare et al., 2005). O’Hare and colleagues presented that the Cdk5/p25 complex 
would promote cell death within the nucleus whereas the cytoplasmic Cdk5/p35 complex 
would mediate prosurvival signals. In support of their conclusion, Cdk5 is known to 
modulate the activities of nuclear proteins. For example, survival factor MEF2 is 
inactivated by Cdk5 (Gong et al., 2003, Tang et al., 2005) whereas Cdk5 stimulates the 
cell cycle regulator Rb causing an aberrant and detrimental cell cycle reentry (Hamdane 
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et al., 2005). We sought to define the effect of nestin on the subcellular localization of 
p35/p25 during oxidative stress. ST15A cells were transfected with plasmids encoding 
p35 together with either GFP-tagged nestin deletion mutants or empty GFP-vector as a 
control, incubated with H2O2 and stained with anti-p35 antibody recognizing both p35 
and p25. Nestin deletion mutants turned out to sequester p35 to the cytoplasm as the 
cytoplasmic labeling of p35 was clearly decreased in the presence of empty GFP-vector 
(Figure 7E, I). Respectively, p25 accumulated in the nucleus of control cells transfected 
with empty GFP-vector as demonstrated by the immunostaining and Western blot 
analysis of nuclearly enriched fractions (Supplementary figure 6, I).  
 
In conclusion, in the utilized model system where neuronal progenitor cells were 
exposed to oxidant-induced cell death, the enhanced Cdk5 activity and the appearance 
of p25 correlated with the induction of apoptosis. The protective effect of dnCdk5 (Figure 
7A, I) indicates that Cdk5 has functional significance and that the generation of p25 is 
not only a mere consequence of apoptotic protease activity. Furthermore, the cleavage 
of p35 to p25 is known to change the subcellular distribution of activated Cdk5 and allow 
the phosphorylation of aberrant target proteins. Thus, the accurate regulation of the 
Cdk5/p35 signaling complex appears extremely essential. We observed that ectopic 
expression of IF protein nestin remarkably promoted cell survival in neuronal progenitor 
cells exposed to oxidative stress. This was proposed to reside from the nestin-mediated 
sequestration of the Cdk5/p35 signaling complex into the cytoplasm and the ability to 
increase the stability and decrease the processing of p35 to death-promoting p25 
(Figure 14). Therefore, nestin can be concluded to function as an important regulator of 
the Cdk5/p35/p25-mediated signaling pathway and the survival-promoting function of 
nestin to stem from the regulation of apoptosis-modulating signaling (section 2.1.2). The 
downregulation of nestin appears as an essential step in the cascade of events leading 
to the activation of Cdk5 and the induction of apoptosis during oxidative stress.  
 
 
1.5 Does nestin scaffold regulate the Cdk5/p35 complex in other 
physiological contexts? 
 
As the Cdk5 activity is restricted to certain cell types and cellular activities, observations 
of nestin as a regulator of the Cdk5/p35 complex raise the following questions: Does 
Cdk5Cdk5
p35
oxidant-induced 
cell death
nestin
inactive
p35 p25
Figure 14. Nestin-mediated regulation of the 
Cdk5/p35/p25 signaling complex during 
oxidative stress. Cdk5 becomes activated during 
oxidative stress either by p35 or its cleavage 
product p25. (To simplify the scheme Cdk5, p35 
and p25 are presented here in one complex, 
although Cdk5 interacts with one activator at a 
time.) Nestin protects neuronal progenitor cells 
from oxidative stress-induced cell death through 
the sequestration of the Cdk5/p35 signaling 
complex into the cytoplasm and through the ability 
to increase the stability and decrease the 
processing of p35 to death-promoting p25. In 
addition, Cdk5 participates in the regulation of its 
own nestin scaffold (discussed in section 3.1). 
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nestin expression typify the cell types undergoing Cdk5-mediated cellular processes? 
Can the neural nestin-mediated regulation of Cdk5 be extended to other cell types and 
distinct cellular events? Indeed, following our observation describing the interplay 
between nestin and the Cdk5/p35 complex in apoptotic neuronal progenitor cells, the 
modulatory function of nestin over Cdk5 has been referred to in other cell systems. 
RNAi-mediated depletion of nestin has been presented to render vascular smooth 
muscle cells more prone to H2O2-induced apoptosis (Huang YL et al., 2009b). However, 
in these cells Cdk5 seemed to play a prosurvival role and phosphorylate Bcl-2 which is 
known to enhance the antiapoptotic potential of Bcl-2 (Cheung et al., 2008). The 
stimulation of stressed vascular smooth muscle cells with EGF induced nestin 
expression and promoted cell survival, the effect assumed to arise from the regulation of 
Cdk5 (Huang YL et al., 2009b). Nestin and Cdk5 have been shown to colocalize also in 
kidney podocytes, the epithelial cells of renal glomerulus, where Cdk5 was suggested to 
regulate the IF cytoskeleton in podocyte processes (Bertelli et al., 2007). Moreover, the 
interrelationship between nestin and Cdk5 could be hypothesized to play a regulatory 
function also in other contexts. Concomitant expression of nestin and Cdk5 is apparent 
in testicular Leydig cells (Lin et al., 2009, Lobo et al., 2004) as well as in neuronal 
progenitors launched to migrate from the ventricular zone of developing cortex (Clarke, 
2007). The latter indication prompts to postulate that nestin could play a role in 
determining the early induction and pace of Cdk5-dependent neuronal migration. 
Recently both nestin and Cdk5 have been described to be essential for the migrational 
ability of prostate cancer cells (Kleeberger et al., 2007, Strock et al., 2006). Moreover, 
considering the specific accumulation of nestin and Cdk5 in growth cones (Nikolic et al., 
1996, Yan et al., 2001), the extensions of developing axons searching synaptic targets, it 
is even more tempting to speculate that nestin would participate in the regulation of 
Cdk5/p35 during cell motility. Taken together, the expression patterns of nestin and 
Cdk5 appear seemingly similar and, hence, the ability of nestin to operate as an 
organizational scaffold for Cdk5/p35 in multiple tissues and cell compartments during a 
variety of cellular functions seems conceivable. In the future, careful examination of the 
upcoming nestin KO mice could provide important in vivo evidences how/if the various 
Cdk5-dependent events in different tissues are affected by nestin.     
 
 
2 PKC acts as an upstream regulator of Cdk5 in differentiating 
myoblasts (II)  
 
Skeletal muscle differentiation is a multistep process entailing the irreversible withdrawal 
of proliferating myoblasts from the cell cycle as well as the expression of muscle-specific 
genes and culminating to the fusion of myoblasts to multinucleated myotubes 
(Buckingham, 2006, Shi and Garry, 2006, Grefte et al., 2007). Myogenesis is tightly 
regulated and characterized by the activation of a vast number of signaling determinants 
ranging from cell surface molecules to transcriptional regulators and cytoplasmic 
signaling modulators (reviewed by Jansen and Pavlath, 2008). Among others, Cdk5 has 
been implicated as a regulator of myogenesis (Lazaro et al., 1997, Philpott et al., 1997). 
We have earlier demonstrated the formation of a Cdk5-nestin signaling complex in 
myoblasts and shown that Cdk5 regulates the reorganization of nestin filaments during 
myogenic differentiation (Sahlgren et al., 2003). However, relatively little is known about 
the upstream regulation of Cdk5 during myogenesis. In differentiating L6 rat myoblasts 
the PI3K-Akt-p70S6K pathway has been presented to promote Cdk5 activity by 
upregulating the transcription factor Egr-1, known to mediate the induction of p35 
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expression (Sarker and Lee, 2004). We wanted to further explore the signaling cascades 
essential for myogenic differentiation and investigate the mechanisms of Cdk5 activation 
in differentiating myoblasts in more detail. In the light of the information of PKC in 
development (for example Wooten et al., 1994, 1999, Mansat-De Mas et al., 2002, 
Martin et al., 2002, 2005), we pursued to study whether PKC acts in myogenesis. 
 
 
2.1 Progress of myoblast differentiation is critically regulated by PKC (II) 
 
To asses the possible role of PKC in myogenic differentiation, we downregulated PKC 
using RNAi or inhibited PKC activity by employing a specific PKC pseudosubstrate 
(PS) inhibitor both in mouse primary myoblasts and in C2C12 myoblast cell line. The PS 
inhibitor is a synthetic peptide corresponding to the PKC PS sequence. It is linked to a 
myristoyl group to facilitate the transport through the cell membrane. This peptide 
suppresses the activity of PKC by an autoinhibitory mechanism by associating to the 
substrate-binding cavity of PKC catalytic domain. The specificity and the effective dose 
of PS inhibitor have been extensively verified in several studies (Sun et al., 2005, 
Fishelevich et al., 2006). Scrambled peptide with identical myristoyl group was utilized to 
exclude the unspecific effects of the myristoyl group and peptide treatment.  
 
Myoblasts were induced to differentiate and the progress of differentiation was analyzed 
by detecting the formation of multinucleated myotubes and the presence of the 
differentiation markers MHC, desmin and troponin. The downregulation of PKC 
(siPKC) in primary myoblasts efficiently abrogated myoblast fusion and the expression 
of myogenic markers when compared to the cells transfected with scrambled RNAi 
oligos (Figures 1A and 2A, II). Similarly, the PS inhibitor efficiently blocked myoblast 
differentiation without any toxic effects. The formation of multinucleated myotubes was 
impaired and the expression of myogenic markers reduced following the PS treatment 
both in primary (Figures 1B and 2B, II) and C2C12 myoblasts (Supplementary figures 
1A-B, II). Differentiation of myoblasts was not affected in the presence of Calphostin C, 
an inhibitor of conventional and novel PKCs (Supplementary figure 1C, II), thereby 
confirming the specific and essential function of atypical PKC in myoblast 
differentiation.  
 
 
2.2 PKC is a master controller of Cdk5 activity during myogenic 
differentiation (II) 
 
By examining the protein levels and the activation of PKC during myoblast 
differentiation we aimed at to analyze in more detail the role of PKC in this process. 
While the protein levels of PKC remained relatively stable during the differentiation 
process (Figure 3A, II), the activity of PKC was significantly increased at 48 hours of 
differentiation (Figure 3B, II). In addition to our research group, Ödemis and coworkers 
(2007) have examined and reported the effects of PKC in differentiating myoblasts. 
However, they utilized a different model system as they investigated the potential effects 
of stromal derived factor 1 (SDF-1) on the migration and differentiation of myoblasts. 
Chemokine SDF-1 and its receptor, CXC chemokine receptor 4 (CXCR4), have been 
extensively studied in hematopoietic cells but have also been reported to affect limb 
myogenesis (Ödemis et al., 2005). Ödemis and coworkers (2007) observed that the 
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treatment of myoblasts with SDF-1 induced the activation of PKC and promoted the 
ability of myoblasts to migrate but attenuated differentiation. Inhibition of PKC abolished 
the inhibitory effect of SDF-1 on the induction of differentiation. The results by us and 
Ödemis and coworkers besides demonstrate the critical role of PKC in myogenesis but 
also highlight the importance of the strict temporal regulation of PKC activity.  
 
We paid also attention to the kinetics of PKC activation which correlated with the 
previously investigated Cdk5 activity (Sahlgren et al., 2003). Thus, we were eager to 
explore the possible crosstalk between PKC and Cdk5. To address whether the 
inhibition of Cdk5 reduces PKC activity, we treated the differentiating C2C12 myoblasts 
with the Cdk5 inhibitor Roscovitine. However, no difference was detected in the PKC 
activation although Cdk5 inhibition efficiently blocked the progress of differentiation 
(Supplementary figure 2, II). As this result indicated that PKC acts upstream of Cdk5 in 
the differentiation process, we proceeded to investigate the effect of PKC inhibition on 
Cdk5 activity. The PS-treatment resulted almost total inhibition of Cdk5 activity (Figure 
4A, II) which we interpreted to confirm our hypothesis of PKC lying upstream of Cdk5 in 
the signaling cascade directing the differentiation of myoblasts.    
 
 
2.3 PKC promotes the calpain mediated processing of p35 to p25 (II)  
 
While searching the mechanism of PKC to stimulate Cdk5 activity, we tested the ability 
of PKC to directly interact with p35 in myoblasts. We were able to point out that the 
association between PKC and p35 was rather weak in undifferentiated myoblasts but 
increased when differentiation proceeded implying that the PKC-mediated regulation of 
Cdk5 activity could stem from the regulation of p35 (Figure 5B, II). Prompted by this 
result we surveyed whether PKC phosphorylates p35 and found that, indeed, p35 was 
a substrate of PKC (Figure 5C, II). The stretch of p35 targeted by PKC was narrowed 
down by two different recombinant fragments of p35 utilized in in vitro phosphorylation 
assays with recombinant PKC. Only the N-terminal fragment of p35 turned out to be 
phosphorylated by PKC (Figure 5D, II). For us this experiment provided interesting 
information, as it showed that p35 is phosphorylated on the N-terminus which is cleaved 
and removed to give rise to the p25 activator. Later on S33 on p35 was verified as a 
PKC-specific phosphorylation site with mass spectrometry and in vivo phosphorylation 
analyses (Supplementary figures 4-5, II). 
 
Although Cdk5 has been implicated to be important for skeletal muscle development 
(Lazaro et al., 1997, Philpott et al., 1997), the mechanisms of Cdk5 and p35 regulation 
have not been thoroughly analyzed. While exploring the effect of PS-treatment on the 
protein levels of p35 during myoblast differentiation, we detected an appearance of a 
protein band the size of which appeared to be around 25 kDa (Figure 6A, II). This band 
was recognized by the C-19 anti-p35 antibody that specifically interacts with the p35 C-
terminus. The calpain-mediated cleavage of p35 to p25 is well established in 
neurodegenerative diseases where the hyperactivation of Cdk5 by p25 leads to 
damaging phosphorylation events (Patzke and Tsai, 2002a, Cruz and Tsai, 2004). 
Therefore, the possible occurrence of p25 during myoblast differentiation was a major 
surprise for us and we invested a lot of work to convince ourselves about the identity of 
p25. In addition to confirming the dependence of p25 generation on calpain activity 
(Figure 6B, II), we reproduced an experiment described in the literature where the CaCl2-
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treatment of brain lysates induces the cleavage of p35 and the generation of p25 (Sato 
et al., 2007). We were able to show that the p25 produced in CaCl2-treated mouse brain 
lysates matches with the p25 produced during the differentiation of mouse primary 
myoblasts (Supplementary figure 6B, II). The treatment of differentiating myoblasts with 
the calpain inhibitor revealed that besides inhibiting the generation of p25, calpain 
inhibitor blocked the differentiation process (Figure 6B, II). This result supports the 
physiological relevance of p25 as an effector of Cdk5 during myogenic differentiation. 
Despite the prominent neurodegenerative functions, p25 has been depicted also in other 
non-detrimental physiological processes. Moderate amounts of p25 have been 
described to positively modulate the signal transduction at synapses and improve 
cognitive functions (Fischer et al., 2005, Ris et al., 2005). However, the putative role of 
Cdk5/p25 in normal homeostasis emphasizes the need for a tight spatiotemporal 
regulation of p35 processing.   
  
The experiments that uncovered the generation of p25 during the differentiation of 
C2C12 and primary myoblasts indicated also an involvement of PKC in the process as 
the PS inhibitor significantly decreased the formation of p25 (Figures 6A and 6C, II). 
Thus, the obvious question arising was, how PKC affects the calpain-mediated 
processing of p35. Cdk5-mediated phosphorylation of T138 on p35 has been proposed 
to negatively regulate the susceptibility of p35 to calpain-dependent cleavage (Kamei et 
al., 2007). Therefore, we decided to investigate if the PKC-specific phosphorylation site, 
S33 on p35, affects the calpain-mediated processing of p35. We performed site-directed 
mutagenesis to replace S33 with an alanine residue and studied the susceptibility of the 
mutated p35 to calpain-mediated processing by utilizing two well-established methods 
where the calpain activation is triggered either by the calcium ionophore A23187 or by 
CaCl2 (Kusakawa et al., 2000, Kamei et al., 2007). The treatment of C2C12 myoblasts 
transfected with WT p35 or p35 S33A with A23187 or the treatment of transfected cell 
lysates with CaCl2 followed by Western blot analysis revealed that p35 S33A is more 
resistant to calpain-mediated cleavage than WT p35 (Figure 8A and Supplementary 
figure 8, II). Moreover, an in vitro cleavage assay where the Cdk5/p35 complex was pre-
incubated with the recombinant PKC prior to the incubation with the recombinant 
calpain 1 confirmed that the cleavage of p35 to p25 was more prominent following the 
PKC-dependent phosphorylation (Figure 8B, II). Our results were consistent with the 
existing literature showing that the inhibition of Cdk5 by Roscovitine increases the 
generation of p25 in in vitro cleavage assays (Kamei et al., 2007). However, we 
observed that the PKC-mediated regulation of p35 processing was not affected by 
Cdk5 but more likely PKC potentiates the proteolytic degradation of p35. This illustrates 
the capability of PKC to override the Cdk5-dependent autoinhibitory loop. Based on our 
data we hypothesized that the PKC-dependent phosphorylation of p35 on S33 is a 
regulatory switch enabling the fast spatiotemporal formation of p25 in differentiating 
myoblasts. The mechanistic details, whether the PKC-mediated phosphorylation of p35 
to S33 directs p35 to calpains or promotes the calpain-dependent cleavage by 
preventing the protecting phosphorylation events (other than Cdk5-dependent), remain 
to be determined.  
 
While studying the role of PKC-dependent phosphorylation on the calpain-mediated 
p35 processing, we tested also the ability of PKC to affect the p35 cleavage by directly 
regulating calpain activity. The identification of another aPKC, PKC, as a regulator of 
calpains (Xu and Deng, 2006) prompted us to test this hypothesis. We observed that the 
inhibition of PKC activity by the PS inhibitor or downregulation of PKC expression by 
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RNAi decreased the autocleavage (indicating activation) of both ubiquitous calpain 1 (-
calpain) and muscle-specific calpain 3 in C2C12 and mouse primary myoblasts (Figures 
7A-B, II). Moreover, according to a luciferase-based calpain activity assay, the inhibition 
of PKC resulted in an overall decrease in calpain activity at 72 hours of differentiation 
(Supplementary figure 7A, II).  
 
Ca2+-dependent intracellular proteases, calpains have been previously depicted to have 
a critical regulatory role during the different stages of myogenic differentiation. Calpain 
activation has been described to regulate myoblast migration critical for the early steps 
of muscle development (Leloup et al., 2007). The overexpression of endogenous calpain 
inhibitor, calpastatin, has been reported to prevent myoblast fusion and inhibit the 
degradation of talin (Barnoy et al., 1998, 2005), the proteolysis of which is important for 
adhesion site disassembly and turnover (Franco et al., 2004). Specific downregulation of 
calpain 2 diminished the adhesiveness and inhibited the fusion of C2C12 myoblasts 
(Honda et al., 2008). The importance of calpains in myogenesis has been examined also 
in vivo. Specific disruption of calpain 3 gene in mice resulted reduced muscle mass 
(Kramerova et al., 2004). More elaborate analysis of the calpain 3 KO myoblasts 
revealed a disturbed sarcomere organization although myoblast fusion occurred rather 
normally. Later on the membrane-bound M-cadherin/-catenin complex was stated to be 
cleaved by calpain 3 but, intriguingly, this modification appeared to regulate myogenesis 
by preventing the excess of myoblast fusion (Kramerova et al., 2006). Calpains have 
also been shown to target signaling determinants such as PKC in differentiating 
myoblasts (Liang et al., 2006). Our results delineate an interesting role for PKC at the 
outset of calpain activation in differentiating myoblasts. Moreover, we managed to show 
that calpain 3 interacts with PKC during differentiation and is a direct phosphorylation 
target of PKC (Supplementary figure 7B-C, II). Whether PKC-dependent regulation 
governs also other calpains or different cellular activities marked by calpain activation 
would be fascinating to study.   
 
In summary, we provide data from the requirements for p25 during myogenic 
differentiation and depict PKC as the major upstream regulator of the Cdk5/p35/p25 
signaling pathway in differentiating myoblasts (Figure 15). PKC is suggested to function 
both by phosphorylating p35 into a calpain cleavage-permissive form and by boosting 
calpain activity. Although PKC KO mice are available for research purposes, there are 
no reports, however, applying the involvement of PKC with muscle development. In 
fact, the mouse models for PKC and also for Cdk5 have been characterized in detail 
only in terms of lymphoid organs (Leitges et al., 2001, Martin et al., 2002) and CNS 
(Ohshima et al., 1996, 1999, Gilmore et al., 1998) respectively. In the light of our results, 
the specific reexamination of the skeletal muscles and myocardium in PKC KO mice 
would be of concern, although in vivo, however, it is worth remembering that the other 
aPKC, the ubiquitously expressed PKC, could compensate for the loss of  isoform 
(Martin et al., 2002). Furthermore, considering the potential beneficial role of Cdk5/p25 
in non-pathological CNS processes, such as learning and memory (Fischer et al., 2005, 
Ris et al., 2005, Angelo et al., 2006), it would be captivating to analyze what kind of 
mechanism could define the strictly regulated generation of p25. Brain-specific atypical 
protein kinase M  (PKM) is generated from mRNA transcribed from an internal 
promoter within the PKC gene (Hernandez et al., 2003). Thus, the sequence of PKM 
contains the C-terminal catalytic domain of PKC without the N-terminal regulatory 
region due to which PKM is autonomously active. Interestingly, PKM activity is 
associated with Cdk5/p25-dependent processes. It is involved in the maintenance of 
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LTP at synapses, which is critical for synaptic plasticity and memory formation 
(Hernandez et al., 2003, Yao et al., 2008). In addition, PKM is observed to accumulate 
to neurofibrillary tangles in the neurons of limbic system in AD (Crary et al., 2006). 
Although being less abundant in CNS, also PKC has been implicated important for 
neurite elongation, a process utilizing Cdk5 (Mori et al., 2009). Therefore, studying the 
significance of aPKCs in the regulation of p35 during neuronal development and 
homeostasis as well as during neurodegenerative disorders could perhaps provide novel 
information of the p35 processing in CNS.  
 
 
2.4 Putative functions of Cdk5/p25 during myogenesis  
 
When deliberating the potential functions of the Cdk5/p25 complex during myogenesis 
one often encounters the fact that the formation of p25 generally depicts apoptotic 
responses (O’Hare et al., 2005, Saito et al., 2007). However, myogenic differentiation 
has been described to possess several features of apoptosis. Matrix metalloproteinases, 
the activation of which triggers programmed cell death, appear essential for the myotube 
formation (Yagami-Hiromasa et al., 1995). Caspase-3 activation is required for myoblast 
fusion and, moreover, those caspase-3 KO mice that survive to early perinatal life show 
a reduction in skeletal muscle mass compared to WT littermates (Fernando et al., 2002). 
In addition, the overexpression of apoptosis repressor with caspase recruitment domain 
inhibits myoblast differentiation (Hunter et al., 2007). Therefore, one could assume that 
the functions and target proteins of the Cdk5/p25 complex in differentiating myoblasts 
would resemble those identified in stressed neurons. For example, the Cdk5-mediated 
phosphorylation of the transcription factor MEF2 incurs the caspase-dependent MEF2 
degradation, thereby impairing the ability of MEF2 to protect neurons from apoptosis 
(Gong et al., 2003, Tang et al., 2005). Consistently, the Cdk5/p25-dependent 
phosphorylation of MEF2, central factor also in differentiating myoblasts (Naya and 
Olson, 1999), could perhaps adjust the timing and progression of myogenesis. 
 
The generation of p25 in differentiating myoblasts could also reflect the need for 
prominent although rather acute Cdk5 activity as well as the less restricted subcellular 
distribution of activated Cdk5. It has been reported that the nuclear localization of Cdk5 
defines the postmitotic state of neurons (Zhang et al., 2008). Thus, keeping in mind the 
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Figure 15. PKC acts as a master controller of 
Cdk5 activity in differentiating myoblasts. PKC 
regulates the activity of Cdk5 by enhancing the 
calpain-mediated processing of p35 to a more stable 
activator, p25, through p35 phosphorylation and 
calpain activation.  
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nuclear localization of p25 (Patrick et al., 1999, Kusakawa et al., 2000), it would be 
tempting to postulate that the PKC-mediated formation of p25 would enable the nuclear 
activity of Cdk5, thereby prohibiting differentiating myoblasts from reentering the cell 
cycle. However, it was recently reported that the Cdk5-dependent cell cycle suppression 
in neuronal cells derives from the association between Cdk5/p35 complex and 
transcription factor E2F1 in the nucleus (Zhang et al., 2010). This interaction, reducing 
the DNA binding ability of the cell cycle regulator E2F1, was observed to be dependent 
on p35 but not p25. Among nuclear proteins, the activities of which are facilitated by 
Cdk5, are also p53 and Rb (Hamdane et al., 2005, Lee et al., 2007). Interestingly, both 
p53 and Rb have been established important for myoblast differentiation the latter being 
implicated in irreversible cell cycle withdrawal and in the expression of late muscle 
differentiation markers (Porrello et al., 2000, De Falco et al., 2006). Although claiming 
the importance of p25 during myogenesis seems justified based on the introduced 
studies, to fully understand the role of p25 during myogenesis requires further 
experimentation.  
 
 
3 Nestin stability and organization are regulated by Cdk5 (I, II, III) 
 
Phosphorylation-based regulation critically determines the dynamic nature of IF proteins 
(Omary et al., 2006, Pallari and Eriksson, 2006a). Both the assembly state and stability 
can be modulated by the phosphorylation of IF protein head and tail domains. In addition 
to functioning as a scaffold for the Cdk5/p35 complex, nestin has appeared to be 
prominently phosphorylated by Cdk5 (Sahlgren et al., 2003). From our earlier studies we 
knew that the Cdk5-mediated phosphorylation is essential for the disassembly and 
reorganization of nestin filaments upon myoblast differentiation (Sahlgren et al., 2003). 
In this PhD project I wanted to address whether Cdk5 affects also nestin turnover and 
stability. 
 
 
3.1 Cdk5 affects nestin turnover in H2O2-treated neuronal progenitor cells (I) 
 
Previous work from our laboratory had characterized T316 and T1495 in the nestin C-
terminal domain as Cdk5-dependent phosphorylation sites (Sahlgren et al., 2003). In 
addition, we have got indications of two additional putative Cdk5 phosphorylation sites, 
S620 and S729, residing both in the nestin tail domain (Hanna-Mari Pallari and Vitaly 
Kochin unpublished observations). Taking into account this pronounced targeting of 
nestin by Cdk5, we decided to analyze if activated Cdk5 regulates its own scaffold in 
H2O2-treated ST15A neuronal progenitor cells. Inhibition of Cdk5 activity by Roscovitine 
or transfection with dnCdk5 reduced nestin degradation upon oxidative stress, indicating 
that Cdk5 is involved in the regulation of nestin turnover (Supplementary figure 3, I). The 
possible direct involvement of Cdk5 in regulating nestin degradation is consistent with 
the observation that the nestin deletion mutant, nest-640, lacking the established Cdk5 
specific phosphorylation site T1495 (as well as the potential site S729) is significantly 
more stable during oxidative stress than the full length nestin (Figure 5C, I). According to 
these observations it seems that Cdk5-mediated phosphorylation may promote the 
degradation of nestin in stressed neuronal progenitor cells. As earlier indicated, despite 
the apparent nestin degradation and the generation of a nestin cleavage product during 
oxidative stress (Figure 1A, I), nestin is not proteolyzed by caspases. However, stress 
induces the activation of several proteolytic enzymes including calpains, the ability of 
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which to process nestin has not been investigated. Dephosphorylation of NFs has been 
reported to protect NFs from calpain-mediated proteolysis (Pant 1988, Greenwood et al., 
1993) raising the questions whether also nestin could be a calpain target and what 
would be the significance of the Cdk5-mediated nestin phosphorylation in this mode of 
degradation. 
 
 
3.2 PKC-Cdk5 signaling cascade determines nestin reorganization and 
stability in differentiating myoblasts (II, III) 
 
An earlier piece of work by our research group had proven that Cdk5 is required for the 
reorganization of nestin filaments into parallel fibers during the fusion of C2C12 
myoblasts into multinucleated myotubes (Sahlgren et al., 2003). Cdk5 phosphorylated 
nestin on T316, thereby promoting the disassembly of nestin filaments which was 
postulated to precede and enable the structural modifications in nestin IFs occurring 
during myoblast fusion. Therefore, while investigating the functions of PKC-Cdk5 
signaling axis in differentiating myoblasts, we decided to use nestin as a physiological 
downstream marker for Cdk5 activity. We observed that in the presence of the PS 
inhibitor or when PKC was downregulated with RNAi, nestin reorganization was 
severely disturbed in differentiating myoblasts (Figure 4B-C, II). The morphological 
abnormalities in cells corresponded with the previously observed modifications upon 
Cdk5 inhibition (Sahlgren et al., 2003) and further confirmed that PKC controls 
myogenic differentiation through the regulation of Cdk5. During our attempts to 
characterize the PKC downstream target proteins we tested also the ability of PKC to 
phosphorylate IF proteins. Interestingly, using IF preparation isolated from ST15A 
neuronal progenitor cells as a substrate, we noticed that PKC efficiently phosphorylated 
vimentin but not nestin (data not shown, Hanna-Mari Pallari and Aurelie de Thonel, 
unpublished observations). The result was further confirmed using bacterially expressed 
vimentin as a PKC substrate. In future it would be interesting to examine whether 
vimentin is phosphorylated by PKC also in vivo and whether this phosphorylation 
affects the vimentin filament structure. It is tempting to speculate that the Cdk5-mediated 
nestin disassembly would be accompanied by the PKC-dependent regulation of 
vimentin to accomplish the extensive IF reorganization characteristic to myoblast fusion. 
Furthermore, taking into account the described interaction between PKC and K10 
(Paramio et al., 2001), it would be worth exploring whether the nestin/vimentin IFs 
control the PKC-dependent regulation of p35 through scaffolding.        
 
In addition to the structural modifications, we decided to dissect the effect of the PKC-
Cdk5 signaling pathway on nestin protein levels in differentiating C2C12 and primary 
myoblasts. Contrary to the stabilization of nestin upon Cdk5 inhibition in stressed 
neuronal progenitor cells, we discovered a remarkable decrease in nestin protein 
amount at 48 and 72 hours of differentiation when the PKC-Cdk5 signaling axis was 
inhibited by the PS inhibitor or PKC downregulation (Figure 4B-C, II, Figure 6B, III). In 
our previous work we did not detect as drastic changes in nestin protein amount 
following the Cdk5 inhibition (Sahlgren et al., 2003) but this could derive from 
experimental differences. Cdk5 inhibitor was applied on cells 24 hours before harvesting 
to focus on the effects of Cdk5 on nestin reorganization (Sahlgren et al., 2003) while the 
PS-treatment was initiated simultaneously with differentiation. Later on we confirmed 
that also long-term Cdk5 inhibition by Roscovitine or by transfection of dnCdk5 leads to 
decreased nestin protein amounts in differentiating myoblasts (Figure 6C, III). Hence, 
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the inhibition of the PKC-Cdk5 signaling cascade appears to have a prominent effect 
not only on nestin reorganization but also on nestin stability. Using an antibody 
recognizing the phosphorylated T316 on nestin C-terminus we detected stabilization in 
the amount of phosphorylated nestin during the late stages of myoblast differentiation 
when the overall nestin protein levels had started to decline (Figure 6A, III). This result is 
in agreement with the data from Cdk5 inhibition experiments and renders the Cdk5-
dependent phosphorylation of nestin a critical determinant of nestin stability in 
differentiating myoblasts. In our previous report we observed that nestin phosphorylated 
on T316 is almost completely absent from the pelletable protein fraction containing 
filamentous IF proteins (Sahlgren et al., 2003). Therefore, the Cdk5-mediated 
phosphorylation of nestin upon myogenic differentiation could be hypothesized to protect 
the solubilized nestin from degradation while nestin filaments undergo reorganization.     
 
In our experimental model systems, Cdk5 appeared to regulate the stability of nestin 
with opposing influences. Cdk5 had a degradation-promoting role in stressed neuronal 
progenitor cells but an apparent stabilizing effect in differentiating myoblasts. Since we 
have not so far achieved a complete understanding of the Cdk5-mediated 
phosphorylation of nestin concerning the phosphorylation sites and the specific effects of 
phosphorylation on each particular site, we can not rule out that there might be 
differences in the nestin phosphorylation profile and, therefore, in the outcome of Cdk5-
mediated nestin phosphorylation in different circumstances. In addition, the 
phosphorylation of K8 on S74 has been depicted to protect K8 from ubiquitylation and 
proteasomal degradation (Ku et al., 2000) but in response to shear stress, the same 
phosphorylation site triggers the proteosomal degradation of K8 in alveolar epithelial 
cells (Jaitovich et al., 2008). These reports further emphasize the significance of the 
biological context in determining the role of posttranslational modifications and protein 
fate. Different biological processes trigger distinct signaling pathways indicating that, for 
example, the Cdk5-dependent regulation of nestin could be supplemented with context-
specific signaling events participating in the determination of nestin stability.   
 
 
3.3 Neuromuscular junction-associated signaling regulates nestin in a 
Cdk5-dependent manner  
 
NMJs originate from the innervation of skeletal muscle. Agrin and NRG, released by the 
innervating neuron, have been implicated as important regulators of synaptogenesis 
controlling the organization of receptor clusters and NMJ specific gene expression 
respectively (Henriguez et al., 2008, Herndon & Fromm, 2008). Although nestin 
expression is downregulated in adult muscle, a portion of nestin remains specifically at 
the NMJs in an innervation-specific manner (Vaittinen et al., 1999). A close association 
between nestin and p35 is characteristic for NMJs alluding to the nestin-mediated 
scaffolding of Cdk5/p35 to junctions (Sahlgren et al., 2003). In fact, Cdk5 has been 
implicated to function at the NMJs. It is activated by NRG and critically regulates the 
activation of ErbBs, receptor tyrosine kinases through which NRG ensures the NMJ-
specific gene expression (Fu et al., 2005). We decided to explore whether the 
synaptogenesis-mimicking signaling regulates nestin protein levels. Considering our 
results revealing the Cdk5-dependent nestin stabilization in differentiating myoblasts, we 
wanted to address also the possible role of Cdk5 in the accumulation of nestin at the 
NMJs. C2C12 myoblasts were induced to differentiate and fuse to myotubes and treated 
with agrin followed by a treatment with NRG. The results demonstrated an augmentation 
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in the protein amount of nestin upon NRG stimulus (Figure 16A). The accumulation of 
nestin was hampered by the Cdk5 inhibition (Figure 16B) suggesting that the agrin/NRG-
signaling regulates nestin expression and stability at the NMJs in a Cdk5-dependent 
manner. Thus, it appears that Cdk5 could modulate its own targeting and activity by 
determining the nestin protein levels. Currently we are examining whether the effect of 
Cdk5 on nestin is due to the posttranslational modulation of nestin, affecting nestin 
stability, or stemming from an ErbB-induced increase in nestin expression. It seems that 
the increase in nestin protein levels is due to stabilization as RT-PCR analysis does not 
point to changes in nestin mRNA production (data not shown).  
 
Cdk5 has also been depicted as being essential for the dispersion of AChR clusters that 
have not been innervated (Figure 10; Lin et al., 2005). Lin and colleagues (2005) 
presented a hypothesis that the Cdk5-mediated nestin phosphorylation leading to nestin 
reorganization could be a way to modulate the receptor organization, thus further 
underlining the dynamic interrelationship between nestin and Cdk5 at the NMJs. This 
hypothesis stems from the observation showing that due to the denervation of adult 
skeletal muscle nestin becomes spatially distributed from NMJs (Vaittinen et al., 1999), a 
phenomenon that could result from the phosphorylation-mediated reorganization of 
nestin. To summarize, the interplay between nestin and Cdk5 at the NMJs appears 
complex. Cdk5 may control its anchoring to NMJs through the regulation of nestin 
stability (Figure 16) but may also disperse the unwarranted receptor complexes by 
modulating the nestin organization (Lin et al., 2005). Thorough understanding of the 
different outcomes of Cdk5-dependent regulation of nestin at the NMJs requires a 
comprehensive insight into the effects of the Cdk5-mediated phosphorylation of nestin.     
 
 
 
 
 
 
 
Figure 16. Agrin and NRG regulate nestin in a 
Cdk5-dependent manner. (A) C2C12 cells were 
induced to differentiate for 96 hours and treated with 
10 ng/ml agrin overnight (16h) followed by a treatment 
with 50 ng/ml NRG for indicated times. Nestin protein 
levels were detected by Western blotting. Hsc70 was 
used as a loading control. (B) C2C12 cells were 
induced to differentiate for 120 hours and treated with 
10 ng/ml agrin overnight (16h). After careful rinsing 10 
or 20 µM Roscovitine was added to cells 30 min prior 
to the addition of NRG (50 ng/ml). Cell lysates were 
harvested 12 hours after NRG induction and subjected 
to Western blotting. Vimentin was used as a control to 
confirm the specific effect of agrin/NRG-treatment on 
nestin.   
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4 Onset and pace of myogenic differentiation are controlled by 
nestin (III) 
 
Transient is perhaps the most apparent word to be used when describing the expression 
pattern of nestin. Nestin is present in stem and progenitor cells of various tissues but 
becomes downregulated and replaced by tissue specific IF proteins in the course of 
differentiation (Figure 17; Lendahl et al., 1990, Sejersen and Lendahl, 1993, Kachinsky 
et al., 1995, Fröjdman et al., 1997, About et al., 2000, Selander and Edlund, 2002, Chen 
et al., 2006, Bertelli et al., 2007). Due to this highly specific expression profile nestin 
could be assumed to define the general features of progenitor cells, such as increased 
viability, proliferation potential and capacity to migrate. In fact, as implicated in previous 
chapters, nestin is involved in protecting precursor cells from programmed cell death 
(Bieberich et al., 2003, I), regulating the cell cycle progression (Reimer et al., 2009) and 
mediating the motile properties of cells (Kleeberger et al., 2007). An alternative function 
of nestin in developing tissues could be either to maintain the undifferentiated state of 
progenitor cells or to regulate the differentiation process itself, with special impact on 
timing, induction, and progression. According to our knowledge, the role of nestin in 
progenitor cell differentiation has not been addressed.        
 
 
 
4.1 Downregulation of nestin accelerates myoblast differentiation (III) 
 
We decided to utilize differentiating myoblasts as a model system to investigate the 
effect of nestin on cell differentiation. We downregulated nestin both in C2C12 myoblast 
cell line and in primary myoblasts derived from neonatal limb muscles. Myoblasts were 
induced to differentiate by serum withdrawal and the progress of differentiation was 
monitored. Downregulation of nestin was efficient and did not have any major effects on 
vimentin protein amounts (Figure 1C, III). Interestingly, nestin depletion appeared to 
have an effect on myoblast differentiation that was significantly accelerated. Nestin 
downregulated cells were more aligned and elongated compared to the cells transfected 
with scrambled oligos (Figure 1A, III). The cell cycle withdrawal of nestin-depleted cells 
was more efficient as indicated by the increased amounts of CKIs p21 and p27 (Figure 
1B and Supplementary figure 2A, III). Furthermore, the expression of MRF myogenin as 
myogenin
MHC
nestin
Hsc70
desmin
vimentin
0    24    48    72    96   120   144 
hours of differentiation
troponin
Figure 17. Dynamic expression pattern of nestin 
during the differentiation of C2C12 myoblasts. C2C12 
myoblasts were induced to differentiate and samples for 
Western blot analysis were harvested at indicated time 
points. Nestin expression displays the characteristic 
pattern where the protein levels peak during the myotube 
formation at 72 hours of differentiation. Desmin, 
myogenin, troponin, and MHC were used to monitor the 
progress of differentiation. Hsc70 served as a loading 
control. 
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well as the late myogenic markers troponin and MHC was clearly augmented (Figure 1C 
and Supplementary figure 2B, III).  
 
The specific influence of cytoplasmic IF proteins on development has not been 
extensively studied but some interesting observations have been presented. 
Downregulation of muscle-specific IF protein desmin was indicated already years ago to 
have detrimental impact on myogenesis as the RNAi-based inhibition of desmin in 
C2C12 myoblasts perturbed differentiation (Li et al., 1994). Desmin KO mice are unable 
to maintain the proper muscle architecture and show severe disruption of muscle tissue 
with signs of degeneration increasing in the course of time indicating problems in muscle 
regeneration (Milner et al., 1996, Capetanaki et al., 1997). The most abundant glial cells, 
astrocytes, are known to modulate the differentiation of neuronal stem cells in 
neurogenic regions of adult brain. When neuronal stem cells were cocultured with 
astrocytes depleted of vimentin and GFAP, stem cells were observed to show enhanced 
neurogenesis suggesting that the IF network is elemental in determining the signaling 
cues provided by astrocytes (Widestrand et al., 2007). These findings, pointing to the 
role of IFs as regulators of differentiation, substantiate our data. The opposite outcomes 
of IF modulation in the presented examples, however, may be explained by the cell-
specific functions of different IF proteins.      
 
We would have been very eager to try to corroborate our results in vivo but, 
unfortunately, the nestin KO mice are not commonly available yet. IF protein vimentin, 
however, is implicated as a specific polymerization partner of nestin which alone is 
unable to form filaments (Steinert et al., 1999). Hence, we decided to isolate primary 
myoblasts from vimentin KO mice for differentiation analysis as previous studies have 
shown that the absence of nestin polymerization partner affects both nestin protein 
amount and assembly-state (Eliasson et al. 1999). We hypothesized that the ablation of 
vimentin would have consequences on nestin polymerization, thus affecting the 
mechanical and non-mechanical properties of nestin whereupon vimentin KO myoblasts 
could be used as an interim model for nestin effects. Indeed, we observed that the 
vimentin-deficient myoblasts were more prominently withdrawn from the cell cycle and, 
in a corresponding manner, showed elevated expression of the differentiation markers 
desmin and troponin (Figure 3A-B, III). Total nestin protein amount increased during 
differentiation but, contrary to our presumptions, there was no major difference in nestin 
protein levels between WT and KO myoblasts (Figure 3A, III). The ablation of vimentin 
has been reported to result a substantial decrease in nestin protein amount in primary 
astrocytes despite a considerable increase in nestin expression (Eliasson et al. 1999). 
This implies that the regulation of nestin in the absence of vimentin would be 
posttranslational. Therefore, our results showing rather equal amount of nestin both in 
WT and vimentin KO myoblasts could be interpreted to derive from the muscle specific 
posttranslational mechanism increasing the stabilization of nestin. The PKC-Cdk5 
signaling axis could be postulated to answer for nestin stability during myoblast 
differentiation. Alternatively, the unaltered nestin protein levels could be explained by the 
ability of the existing IF protein desmin to stabilize nestin (Sjöberg et al., 1994b). If the 
latter option appears to be correct, it remains to be investigated whether nestin 
heteropolymerizes with desmin and how the putative nestin/desmin filaments would 
differ from nestin/vimentin structures especially in terms of non-mechanical properties. 
Nevertheless, our data clearly suggests that the modulation of either nestin protein 
amount or nestin filament structure affects the progress of myogenic differentiation.       
 
Results and Discussion 
88 
The onset of myoblast differentiation provides an efficient cell cycle arrest and, therefore, 
increased differentiation is often associated with reduced proliferation rate. The cell cycle 
withdrawal and myogenic differentiation are regulated by a diverse range of intracellular 
signaling mechanism. For example, the attenuation of the leukemia inhibitory factor-
stimulated JAK1–STAT1–STAT3 pathway inhibits myoblast proliferation and accelerates 
differentiation (Sun et al., 2007). Signaling launched by TGF- significantly increases 
proliferation, thereby incurring a delay in differentiation (Schabort et al., 2009). Inspired 
by the surveys pointing to the importance of nestin for cell proliferation (Mokrý et al., 
2004, Daniel et al., 2008, Huang YL et al., 2009a, Xue and Yuan, 2010) we sought to 
understand if the enhanced differentiation of nestin-depleted myoblasts correlated with 
the reduced proliferation rates. However, we did not detect any difference in cell 
proliferation between nestin-downregulated and control myoblasts measured by 
metabolic MTS assay (a measure of metabolic activity which in turn can be used as a 
cell number indicator) and the protein amounts of cellular proliferation markers Ki-67 and 
PCNA (Figure 1D-E, III). Moreover, nestin depletion did not lead to a precocious cell 
cycle withdrawal prior to the induction of differentiation with serum removal (Figure 1E, 
III). We also analyzed the migrational properties of nestin-deficient myoblasts as 
migration is critical for myoblasts to become dispersed in developing and regenerating 
muscle as well as to move towards their fusion partners (reviewed by Rochlin et al., 
2010). Extracellular factors such as chemoattractants are implied to function as cues to 
myoblasts. SDF-1 and its receptor CXCR4 are associated with chemotaxis of a variety 
of cell types including myoblasts (Ödemis et al., 2007, Bae et al., 2008). However, we 
did not discern changes in the migratory response of nestin downregulated cells towards 
SDF-1 in Transwell migration assays compared to cells targeted with scrambled oligos 
(Figure 18). Neither scratch wound assays gave any difference between nestin-depleted  
and control cells (Figure 18). These results indicate that the main regulatory function of 
nestin is not to maintain the undifferentiated state of myoblasts or modulate the motility 
of myoblasts but relates to the differentiation process that has already been 
commenced. More specifically, nestin-depleted myoblasts do not become subjected to 
spontaneous differentiation but require additional differentiation-mediating cues from 
signaling related to serum deprivation and cell-cell adhesion.  
 
Figure 18. Downregulation of nestin does not affect the migrational abilities of undifferentiated 
myoblasts. (A) Nestin was downregulated in C2C12 myoblasts and the myoblasts were induced to migrate 
towards 10 ng/ml SDF-1 in Transwell inserts. Results are presented as relative cell migration and 
illustrated by GraphPad Prism. (B) Nestin-depleted C2C12 myoblasts were let to proliferate until reaching 
the confluence. Confluent monolayers were wounded using a pipette tip and images were captured at 
indicated time points to analyze the ability of myoblasts to migrate to wounded area.  
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To confirm our hypothesis about the role of nestin in determining the pace of myoblast 
differentiation we decided to make an attempt to delineate the reverse situation. To 
obtain stable levels of overexpressed nestin we transiently transfected C2C12 myoblasts 
with the N-terminal nestin deletion mutant containing the first 640 amino acids. The 
manipulation of myoblasts by the overexpression of nestin had a dramatic effect on 
differentiation as it almost completely inhibited the differentiation process (Figure 2, III). 
Cell cycle withdrawal was less efficient among nest-640 transfected myoblasts and the 
expression of myogenic differentiation markers remained low (Figure 2C-D, III). These 
analyses further strengthen the concept of nestin as a regulator of myoblast 
differentiation.    
 
Studies aimed at delineating the cellular functions of nestin have been hampered by the 
lack of nestin KO mouse. This mouse model could be utilized to further investigate the 
role of nestin during besides embryonic but also injury-related regenerative myogenesis. 
The adult myogenesis is stated to differ from embryonic muscle development in terms of 
the gene expression profile of satellite cells and the physiological environment i.e. niche 
where the satellite cells differentiate (Lepper et al., 2009, Wang and Conboy, 2010). 
Moreover, as vimentin, desmin and GFAP, all coexpressed with nestin, are suggested to 
have a prominent effect on regenerative processes (reviewed by Capetanaki et al., 
1997, Ivaska et al., 2007, Pekny and Lane, 2007), it would be worthwhile to assess the 
progress of satellite cell differentiation and the restoration of muscle architecture as well 
as how the muscle strength is recovered in injured muscle depleted of nestin. Despite 
the impaired regeneration, the ablation of vimentin or GFAP does not appear to disturb 
development (Colucci-Guyon et al., 1994, Pekny et al., 1999). It is interesting to see 
whether the same paradigm, more or less normal development but unfavorable outcome 
of regeneration, is repeated in nestin KO mice. Furthermore, what comes to the possible 
other functions of nestin, the features of programmed cell death have been related to 
myogenesis (Fernando et al., 2002). Therefore, an obvious question arising is whether 
nestin operates as a survival factor also in myogenic precursor cells similarly than in 
neuronal progenitors (I). More generally, considering the expression patterns of nestin 
being mainly restricted to progenitor cells, it would be intriguing to investigate whether 
the functions of nestin in developmental/regenerative processes are widespread and 
dissect whether nestin plays a role also in neuronal differentiation.  
 
 
4.2 Nestin depletion increases the p35 processing in differentiating 
myoblasts (III)  
 
Hitherto we have revealed that the interaction between nestin and the Cdk5/p35 
complex is dynamic and suggested that there might be a Cdk5-dependent turnover of 
p35 on nestin scaffold in myoblasts induced to differentiate (Sahlgren et al., 2003). As a 
continuation on our efforts to delineate the role of nestin as a Cdk5/p35 scaffold we 
decided to assess the influence of nestin on the cleavage of p35 to p25 that was proven 
critical for the sustained Cdk5 activity in differentiating myoblasts (II). In neuronal 
progenitor cells exposed to Cdk5-dependent apoptosis, the overexpression of nest-640 
was observed to have a survival promoting effect due to the sequestration of the 
Cdk5/p35 signaling complex and diminished generation of the more stable activator 
protein p25 (I). We decided again to elevate nestin expression with nest-640 and disturb 
the normal equilibrium between soluble and filamentous nestin in myoblasts. 
Consistently, we observed that nest-640, while inhibiting myoblast differentiation, 
sequestered Cdk5 (Figure 4C, III) and caused clear perturbations in the formation of p25 
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under differentiation promoting conditions (Figure 5A, III). Conversely, upon nestin 
silencing the amount of p25 generated was considerably increased arguing that the 
nestin scaffold regulates the cleavage of p35 to p25 (Figure 5B, III).  
 
We determined to follow in more detail the Ca2+/Calpain-dependent processing of p35 in 
the presence of nest-640 and came to a conclusion that most likely the small pool of 
nest-640 remaining soluble is responsible for protecting p35 from calpains (Figure 5C-E, 
III). We surmised that the soluble nest-640 facilitates the formation of the Cdk5/p35 
complex through sequestration more efficiently than the filamentous nestin, thereby 
attenuating the p35 processing. Given these results and the increased differentiation of 
vimentin KO myoblasts, it could be speculated that nestin residing in vimentin KO cells is 
perhaps not entirely soluble but instead forms structures which, however, are unable to 
control the Cdk5/p35 complex and, thereby differentiation. In conclusion, our data 
depicts nestin as a potent effector of the Cdk5/p35/p25 signaling pathway and 
strengthens our primary findings presenting nestin as a key determinant affecting the 
p25 generation (I). The expression of nestin could be postulated critical for controlling 
physiological, non-detrimental cellular events requiring the p25-boosted Cdk5 activity by 
limiting the processing of p35. In addition, these results point to the power of soluble IF 
pool over signaling determinants, a subject that has not been extensively explored. Next 
step in our studies is to resolve whether the nestin-mediated sequestration of p35 in 
differentiating myoblasts regulates the PKC-dependent phosphorylation of p35 or 
protects the phosphorylated p35 form calpain attack or, alternatively, does the protection 
of p35 stem from a regulatory mechanism still unidentified.          
 
 
4.3 Nestin and Cdk5 cooperate in promoting differentiation (III) 
 
The substantial influence of nestin on the p35 processing indicated that nestin and Cdk5 
function in the same pathway promoting differentiation. We sought to unravel this 
question by inhibiting Cdk5 in nestin-depleted myoblasts. Indeed, we were able to 
reverse the accelerating effect of nestin downregulation by the overexpression of 
dnCdk5 or inhibiting Cdk5 activity with Roscovitine (Figures 4A-B, III). The progress of 
differentiation was verified by immunoblotting myogenin, troponin and MHC. This 
observation together with the results showing the dependence of nestin stability and 
reorganization on the PKC-Cdk5 signaling cascade support a model where Cdk5 
operates both upstream and downstream of nestin. While nestin elevation is dependent 
on Cdk5 activity, nestin will, once elevated, affect the activity of Cdk5 (Figure 19). Thus, 
the role of nestin in differentiating myoblasts could perhaps be to tightly regulate the 
accuracy of myoblast differentiation by affecting the timing, location and intensity of 
Cdk5 activity. Based on our data, we suggest that a strict PKC-Cdk5-dependent control 
of nestin stability and polymerization in fusing myoblast is essential as nestin appears to 
have a pronounced effect on the Cdk5/p35 complex and differentiation.    
 
The profound regulatory effect of nestin on the induction of myogenesis can be observed 
already during the very early phases of differentiation. Therefore, it seems evident that, 
in addition to Cdk5, nestin could influence redundant signaling pathways. Myogenesis is 
regulated by a diverse range of signaling events and it is not hard to envision nestin as a 
recognized protein scaffold with precisely controlled expression pattern during myoblast 
differentiation to be involved also in other signal transduction pathways. The long C-
terminal domain of nestin could be pictured to interact with signaling proteins similarly 
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than the long tail domain of synemin which has been described to directly associate with 
structural proteins, -actinin, vinculin and talin, in muscle tissue (Bellin et al., 1999, Sun 
N et al., 2008a, 2008b). Building a detailed hypothesis or direct linking of nestin to a 
particular pathway, however, is more demanding. The Notch signaling pathway is 
extensively studied and evolutionary conserved signaling mechanism that has been 
implicated critical in cell fate decisions during development and differentiation in several 
tissues including muscle (Schuster-Gossler et al., 2007, Vasyutina et al., 2007). In 
myogenic precursor cells the Notch cascade has been described to inhibit the 
differentiation through the activity of Notch effectors, transcriptional repressors of Hey 
family, which hamper the expression of MRFs (Buas et al., 2010). Avian ortholog of 
nestin, transitin, has been associated with the Notch signaling in neuronal system as it 
through a direct interaction regulates the stability and the subcellular localization of 
Numb, a negative regulator of Notch (Wakamatsu et al., 2007). Thus, it would be 
interesting to analyze the role of nestin in myogenic Notch signaling. The Wnt pathway is 
another signaling cascade driving the differentiation of myoblasts during regeneration 
(Brack et al., 2008). We have got indications of a possible interaction between nestin 
and the Wnt effector -catenin during the myoblast differentiation process which could 
implicate an involvement of nestin in the Wnt pathway (data not shown). However, 
further experiments are required to solidly link nestin in this signaling machinery. A 
specific analysis of nestin interaction partners with the help of immunoprecipitation and 
mass spectrometry would definitely provide great benefits for nestin studies besides in 
myoblasts but also in other nestin expressing cell and tissue types.   
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Figure 19. Dynamic interplay between 
nestin and the PKC-Cdk5 signaling axis 
in differentiating myoblasts. Nestin 
regulates the progress of myoblast 
differentiation by controlling the Cdk5/p35/p25 
signaling complex through sequestration. The 
processing of p35 to p25 is critically affected 
by the nestin scaffold. The interrelationship 
between nestin and Cdk5 is bidirectional as 
the PKC-Cdk5 signaling cascade regulates 
the nestin stability and reorganization during 
myoblast differentiation. 
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CONCLUDING REMARKS 
 
 
The last decade of research has broadened the view of IF functions previously 
considered solely mechanical. The intriguing ability of IFs to modulate the localization 
and activity of a variety of signaling determinants through scaffolding has proven IFs to 
be regulators of cell signaling. This feature provides perhaps an explanation for the 
multimember IF protein family arguing that IFs could function as specialized regulatory 
elements for distinct cell types and physiological processes. Understanding the role of 
IFs in signal transduction not only provides insight into the specific IF functions but also 
places IFs in an interesting position where the modulation of IF expression or structure 
could be hypothesized as a mechanism to regulate cell signaling.  
 
An earlier work from our laboratory had characterized an interaction between IF protein 
nestin and the Cdk5/p35 signaling complex. Therefore, in this PhD thesis a strong 
emphasis was placed on clarifying the functional significance of nestin in the regulation 
of the Cdk5/p35 complex. Using oxidative stress-induced neuronal apoptosis as a model 
system we revealed a prominent antiapoptotic function of nestin deriving from the 
regulation of detrimental Cdk5 activity. Through its ability to anchor the Cdk5/p35 
signaling complex, nestin regulated the turnover of p35, the calpain-mediated processing 
of p35 to a more stable activator, p25, and the subcellular localization of the Cdk5/p35 
complex, thereby having a profound influence on Cdk5 activity.       
 
Myogenic development is another physiological process characterized by the 
concomitant nestin expression and Cdk5 activity. During the work of this thesis we 
succeeded in elucidating the upstream regulatory mechanisms of Cdk5 in differentiating 
myoblasts by illustrating PKC as a master controller of Cdk5 activity. By means of p35 
phosphorylation and calpain activation, PKC promoted the calpain-mediated cleavage 
of p35 to p25, thus enhancing Cdk5 activity. These results expand the understanding of 
the regulatory mechanisms governing Cdk5 activity. More importantly, our data 
challenges the current dogma of p25 considered primarily responsible for the 
uncontrolled and harmful Cdk5 activity during stress and disease, by indicating the utility 
of p25 when prominent but temporary Cdk5 activation is required. While analyzing the 
regulation of Cdk5 we made an effort towards understanding the functions of nestin in 
myogenesis. We observed that the onset and pace of myoblast differentiation were 
significantly accelerated upon nestin downregulation. The absence of nestin scaffold 
induced a substantial increase in the generation of p25 indicating that the nestin scaffold 
sets the pace for myoblast differentiation by affecting Cdk5 activity. Moreover, we 
detected a dynamic crosstalk between nestin and the PKC-Cdk5 signaling axis in 
differentiating myoblasts. While nestin appeared to determine the Cdk5 activation, nestin 
reorganization and stability where dependent on the PKC-Cdk5 signaling cascade 
referring to the ability of Cdk5 to modulate its own activity by regulating the stability and 
assembly-state of the nestin scaffold. Taken together, my PhD thesis provides novel 
information of the regulation of Cdk5 introducing nestin and PKC as key determinants. 
Forthcoming studies are warranted to define whether this knowledge is of relevance also 
in the context of CNS development and functionality or neurodegenerative disorders 
typified by Cdk5 activity.  
 
In this PhD thesis we implemented the analysis of nestin functions in neuronal stress 
and in myogenesis by using the RNAi technology. We depicted the remarkable ability of 
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nestin to regulate the progenitor cell fate by affecting critical progenitor cell features, 
stress tolerance and potential to differentiate, through the scaffolding of the Cdk5/p35 
complex. During the course of these studies a nestin KO mouse was generated and is 
currently under analysis. Detailed dissection of development and tissue regeneration in 
nestin KO mice not only in terms of the Cdk5/p35 signaling complex but also other 
cellular factors would greatly benefit the endeavors to characterize the cellular functions 
of nestin.   
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